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Study of the Term Neonatal Brain Injury with combined Diffuse Optical 
Tomography and Electroencephalography  
 
Dr Maria Chalia 
 
This thesis describes the application of combined diffuse optical tomography (DOT) and 
electroencephalography (EEG) in the investigation of neonatal term brain injury. With 
hypoxic ischaemic encephalopathy (HIE) and perinatal stroke being the most frequent 
contributors to brain injury in the term neonatal population, the first part of the thesis 
focuses on the description and ongoing requirement for their further investigation. In 
continuation to that, the characteristics and unique properties of both DOT and EEG are 
described and explored.  
The combination of these two modalities was utilised in elucidating the 
relationship between neuronal activity and cerebral haemodynamics both in physiological 
processes as well as in disease, by the infant’s cot side. This work differs to previous 
studies using near-infrared technologies and EEG, as a denser whole head array was used, 
offering the potential of 3-dimensional image reconstruction of the cortical 
haemodynamic events in relation to electro-cortical activity. These methods were applied 
in the study of critically ill infants presenting with seizures in the first few days of life.  
The relevant results are presented in three separate chapters of the thesis. Distinct 
neurophysiological phenomena such as seizures and burst suppression were detected and 
studied in association to underlying HIE. On the grounds of a pre-existing pilot study of 
our research group, distinct prolonged de-oxygenated cortical areas were identified 
following electrical seizure activity. Further exploration of infants with seizures provided 
limited supporting evidence. The investigation of burst suppression in HIE led to the first 
ever identification of repeated, waveform, cortical haemodynamic events in response to 
bursts of electrical activity with some spatial correlation to regions of brain injury. Further 
analysis of the low frequencies within the diffuse optical signal in cases of perinatal 
stroke, showed a consistent interhemispheric difference between the healthy and stroke-
affected brain regions.  
The limitations, prospects and conclusions are presented in the final chapter. The 
use of simultaneous DOT and EEG offers a unique neuro-monitoring and neuro-
investigating tool in the neonatal intensive care environment, which is safe, portable, and 
cost-effective, Ongoing research is required for the exploration and development of the 
methodology and its potential diagnostic properties. 
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The only true wisdom is in knowing you know nothing 
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Preface and specified in the text. 
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concurrently submitted for a degree or diploma or other qualification at the University of 
Cambridge or any other University or similar institution except as declared in the Preface 
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EEG data.  
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Abstract 
This thesis describes the application of combined diffuse optical tomography (DOT) and 
electroencephalography (EEG) in the investigation of neonatal term brain injury. With 
hypoxic ischaemic encephalopathy (HIE) and perinatal stroke being the most frequent 
contributors to brain injury in the term neonatal population, the first part of the thesis 
focuses on the description and ongoing requirement for their further investigation. In 
continuation to that, the characteristics and unique properties of both DOT and EEG are 
described and explored.  
The combination of these two modalities was utilised in elucidating the 
relationship between neuronal activity and cerebral haemodynamics both in physiological 
processes as well as in disease, by the infant’s cot side. This work differs to previous 
studies using near-infrared technologies and EEG, as a denser whole head array was used, 
offering the potential of 3-dimensional image reconstruction of the cortical 
haemodynamic events in relation to electro-cortical activity. These methods were applied 
in the study of critically ill infants presenting with seizures in the first few days of life.  
The relevant results are presented in three separate chapters of the thesis. Distinct 
neurophysiological phenomena such as seizures and burst suppression were detected and 
studied in association to underlying HIE. On the grounds of a pre-existing pilot study of 
our research group, distinct prolonged de-oxygenated cortical areas were identified 
following electrical seizure activity. Further exploration of infants with seizures provided 
limited supporting evidence. The investigation of burst suppression in HIE led to the first 
ever identification of repeated, waveform, cortical haemodynamic events in response to 
bursts of electrical activity with some spatial correlation to regions of brain injury. Further 
analysis of the low frequencies within the diffuse optical signal in cases of perinatal 
stroke, showed a consistent interhemispheric difference between the healthy and stroke-
affected brain regions.  
The limitations, prospects and conclusions are presented in the final chapter. The 
use of simultaneous DOT and EEG offers a unique neuro-monitoring and neuro-
investigating tool in the neonatal intensive care environment, which is safe, portable, and 
cost-effective, Ongoing research is required for the exploration and development of the 
methodology and its potential diagnostic properties.  
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Project Rationale and Aims 
The combination of multi-channel near-infrared diffuse optical tomography (DOT) and 
electroencephalography (EEG) offers the ability to study the vascular changes of the 
surface of the brain (cortex) and electrical brain activity. This makes it possible to study 
the relationship between cortical haemodynamics and electrical activity known as 
neurovascular coupling. 
A previous pilot study examining the neurovascular coupling of neonatal seizures, 
conducted by the group, demonstrated the significance of combining DOT and EEG in 
detecting cortico-vascular changes in a newborn infant with hypoxic ischaemic 
encephalopathy (HIE). Distinct cortical haemodynamic changes were identified in 
relation to recurrent electroencephalographic seizures.  
Therefore, this MD project is based on the use of combined DOT and EEG in the 
investigation of brain injury in the term neonatal population, with focus on the two, 
commonest such clinical entities, hypoxic ischaemic encephalopathy (HIE), and cerebral 
infarction.  
The principal two aims of this project were to continue to investigate term 
newborn infants presenting with seizures and to demonstrate the practicality and readily 
available use of combined DOT-EEG at the cot side in the neonatal intensive care unit.  
The objectives of the project as presented in chapters 4, 5 and 6 were the 
following: 
• To investigate and improve the understanding of the potential cortical 
haemodynamic changes measured by DOT during neonatal seizures as detected 
by EEG. 
• To investigate the cortical haemodynamic changes in relation to other 
neurophysiological phenomena seen in cases of HIE and neonatal 
encephalopathy, such as discontinuous cortico-electrical activity and/or burst 
suppression.  
• To explore the potential of DOT-EEG in the detection of uni-hemispheric 
perinatal stroke.  
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1.1 Neonatal Encephalopathy and Seizures 
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1.1 Neonatal Encephalopathy and Seizures  
A wide range of pathologies comes under the umbrella of brain injury in the term, 
neonatal population. Neonatal encephalopathy is a clinical expression of deranged brain 
function in the term infant manifesting in the early postnatal phase. It is characterised by 
a decreased level of consciousness and/or seizures and may be associated with respiratory 
distress or depression, abnormal tone, and reflexes (1). It may be the consequence of a 
hypoxic-ischaemic insult. However, there are other conditions which can be attributed to 
an infant being encephalopathic in the neonatal period, such as metabolic conditions, 
maternal drug abuse, and cerebral infarction. The conditions associated with neonatal 
encephalopathy are also associated with neonatal seizures; however, one needs to make 
the distinction that not all infants with encephalopathy present with seizures and not all 
infants presenting with seizures are encephalopathic.  
Seizures are one of the commonest neurological presentations in the neonatal 
period with varied evolution of clinical semiology and symptoms. Therefore, their 
aetiology has almost become synonymous to the aetiology of term, neonatal brain injury 
(see Table 1.1). In term and near-term infants, the dominant causes are hypoxic ischaemic 
encephalopathy (HIE) and cerebral infarction. Their incidence does vary slightly 
depending on access to maternal and neonatal services amongst low, middle, and high-
income countries.  
The incidence of neonatal seizures has been reported between 0.5 to 5 per 1,000 
live births (2-4), predominantly occurring in the first few days of postnatal life. Older 
studies were purely based on clinical observation with a mixed population of different 
gestational age (GA) and postconceptional age. Other studies were based on prolonged 
amplitude-integrated electroencephalography (aEEG) recordings with variation in the GA 
of infants and underlying clinical pathologies. Using this methodology, the number 
reported is approximately 2 in 1,000 live born infants diagnosed with seizures with this 
figure increasing in the instance of prematurity (5, 6). In preterm infants, who were later 
found to have developed intraventricular haemorrhage (IVH), aEEG studies have shown 
occurrence of subclinical seizures in up to 75% (7, 8).   
The principal aetiological factor of neonatal seizures in both preterm and term 
infants is HIE, accounting for almost 60% of reported cases (2, 9-11). Cerebral infarction 
follows HIE in frequency in term infants. Another main factor is intracranial 
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haemorrhage, which includes cases of subarachnoid, germinal matrix, intraventricular 
and subdural haemorrhage. Intracranial infection (i.e. meningitis, encephalitis) and 
developmental defects (i.e., lissencephaly, pachygyria) account for 5-10% of cases 
respectively. Metabolic disturbances such as hypoglycaemia, hypocalcaemia, 
hypomagnesaemia, other metabolic conditions and drug withdrawal in cases of maternal 
substance abuse need to be highly considered in the differential diagnosis. There is also 
a group of miscellaneous neonatal seizure syndromes, such as benign familial neonatal 
seizures, benign idiopathic neonatal seizures, early myoclonic encephalopathy, and early 
infantile epileptic encephalopathy and others which are rarer but should be considered in 
the absence of any other aetiology and persistence of seizure activity. These aetiological 
factors are summarised in table 1.1. (please also refer to section 2.1.7 of chapter 2 for 
further details on neonatal seizures). 
Causes of Neonatal Seizures Incidence  Examples 
Hypoxic ischaemic encephalopathy 37-57.5% Grade I to III 
Ischaemic infarction or cerebral sinus 
venous thrombosis 
7-18% Middle cerebral artery infarct 
Intracranial haemorrhage 4,8-17% Subdural, subarachnoid 
Intracranial infections 3-20% Group B Streptococcal meningitis 
Metabolic or electrolyte disorders 3-19% Hypoglycaemia, Hypocalcaemia, Hypo-
or Hypernatraemia, Kernicterus 
Inborn errors of metabolism 1-11.3% Pyridoxine-dependent seizures, Glycine 
encephalopathy 
Congenital anomalies or developmental 
defects 
3.2-11.3% Lissencephaly, Schizencephaly 
Idiopathic 0.5-14% Benign familial neonatal seizures 
Intoxication 0.5% Local anaesthesia 
 
Table 1.1: Causes of neonatal seizures in the term neonatal population. This table has been 
adapted and modified based on reference (12). The incidence of the possible aetiological 
conditions for neonatal seizures was adapted from references (2, 11, 13, 14). 
Although the incidence of neonatal seizures varies depending on its cause, 
investigatory tools, and healthcare system, its importance lies in prevention, early 
diagnosis and prompt, disease specific management. The aim is to improve long term 
prognosis, as there is increasing evidence over the years that neonatal seizures adversely 
affect neurodevelopmental outcome (15-19). In that perspective, there is an increasing 
interest within neuroscience in the recognition of neonatal brain injury as a life-long 
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disease, which can potentially be managed more effectively by understanding its 
predisposing factors and mechanisms and by developing tools for early detection, specific 
diagnosis, and differentiation of disease severity. 
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1.2 Hypoxic Ischaemic Encephalopathy  
Hypoxic ischaemic encephalopathy is the result of decreased or lack of oxygen supply 
(hypoxia) and decreased blood perfusion (ischaemia) leading to disruption of cerebral 
energy metabolism (20). Hypoxia and ischaemia can occur acutely or chronically and can 
be associated with maternal factors (i.e. hypotension), cord factors (obstruction, 
prolapse), placental factors (placental insufficiency, abruption) and uterine factors 
(rupture) (21). Events in the first 28 days of postnatal life such as respiratory or cardiac 
arrest can also lead to HIE. It is interesting to note that HIE is often confused or used 
instead of the term neonatal encephalopathy which is a more descriptive term of deranged 
neurological status without assumptions on its pathogenetic mechanisms. Neonatal 
encephalopathy is called HIE if there is clear evidence of intrapartum asphyxia as the 
cause of neonatal neurological depression and/or seizures. Table 1.2 encompasses a range 
of clinical conditions which mimic intrapartum asphyxia and infants may present as 
depressed or encephalopathic (21). 
Condition Examples 
Neonatal Sepsis Group B Streptococcal septicaemia 
Congenital infections Viral, toxoplasmosis 
Neuronal migration disorders  
Congenital myotonic disorders Prader-Willi syndrome, congenital and transient 
myasthenia gravis 
Lung or airway disorders Pneumothorax, congenital diaphragmatic hernia 
Metabolic conditions Non-ketotic hyperglycinaemia 
Extracranial trauma Subgaleal haemorrhage, subdural haematomas 
Genetic disorders associated with thrombotic 
or thrombophilic abnormalities 
Protein C and S deficiencies, factor V Leiden 
deficiency 
Table 1.2: Conditions causing neonatal depression and/or neonatal encephalopathy that 
mimic intrapartum asphyxia. This table was adapted from reference (21).  
The difference in population demographics, healthcare availability and a lack of 
a unified, global use of terminology and definition in reporting and investigating HIE 
leads to a wide range in incidence from 1 to 8 per 1,000 live births (22), with more recent 
population studies reporting an incidence of 1.5 per 1,000 live births  (23). Global 
estimations on birth asphyxia related deaths vary from 0.7 to 1.2 million per year (24). A 
history of perinatal asphyxia is strongly associated with life-long sensorineural 
impairment and neuro-disability (25, 26). HIE remains the leading cause of acquired brain 
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injury and neuro-disability in the term neonatal population in both the developed and 
developing world (27).  
An understanding of the pathophysiology of HIE comes from a combination of 
clinical observations and animal studies. Based on animal work (28), the initial response 
to hypoxia in the foetus results in redistribution of the blood circulation to vital organs 
such as the heart and the brain. The heart rate decreases to minimise myocardial work but 
at the same time, maintaining circulation in the vital organs. Further hypoxia leads to 
metabolic acidosis and finally cessation of circulation to all organs including heart and 
brain.   
 
Figure 1.1: Schematic representation of the cascade of events following hypoxia-ischaemia 
hours to days post initial insult. Note the progressiveness of the insult months after the initial 
event (ROS stands for reactive oxygen species). Adapted from reference (29). 
The pathophysiological mechanisms of brain injury following hypoxia-ischaemia 
are based on a cascade of events following the primary hypoxic episode, known as 
primary energy failure; lack of oxygen translates into cessation of oxidative metabolism 
leading to accumulation of lactate and depletion of energy supply, which at a cellular 
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level translates into depletion of adenosine triphosphate (ATP). This leads to failure of 
the ATP dependent Na+/K+ pump. In the very severe cases there is influx of Na+ and water 
in the cell and subsequent necrosis. In the less severe cases, there is depolarisation of the 
membrane with increased extracellular accumulation of excitatory amino acids 
(glutamate) and increased intracellular Ca2+ with a subsequent gradual cascade of events 
leading to cellular apoptosis (see Fig. 1.1). The initial metabolic acidosis and increase in 
lactate results in increase in cerebral blood flow and production of ATP from phosphor-
creatinine (PCr). While acidosis progresses ATP production diminishes and 
autoregulation is lost with ultimate neuronal injury and necrosis (20).  
Classically there are two main types of brain injury following hypoxia-ischaemia 
affecting different brain regions such as the cortex and the deeper nuclear structures, basal 
ganglia and thalamus (30) (see Fig.1.2). The basal ganglia and thalamus (BGT) type of 
injury pattern is the one most frequently seen following an acute insult (31). These deep 
structures are particularly susceptible due to their high metabolic rate and rich 
concentration in N-methyl-D-aspartate (NMDA) glutamate receptors (the main excitatory 
receptor in neuronal synapses). BGT lesions vary in extent form focal to widespread 
abnormal signal intensity seen on MRI. A marker of the severity of the lesions is 
associated injury to the posterior limb of the internal capsule, an area which is actively 
myelinating at term and is highly susceptible to hypoxia-ischaemia (32). A normal 
appearance of the internal capsule is a good prognostic sign for normal motor function 
after hypoxic–ischaemic insults (see Fig. 1.3 and 1.4). 
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Figure 1.2: Susceptible brain regions to hypoxia-ischaemia. HIE results in global injury, 
affecting neurons of the cortical plate and basal ganglia as well as white matter tracts. Image 
adapted by reference (30). 
 
Figure 1.3: Normal axial MR images at the level of the basal ganglia of term infant brain: 
(a) a T1-weighted inversion recovery and (b) a T2-weighted sequence. The myelin in the 
posterior limb of the internal capsule (long arrows) is visualised as high signal intensity for 
about half its length in T1-weighted image (a) but is not as advanced on the T2-weighted 
image (b) where it is of low signal intensity. The short black arrows indicate the anterior 
limb of the internal capsule. Image adapted from reference (32). 
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Figure 1.4: Posterior limb of the internal capsule (PLIC) in severe HIE in axial T1-weighted 
image (A) and cranial ultrasound (B). (A) Note the loss of the normal high signal from 
myelin (black arrow) with abnormal signal in the thalami and the lentiform nuclei. (B) Note 
the linear strip of low echogenicity (white arrow) in the basal ganglia between the lentiform 
nucleus and the thalami indicating the line of the internal capsule with abnormally high 
echogenicity in the basal ganglia and thalami in this infant with severe HIE (B). Adapted 
from reference (32). 
The brainstem may be involved and affected in the presence of BGT injury. It 
tends to be present in the most severe end of the spectrum of HIE. Recent studies have 
shown that up to 50% of infants with brainstem lesions died in the neonatal period or 
within the first year of life (31). Survivors with BGT injury face a range of disabilities 
with cerebral palsy (CP), feeding difficulties, speech and language problems, visual and 
hearing impairment, seizures, and cognitive impairment. Martinez-Biarge et al., have 
developed flow charts of developmental outcome based on the severity of BGT injury 
(see Fig. 1.5). It appears that the severity of BGT injury dictates the severity of motor 
involvement/impairment in the manifestation of CP with the signal intensity of the PLIC 
on MRI being the best predictor of CP severity (31). 
 
A B 
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Figure 1.5: Flow chart showing the developmental outcome for infants with severe BGT 
injury (DQ stands for developmental quotient). Adapted from reference (31). 
The cortical watershed pattern of injury tends to be associated with forms of 
chronic hypoxia where maternal factors such as hypotension have been shown to be 
related. This injury consists of cortical necrosis with involvement of the subjacent white 
matter. It tends to affect the parasagittal and supra-medial regions of the convexities 
bilaterally with distribution mostly over the parieto-occipital areas than the anterior ones 
(see Fig.1.6).  
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Figure 1.6: Cortical watershed ischaemic injury. (A) Axial T1-weighted image showing low 
signal intensity bilaterally in the anterior and posterior watershed areas. (B) Axial T2-
weighted image showing increased signal intensity in the same areas, suggesting oedema. 
Adapted from reference (33). 
Infants with watershed type of injury predominantly have cognitive impairment 
with motor development being spared. As the cognitive deficit presents after 12 months 
of age and sometimes only when schooling begins, long term follow up is crucial.  
There is a global type of injury where both cortical grey and subcortical white 
matter are involved. These cases are the most severe ones and often fatal. In surviving 
infants, the injury evolves in multi-cystic encephalomalacia with global developmental 
delay. It is interesting to note here that infants respond differently to different degrees of 
acute and chronic hypoxia ischaemia and that the pattern of injury is not easily 
reproducible. Factors such as the primary cause, the degree of hypoxia and ischaemia, the 
maturational stage of the brain prior to the insult, regional cerebral blood flow (CBF), and 
the general health of the infant collectively play a role in the clinical course and final 
neurodevelopmental outcome (21).  
Clinically, HIE is categorised into three stages or grades from I to III based on the 
Sarnat modified classification (34). However, in all grades there is a common background 
of perinatal asphyxia, abnormal neurological status, and varied organ dysfunction. The 
grading of HIE is based on a daily clinical assessment of the infant using the Sarnat 
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modified classification (see Table 1.3). Other scoring tools, such as the Thompson score 
(also known as the HIE score) have been developed and are based on the Sarnat scale 
(35).  The Thompson score is a clinical tool assessing a range of signs associated to 
neurological dysfunction in infants with evidence of perinatal asphyxia (see Table 1.4). 
The score ranges from 0 (normal) to 22 (severe). Infants with a score of 1-10 are 
considered to have mild HIE, infants with a score of 11-14 are considered to have 
moderate HIE and infants with a score of 15-22 are considered to have severe HIE. It has 
been reported that a consistent score of >10 in the first 7 days of life predicts an adverse 
outcome with a 100% sensitivity and 61% specificity (35).  
Neurologically the infant may appear hyperalert and irritable (mild), lethargic and 
hypotonic or utterly comatose with weak or absent respiratory effort and either no 
response to stimuli or exhibition of spinal reflex to painful stimuli. Seizures are present 
in stage II and III of HIE and commonly present within the first 24 hours of life. In stage 
II, there can be an overall reduced electro-encephalographic activity with loss of cyclicity 
between sleep and awake states.  In stage III the electro-encephalographic activity can be 
completely flat (see Fig. 1.7) or may have the appearance of burst suppression (see Fig. 
1.8) (please refer to chapters 2 and 5). Similarly, seizures may be evident (see Fig. 1.8). 
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Modified Sarnat    
STAGE Stage 1 Stage 2 Stage 3 
Level of consciousness Hyperalert Lethargic or obtunded Stupor or coma 
Activity Normal  Decreased Absent 
Neuromuscular Control    
Muscle Tone Normal Mild Hypotonia Flaccid 
Posture Mild distal flexion Strong distal flexion Intermittent decerebration 
(extension) 
Stretch reflexes Overactive Overactive Decreased or absent 
Complex/Primitive 
reflexes 
   
Suck Weak  Weak or absent Absent 
Moro (startle) Strong; low threshold Weak; incomplete; high 
threshold 
Absent 
Tonic Neck Slight  Strong Absent 
Autonomic function    
Pupils Mydriasis Miosis Variable; often unequal; 
poor light reflex; fixed; 
dilated 
Heart rate Tachycardia Bradycardia Variable 
Seizures None Common; focal or 
multifocal 
Uncommon (excluding 
decerebration) 
 
Table 1.3: Sarnat modified classification criteria of HIE. Adapted from reference (34). 
 
In terms of other clinical manifestations, there can be a varied involvement or 
dysfunction of other organs or systems. Hypoxia-ischaemia activates the diving reflex 
which diverts the blood circulation from the skin and the splanchnic area to the most vital 
organs; heart, adrenals, and brain. It was thought until recently, that all infants with HIE 
would at some point have developed some degree of organ or system dysfunction. 
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However, a recent study has shown that multiorgan dysfunction is not related to outcome 
in HIE cases, with renal, hepatic, cardiovascular, and respiratory involvement in 58-88% 
of cases with good outcome and 64-86% of infants with adverse outcome (36). Table 1.5 
shows the clinical criteria for single or multiorgan dysfunction. 
Sign 0 1 2 3 
Tone Normal Hyper Hypo Flaccid 
Level of 
consciousness 
Normal  Hyperalert/stare Lethargic Comatose 
Fits None < 3 per day >2 per day  
Posture Normal Fisting, cycling Strong distal 
flexion 
Decerebrate 
Moro Normal Partial  Absent  
Grasp Normal Poor Absent  
Suck Normal Poor  Absent, bites  
Respiration Normal Hyperventilation Brief apnoea  IPPV (apnoea) 
Fontanel Normal Full, not tense Tense  
Table 1.4: Thompson scoring system of HIE. This is a modification of the original Sarnat 
criteria and is based on 9 clinical signs and gives a score ranging from 0 to 22. Adapted from 
reference (37). 
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Figure 1.7: Burst suppressed trace on an aEEG monitoring device. The top part of the figure 
is indicating the aEEG trace from the cerebral function monitor (CFM), and the bottom 
part is indicating the EEG trace (please refer to section 2.1.3 of chapter 2 for further details). 
Image adapted from website http://www.neoweb.org.uk/CFM/Quiz.htm.  
 
Figure 1.8: Seizure activity with a flat, isoelectric background on an aEEG monitoring 
device. The top part of the figure is indicating the aEEG trace from the cerebral function 
monitor (CFM), and the bottom part is indicating the EEG trace (please refer to section 
2.1.3 of chapter 2 for further details). Image adapted from website 
http://www.neoweb.org.uk/CFM/Quiz.htm.  
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SYSTEM CRITERIA 
Renal Anuria or oliguria (<1 ml/kg/h) for 24 hours or 
more, and a serum creatinine concentration >100 
mmol/l; or anuria/oliguria for >36 hours; or any 
serum 
creatinine >125 mmol/l; or serial serum creatinine 
values that increased postnatally 
Cardiovascular Hypotension treated with an inotrope for >24 
hours to maintain blood pressure within the 
normal range, or electrocardiographic evidence of 
transient 
myocardial ischaemia 
Respiratory Need for ventilator support with oxygen 
requirement >40% for at least the first 4 hours 
after 
birth 
Hepatic Aspartate aminotransferase >100 IU/l or alanine 
aminotransferase >100 IU/l at any time during the 
first 
week after birth 
Table 1.5: Criteria for organ dysfunction in HIE. This was modified and based on a 
retrospective cohort study which showed that there was no association between organ 
dysfunction and outcome (36). Adapted by reference (36).  
Historically treatment of HIE was provision of symptomatic support for all 
organs. However, in recent years there has been a drive towards implementing specific 
neuroprotective measures for the prevention of ongoing brain injury. As described earlier 
and as shown schematically (see Fig. 1.1) HIE is a progressive disease which does not 
stop once the hypoxic insult stops. Improving the peripheral circulation and supporting 
all the systems in maintaining homeostasis does not stop the cascade of biochemical 
events triggered by the initial hypoxic-ischaemic insult. A revolutionary treatment with 
the aim to cease the cascade of these biochemical changes is now offered to all infants 
with HIE in the form of therapeutic hypothermia (TH) in high income countries (38, 39). 
This followed the results of the TOBY (TOtal BodY, whole body therapeutic 
hypothermia for perinatal asphyxia) and several other randomised controlled trials and 
their beneficial results (40-42). Following a clinical assessment based on the TOBY 
clinical criteria (see Table 1.6), the infant with suspected HIE receives a 72-hour course 
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of whole-body TH with target core body temperature between 33 to 34 °C, and parallel 
continuous aEEG or EEG monitoring (depending on the facilities of the centre delivering 
the care). As evident form table 1.6, the treatment is offered to the moderate to severe end 
of the HIE clinical spectrum (stage II and III). The studies have shown that the numbers 
to treat for one infant to be saved, free of neurodevelopmental sequelae is 8 (43).  
Criteria Condition 
Criteria A: Infants ≥36 weeks of gestation 
admitted to the neonatal unit with at least one of 
the following: 
Apgar score of ≤5 at 10 minutes after birth 
 Continued need for resuscitation, including 
endotracheal or mask ventilation, at 
10 minutes after birth 
 Acidosis within 60 minutes of birth (defined as any 
occurrence of umbilical cord, 
arterial or capillary pH <7.00) 
 Base Deficit ≥ 16 mmol/L in umbilical cord or any 
blood sample (arterial, venous 
or capillary) within 60 minutes of birth 
Criteria B: Infants that meet criteria A should be 
assessed whether they meet the following 
neurological abnormality entry criteria of 
moderate to severe encephalopathy or seizures:  
Altered state of consciousness (reduced response 
to stimulation or absent response to stimulation) 
and 
 Abnormal tone (focal or general hypotonia, or 
flaccid) and 
 Abnormal primitive reflexes (weak or absent suck 
or Moro response) 
Table 1.6: TOBY cooling criteria for initiation of TH on infants with suspected HIE. Note 
that at least one of criteria A and all of criteria B need to be fulfilled for TH to be considered 
as a therapeutic strategy. Adapted by the UK TOBY Cooling Register Clinician’s 
Handbook.  
Overall, it has been shown that mild to moderate induced hypothermia in HIE 
cases reduces the risk of death and disability in infants with less severe EEG 
abnormalities, reduces death and moderate to severe disability, and increases the number 
of disability-free survivors (40-42, 44). There is ongoing research in the identification of 
adjacent neuroprotective measures or agents which could be used in addition to TH for 
further improvement of clinical outcome. 
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The TOBY Xe randomised control trial explored the efficacy of TH plus xenon 
within 6 hours of birth versus TH alone perinatal asphyxia. This trial proved the feasibility 
of xenon administration but did not show any added neuroprotective effect in clinical 
outcome (45) despite promising animal studies (46, 47). Potential reasons for his could 
be the timing of Xe administration of the dosage delivered. There is an ongoing clinical 
trial (CoolXenon2), further exploring the efficacy of TH combined with Xe for infants 
born in poor condition (https://clinicaltrials.gov/ct2/show/NCT01545271).   
A recent systematic review summarises the neuroprotective effects of melatonin 
in perinatal hypoxia-ischaemia in animal studies (48) and presents its encouraging 
positive neuroprotective effects, as shown so far by experimental research (49-52). This, 
however, has not yet translated into a clinical trial or standardised clinical approach. 
Researchers are also exploring the use of erythropoietin in combination with TH as an 
added neuroprotective agent with some variable results coming from the experimental 
field (53-56) and randomised controlled trial (57). A more recent randomised control trial 
has shown that when erythropoietin is administered in high doses with TH in infants with 
HIE, it potentially leads to a decrease in MRI brain insult and a better motor outcome at 
1 year of life (58). Another research group is undertaking a clinical trial on the 
effectiveness of allopurinol as an adjacent neuroprotective agent in combination with TH 
(http://www.albino-study.eu/).  
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1.3 Perinatal Stroke  
Perinatal stroke is defined as a region of damaged brain tissue secondary to focal 
disruption in the cerebral blood circulation due to arterial (perinatal arterial ischaemic 
stroke, PAIS) or cerebral sinus venous thrombosis (CSVT) or embolization as confirmed 
on neuroradiological or neuropathological findings (59). The exact timing of injury can 
be difficult to determine and has been defined as occurring anywhere between the second 
trimester of pregnancy (20 weeks of gestation onwards) and the first 28 days of life (59, 
60). Perinatal stroke is an important clinical entity frequently underdiagnosed or under-
reported in the literature. Depending on the age of presentation perinatal stroke can be 
classified into foetal ischaemic stroke (diagnosed antenatally or on autopsy of a stillbirth 
foetus), neonatal ischaemic stroke (diagnosed in the neonatal period; first 28 days of life), 
presumed perinatal ischaemic stroke (diagnosed after the neonatal period in infants, 
where the ischaemic insult is thought to have occurred in the perinatal period) or CSVT 
(59). 
Perinatal arterial ischaemic stroke is a frequent neonatal condition affecting 1 in 
2,300 infants (61) not including cases recognised outside the neonatal period. It is 
secondary to the occlusion of a large cerebral vessel and is ischaemic in nature (see Fig. 
1.9). Approximately 75% of cases are unilateral in which nearly all are in the MCA 
territory. In almost 65% of those cases, there is involvement of the left rather than right 
MCA (62).  
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Figure 1.9: Brain susceptibility to PAIS. (A) Image showing the brain regions most 
susceptible to PAIS. (B) Image showing the supply regions of the large cerebral vessels. 
(ACA: Anterior cerebral artery; MCA: Middle cerebral artery; PCA: Posterior cerebral 
artery). Image (A) was adapted from reference (30) and image (B) from 
neuro4students.wordpress.com.  
The aetiology of PAIS is uncertain in most cases. There is a variety of maternal, 
intrapartum, and neonatal factors considered to predispose to PAIS (see Table 1.7). The 
commonest hypothesis is that of a placental embolus travelling into the foetal circulation, 
because of the patency of the foramen ovale and the frequency at which the left MCA is 
involved. Other direct aetiological mechanisms have been reported, such as meningitis, 
presumably secondary to endothelial injury and inflammation of arteries and veins (63).  
It is also associated with congenital heart disease, especially if intravascular 
catheters, extracorporeal membrane oxygenation (ECMO) or surgery is required (64). 
PAIS has been reported to coexist with NE in up to 5% of cases (65). More recent studies 
have shown that although infants with PAIS might have a complicated perinatal history 
(66), co-presenting with NE is rare, and the incidence presented in older studies may be 
influenced by the misclassification of neonatal seizures under the generic umbrella of NE.  
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Maternal Risk Factors 
Primigravida 
Infertility 
Chorioamnionitis 
Prolonged rupture of membranes (PROM) 
Pre-eclampsia 
Intrauterine growth restriction (IUGR) 
Drugs (i.e. cocaine) 
Twin to twin transfusion (TTTS) 
Gestational diabetes mellitus (GDM) 
Intrapartum Risk Factors 
Prolonged second stage of labour 
Occiput posterior presentation  
Neonatal Risk Factors 
Polycythaemia 
Congenital heart disease 
Diagnostic procedures and surgery for cardiac disease  
Intravascular catheters 
Exchange transfusion 
Persistent pulmonary hypertension (PPHN) 
Extracorporeal membrane oxygenation (ECMO) 
Meningitis 
Arterial dissection in the neck (67) 
 
Table 1.7: Risk factors of PAIS. Modified and adapted by reference (68). 
There is a male predominance and most infants present as low risk until the acute 
onset of symptoms. The main clinical presentation is related to seizures, with a 
predominance of focal seizures manifesting in the first 72 hours of life. PAIS is the second 
most frequent cause of neonatal seizures in the term neonatal population (69). 
Presentation with encephalopathy or with asymmetry of neonatal reflexes (i.e. Moro 
reflex, atonic symmetrical reflex) is less frequently observed early on in the course of 
PAIS (70). Infants or children diagnosed outside of the neonatal period commonly present 
with signs of hemiparesis, i.e. abnormal hand preference. Slight asymmetry in the 
development of the affected limb may also be apparent.  
Based on older studies PAIS appears to be more frequent in the term neonatal 
population compared to the preterm (71). More recent work by Benders et al. looking in 
a cohort of infants between 27 to 36 weeks of gestation showed that PAIS also occurred 
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in preterm infants and was again more common on the left side and in the MCA territory. 
It appeared that infarct of the MCA in gestations of over 32 weeks mainly involved its 
main branch (72).  The underestimation of its prevalence in the preterm population was 
highlighted and the requirement for more frequent neuroimaging was stressed (72, 73). 
Several models have been developed to understand the pathophysiological 
mechanisms of HIE and focal arterial stroke at term (74). A hypoxic-ischemic insult was 
reproduced by unilateral ligation of the common carotid artery (CCA) followed by a 
variable duration of exposure to 8% oxygen postnatally in rats (75) and mice. Focal 
arterial stroke was reproduced by a transient MCA occlusion model in rats on day 7 (76) 
or day 10 of life (77), and mice (78), and a combined permanent MCA occlusion and 
transient CCA occlusion in rats (79). It was shown that the hypoxic-ischaemic insult is 
associated with increased cerebral blood flow (CBF) during systemic hypoxia, whereas 
CBF is disrupted after MCA occlusion. Lack of flow may be evident in the affected artery 
for hours post initial infarct (80). Reperfusion occurs either through the affected artery or 
via anastomotic arteries and the biochemical cascade in the reperfusion phase is very 
much like the one seen in HIE, with macrophages, glial cells, excitotoxic agents (such as 
glutamate), and oxidative stress being responsible for the ongoing injury process in the 
core of the infarct and its penumbra.  
After the first 3 days and up to 6 weeks following the insult, the infarct organises 
and this may consist of gliosis, cyst formation, myelin breakdown, and neovascularisation 
(81). Eventually, after the second month, an infarct involving a major cerebral artery will 
evolve in an area of cortical and subcortical tissue loss, which appears open towards the 
subarachnoid space (see Fig. 1.10(B)).  
The management of PAIS is supportive and consists of adequate hydration, and 
anticonvulsant treatment as clinically indicated. There is not enough evidence to support 
thrombolytic measures in the neonatal period and there is concern over the risk of 
intracranial haemorrhage with thrombolysis. In the instance of a clearly identified, 
ongoing cardio-embolic source the use of low molecular weight heparin (LMWH) may 
be justified but proper evidence deriving form randomised controlled trials is lacking 
(82).  
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Alternative methods of treatment are being explored in the adult population. 
Hypothermia preserves cerebral autoregulation (CA) and reduces cytotoxic oedema 
around clot formatting in the stroke affected region (83) and could play a role in the 
treatment of acute stroke. In a systematic review of animal studies, therapeutic 
hypothermia reduced infarct size by 44% (95% confidence interval 40 to 47%) with the 
best results being obtained at lower temperatures (≤ 31 °C). A reduction in infarct volume 
was also observed by approximately one third with temperature reduction to 35 °C, with 
initiation of treatment between 90 and 180 minutes, and in permanent ischemia models 
(84). Randomised trials of surface or endovascular hypothermia initiation in the treatment 
of acute ischaemic stroke (Cooling for acute ischaemic brain damage - COOL-AID, (85), 
Intravascular cooling in the treatment of stroke - ICTus, (86)) have not shown any 
significant difference in outcome between the cohort of patients receiving hypothermia 
and those who were not. However, the second COOL-AID trial,  with a larger number of 
patients (10 in the initial, 40 in the second one), showed a trend of decreased lesion growth 
on diffusion weighted images (DWI-MR) in the group treated with both thrombolysis and 
hypothermia, although the results in clinical outcome were similar between the two 
groups (87). In a single-centre study it was shown that out of 15 infants diagnosed with 
focal stroke on MRI, 5 of them who also underwent hypothermia did not have any seizure 
activity manifestation, thus providing some promise in the neuroprotective role of TH in 
perinatal stroke (88).  
The outcome of PAIS includes the development of epilepsy later in childhood,  
cognitive impairment, and behaviour problems (89). Language delay may be evident in 
up to 25% (90). PAIS in the MCA territory may lead to hemiplegia in up to 50% of cases. 
In cases where there is additional involvement of the basal ganglia and PLIC, the risk of 
developing contralateral hemiplegia is higher regardless of the extent of the infarct (91).  
Examples of perinatal stroke and its potential extent in preterm and term infants can be 
seen in figures 1.10-13. 
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Figure 1.10: CT and MRI examples of perinatal stroke: (A) CT image of 1-day-old infant 
with right MCA stroke. (B) Axial T2 weighted MR image of 9-month-old child with evidence 
of perinatal stroke, which has led to skull asymmetry and large porencephalic cyst. Adapted 
from reference (92).  
 
Figure 1.11: MRI of perinatal left MCA stroke: Axial T2 (top) and diffusion-weighted MRI 
(bottom) images of 5-day-old infant with left MCA stroke. Adapted from reference (92).  
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1.3 Perinatal Stroke 
 
52 
 
 
Figure 1.12: Ultrasound and MRI examples of stroke: (a) Parasagittal view on ultrasound, 
showing a large left MCA infarction in a 27-week infant with history of TTTS. (e) 
corresponding MRI, fluid-attenuated inversion recovery sequence of the same child at 18/12 
showing gliosis and extensive cavitation adjacent to the left ventricle. (b) Coronal view on 
ultrasound, showing right anterior MCA infarction in a 29-week infant (f) corresponding 
MRI, at 8 years, showing gliosis adjacent to the right ventricle and cavitation. (c) Coronal 
view on ultrasound, showing a left-sided large MCA/ACA watershed infarction in a 30-week 
infant, (g) corresponding MRI, at 8 years, showing a gliotic cleft and atrophy of the area 
involved. (d) Coronal view on ultrasound, showing a left-sided ACA infarction in a 36-week 
infant, (h) corresponding MRI, at 7 years. (TTTS: twin to twin transfusion, ACA: anterior 
cerebral artery) Adapted from reference (72).  
 
Figure 1.13: MRI example of perinatal stroke: (A) MRI, T2-weighted showing bilateral 
MCA infarct in an infant born at 34/40 weeks of gestation. (B) The corresponding diffusion 
weighted image. The MRI was performed on day 4 after birth. Adapted by reference (73).  
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Cerebral sinus venous thrombosis (CSVT) is another type of perinatal stroke, less 
prevalent compared to PAIS. It occurs in 2.6 in 100,000 live births (93), a rate most likely 
underestimated mostly due to under-diagnosis and lack of sophisticated neuroimaging 
techniques in many centres. The commonest sinus affected is the superior sagittal, often 
with involvement of the straight and transverse sinus (see Fig. 1.14). More than one sinus 
is commonly affected (94). The mechanism of injury is thought to be associated to venous 
occlusion and haemorrhagic infarction in the brain region drained by the sinus post 
CSVT. Venous engorgement, oedema, and increased capillary hydrostatic pressure lead 
to brain injury (95), which can vary from venous congestion to ischaemic infarction of 
the surrounding cortex, subcortical white matter and deep nuclear structures (see Figures 
1.15, 1.16). The natural progression is haemorrhagic transformation of the infarcted brain 
tissue.  
Cerebral sinus venous thrombosis has also been associated with secondary 
intraventricular, intraparenchymal haemorrhage as well as haemorrhage within the basal 
ganglia and thalamus due to distal draining veins. A multicentre, retrospective study in 
the Netherlands, has shown that amongst the 52 patients identified with CSVT, 
approximately 50% had thalamic haemorrhage, 50% had IVH and up to 80% had 
intraparenchymal haemorrhage (96). 
 
Figure 1.14: The cerebral venous draining system. CSVT is usually located in the major 
dural sinuses; superior sagittal sinus, transverse, straight and sigmoid sinuses. Adapted 
from reference (97). 
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Figure 1.15: Examples of CSVT: (A) Axial T2-weighted MR image showing left-sided 
punctate white matter lesions. (B) Time-of-flight MR venogram image showing absent flow 
in the straight sinus. Adapted from reference (96) 
 
Figure 1.16: Further examples of CSVT: (A) Axial T2-weighted MR image showing right 
thalamic haemorrhage with a thrombosed vein (arrow) in thalamus. (B) Sagittal T1-
weighted MR image showing high intensity signal in a thrombosed internal cerebral vein 
(arrow). Adapted from reference (93). 
 The risk factors predisposing to CSVT are like the ones of PAIS with 
polycythaemia and dehydration being the commonest clinical association. There also 
seems to be a consistent male predominance.  It can present with seizures but sometimes 
the symptoms are subtle, such as hypotonia or apnoea. In the same study, as the one 
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mentioned above, the initial symptoms were seizures in almost 80% of the 52 cases 
reported (96). It may coexist with HIE, meningitis, or meconium aspiration syndrome.  
The management in CSVT is once again supportive, maintaining good hydration, 
normocapnia and normoglycaemia with administration of anticonvulsants as required. 
Similarly, there is no evidence regarding the use of thrombolysis. The use of LMWH is 
variable and awaits formal evaluation.  
Overall, PAIS is the commonest cause of unilateral spastic cerebral palsy (98), 
and up to 50% of cases with CSVT have been reported to possibly have some motor 
deficit from 20 to 80% (99, 100). PAIS is associated with minimal mortality rates with 
its occurrence being rare on the same patient or siblings. There is, however, a high chance 
of recurrence of seizures later in life up to 50% and especially in children who have 
developed unilateral spastic cerebral palsy (101). Seizures are usually easily controlled 
with standard antiepileptic agents. There are few cases where development of 
hypsarrhythmia is noted with later epilepsy and possible requirement for surgical 
resection of the epileptogenic brain region (101). Mortality rates are low in CSVT, up to 
2-5% but higher than in cases of PAIS (99, 100). There are some studies that have 
reported higher mortality rates of CSVT in up to 19% and 25% possibly due to earlier 
diagnosis and different criteria for withdrawal of intensive care (96, 102). Up to 15-40% 
of infants with CSVT are reported to develop epilepsy in childhood (94, 99, 103). Infants 
with associated thalamic lesions are at higher risk of developing epilepsy which may be 
difficult to treat and is related to poor cognitive outcome (104). Mercuri et al., have 
described high association of PAIS (105). Berfelo et al., have described uncoordinated 
ocular movements in cases of CSVT (96).  
The effect of PAIS on cognitive outcome is to yet to be determined, however, 
studies with serial follow ups have shown that cognition deteriorates with age and most 
likely due to the development of epilepsy (106-108). It also appears that learning 
difficulties and behavioural problems are more frequently seen in cases of PAIS who have 
developed unilateral spastic cerebral palsy (89). There is a wide range of occurrence of 
poor cognitive outcome associated to CSVT from 25% up to 73% amongst different 
studies (99, 109, 110).  
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1.4 Neuro-monitoring and Neuro-imaging tools 
The above sections focused on the epidemiology, clinical course, management, and 
outcome of the two most frequent causes of encephalopathy and seizures in the term 
neonatal population. This section presents the mainstay of tools for neurological 
monitoring and neuroimaging in such cases. There are slight variations in practice 
amongst different hospitals across the United Kingdom, mainly due to different expertise 
in neuroradiology and access to advanced neuroimaging techniques. However, there is a 
general approach followed in most tertiary level neonatal intensive care units in 
monitoring and imaging infants with suspected HIE or perinatal stroke. In the following 
paragraphs, these different tools are described.  
In Hypoxic Ischaemic Encephalopathy 
In cases of HIE, the commonest neuromonitoring tool is a device best known as the 
cerebral function monitor (CFM). This is an aEEG device which provides cot side 
baseline monitoring of cerebral electrical activity. It is easily applicable, and both 
clinicians and nurses can be trained on its interpretation. It does show changes in the 
background electrical activity over time and following various clinical interventions. It 
can detect seizures but does have limitations; it is either a single or a two-channel system, 
thus limiting the detection of electro-cortical activity to specific scalp areas. Additionally, 
it does not detect low frequency activity, which is highly significant as some of the 
neonatal seizures can be of low frequency. Numerous studies especially from the 
Netherlands have shown that its correct use and knowledge of its limitations can be of 
immense value in clinical practice (111-115).   
Continuous EEG monitoring with the option of an aEEG display is superior as it 
allows multichannel coverage of the brain electrical activity and thus increases the 
possibilities of capturing electro-cortical events of clinical interest. Few tertiary centres 
have access to the equipment, resources and clinical neurophysiology support required. 
Provision of expert neurophysiological interpretation on a 24-hour basis is costly and 
unsustainable as in most tertiary hospitals there is only one or two clinical 
neurophysiologists with expertise in paediatric and neonatal EEG. (For further details on 
EEG please refer to chapter 2). 
In terms of neuroimaging, cranial ultrasonography (CrUS) is readily available and 
portable to the cot side. It is a convenient tool that allows visualisation of the neonatal 
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brain through the anterior fontanelle serially without having to move or disturb the infant. 
Depending on local practice, it is either performed by neonatologists or paediatric 
radiologists. 
In HIE, the ultrasound findings in the first 48 hours tend to be nonspecific, as the 
biochemical and microvascular changes post the original hypoxic ischaemic insult are 
evolving (116). It is, however, useful in detecting structural abnormalities, possibly 
associated with metabolic or other conditions, calcifications, or cysts, suggestive of 
infection; atrophy, suggestive of a long-standing (intrapartum) insult or cerebral 
haemorrhage. Evidence of brain oedema in the context of HIE is a known association, 
however, it is not always apparent and the common comment on slit-like appearance of 
the lateral ventricles on coronal views can also be a normal appearance in healthy term 
infants. The presence of co-existing loss of differentiation between the different 
anatomical structures, and especially the presence of obscured Sylvian fissures and 
closure of the interhemispheric fissure, that reinforces the appearance of brain swelling. 
The BGT can appear bright in 24 to 48 hours post the initial hypoxic-ischaemic insult 
(see Fig. 1.17). The PLIC can also be visualised in the coronal ultrasound views, as a 
stripe of normal or even hypo-echogenic tissue between the thalami and the lentiform 
nuclei (of the basal ganglia), which may appear abnormally hyper-echogenic post a 
hypoxic ischaemic insult (117).  
Ultrasound Doppler studies to assess cerebral perfusion may also inform the 
severity of the injury. In cases of perinatal asphyxia, low resistance index (RI) values 
(RI<0.55) in the anterior cerebral artery were shown to be associated with adverse 
neurodevelopmental outcome (118). The RI is the fraction of systolic (S) flow minus 
diastolic (D) flow over the systolic flow (S-D/S) within the ACA and is an indicator of 
cerebrovascular perfusion. It is thought that the decrease of the RI in ACA in HIE is 
secondary to increased diastolic flow caused by brain oedema, direct vessel injury and 
release of vasodilating factors in the ischaemic regions. This so called luxury perfusion 
has been associated with moderate to severe HIE with deep grey matter rather than 
cortical injury (118). However, it has been shown that although predictive in 
normothermia, it is significantly less predictive in hypothermia, and where infants with 
low RI measurement would have a poor outcome in normothermia, are more likely to 
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have a better outcome when cooled (119). The predictive value of RI regarding 18 months 
outcome during therapeutic hypothermia for HIE improves after 48 hours.    
 
Figure 1.17: Coronal and sagittal ultrasound views in severe HIE. (A) Coronal ultrasound 
view of midline structures, where the corpus callosum and lateral ventricles are depicted. 
Note the abnormal bright appearance of the basal ganglia and thalami structures, 
suggesting severe hypoxic-ischaemic insult. (B) Sagittal midline view of the same case. Note 
the marked cortical highlighting and well defined echogenic structure of the brainstem 
again suggestive of severe HIE. Images from author’s personal file.  
Computed tomography (CT) is only used in acute situations and mainly to 
determine whether there is a space-occupying subdural haematoma or extradural 
trauma/haemorrhage (i.e. subgaleal haemorrhage), which may require neurosurgical 
intervention. The advantage of CT head is that is a much faster approach to obtain brain 
A 
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images, the exposure of the infant to ionising radiation though must be considered. In this 
respect, CT should only be used in a potential neurosurgical emergency and if further 
neuroimaging is required MRI should be recommended.  
The gold standard neuro-imaging tool for HIE is MRI (120). It allows early 
identification of brain injury secondary to hypoxic-ischaemic insult and assessment of 
treatment efficacy (121). The pattern of injury associated to the deeper grey matter 
structures (BGT-predominant injury) or the cortex (watershed-predominant injury) or 
severe global, may be more evident and specific after the first 4 to 7 days on standardised 
conventional MRI, but may be apparent on diffusion-weighted MR imaging (DWI) much 
earlier (122). Several studies have shown that MRI aids the prediction of outcome in HIE 
(123-126).  
It is worth noting here that MRI is also the imaging technique of choice in 
diagnosing underlying causes of neonatal seizures (127). One study using clinical 
information in combination with CT or MRI identified the cause of neonatal seizures in 
almost 80% of a large cohort of infants (11). A more recent study showed an even higher 
rate, up to 95%, in identifying the aetiology of neonatal seizures and assisting the 
prediction of neurodevelopmental outcome by using MRI (128).  
Studies on cerebral oxygen delivery and consumption have provided more 
information on the pathophysiology of brain injury in HIE and perinatal stroke. The use 
of oxygen-15 positron emission tomography (PET) and xenon-enhanced CT (Xe CT) in 
studies assessing brain haemodynamics are invasive and hence not applicable in the 
neonatal population. However, more specialised MRI techniques allow the investigation 
of different aspects of the brain metabolism; the phase contrast MR angiography (PC-
MRA) and the arterial spin T2-based measurements allow the estimation of oxygen 
saturation (SaO2), with oxygen extraction fraction (OEF) and the cerebral metabolic rate 
of oxygen (CMRO2), being indirectly calculated from the previously mentioned 
parameters (129).  
Such techniques have been applied to demonstrate an increase in CBF with 
postconceptional age (130-132) and to study HIE and perinatal stroke (see Figures 1.18 
and 1.19). For example, De Vis et al., showed significant correlation between increased 
perfusion in deep grey matter, as assessed by pulsed arterial spin labelling (PASL), in 
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infants with poor neurodevelopmental outcome at 9 and 18 months of age following HIE 
(133). Shi et al., showed association between higher signal intensity in deep grey matter 
structures in infants with HIE, thus indirectly implying association with hyper-perfusion 
in the areas of injury (134). However, a study evaluating brain perfusion in the second 
week following HIE, showed hyper-perfusion locally and globally but lower perfusion in 
the thalami, thus implying a regional low metabolic demand post irreversible injury (135). 
This supports a later study which evaluated the progression of brain perfusion in the first 
week following HIE, which identified low perfusion on day one followed by hyper-
perfusion in affected regions (136).  
Studies based on magnetic resonance spectroscopy (MRS) can also aid 
prognostication in cases of HIE (137, 138). Phosphorus MRS studies have shown the 
primary and secondary energy failure in hypoxia-ischaemia (as described in section 1.2 
of chapter 1) (139, 140). Proton MRS based studies have shown that cerebral lactate 
increases in hypoxia-ischaemia, which resolves following effective resuscitation, only to 
be followed by a secondary rise 12 to 24 hours post primary insult (141-143) due to 
intrinsic production (144). Changes detected by MRS have been shown to provide earlier 
indication markers of disease severity in HIE than conventional MRI. Markers such as 
lactate to creatinine, lactate to N-acetyl-aspartate (NAA), lactate to choline peak-area 
ratios aid prognosis of disease severity and later neurodevelopmental outcome in brain 
injury accurately (140, 141, 145-147). 
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Figure 1.18: Brain maturation based on tissue perfusion of an infant born at 30 weeks of 
gestational age: (a) T2-weighted images and PASL images at 31 weeks of postconceptional 
age, (b) T2-weighted images and PASL images at 38 weeks of postconceptional age. Brain 
perfusion is expressed as cerebral blood flow (CBF) in ml/100grams/minute (PASL stands 
for pulsed arterial spin labelling). Image adapted from reference (129).  
 
Figure 1.19: MRIs and PASL images of PAIS and HIE: (a) T2-weighted images and PASL 
images of an infant with PAIS in the right MCA. Note the loss of tissue in the T2 images and 
the associated lower perfusion seen in the PASL images. (b) T2-weighted images and PASL 
images of an infant with HIE. Note the global hypo-perfusion (see colour bar). Brain 
perfusion is expressed as CBF in ml/100grams/minute. (PASL: pulsed arterial spin 
labelling). Image adapted from reference (129).  
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In Perinatal Stroke 
In cases of perinatal stroke, the current available diagnostic tools by the cot side on an 
NICU are CrUS, aEEG and EEG. Both CrUS and aEEG are readily available, while the 
access to multichannel EEG is more variable and dependent upon local practice and 
expertise.  
Studies have shown that aEEG can significantly contribute to the diagnosis of 
perinatal stroke (148). It can, however, be less effective in detecting seizures and provides 
limited information regarding their origin, location, and nature. Early multichannel EEG 
has been shown to aid in the differential diagnosis of between seizures secondary to 
perinatal stroke and seizures secondary to HIE based on the background electrographic 
activity and the focal nature of seizures in stroke (149). Multichannel continuous EEG 
monitoring is a valuable tool in early diagnosis of perinatal stroke in terms of 
lateralisation of seizures and certain electroencephalographic features associated with 
stroke (150). Asymmetry or attenuation of the background activity tend to depend on the 
extent of the infarction (150).  
Approximately 70-80% of perinatal stroke cases can be visualised with ultrasound 
performed by experienced professionals, except for small cortical infarcts in areas away 
from the transducer (i.e. posterior fossa lesions) (151-153) (see Fig. 1.20a). However, the 
lesion may take hours to days to organise in the hyperechoic appearance which can be 
characterised as stroke; therefore ultrasound is a less sensitive tool in detecting stroke 
early (154). Following the infarct there is reperfusion either through the affected or 
anastomotic arteries. The macrophages and glial cells that invade the affected region 
make the lesion hyperechoic and visible to scanning (81).  
Ultrasound Doppler studies can also be utilised in the detection of perinatal stroke. 
This is infrequently used, and it is entirely dependent on expertise. The idea is that during 
reperfusion of the ischaemic region, high flow velocities may be recorded with low values 
of the RI on the affected area compared to the healthy side (155, 156). 
The gold standard for detection of perinatal stroke is MRI (157) (see Figures 1.20a 
and 1.20b). Among specific MRI techniques, DWI may detect the infarct prior to 
standardised conventional T1 and T2 weighted MR images (158). From a 
pathophysiological aspect, immediately after the infarct, there is localised oedema which 
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increases the water content of the affected brain region. Any change in water content is 
detected by DWI; although this is not entirely specific and can also be secondary to 
encephalitis or venous ischaemia (81).  
As with HIE, different MRI techniques such as PC-MRA and ASL have been used 
to assess perfusion in cases of perinatal arterial stroke. The findings appear to be variable 
between hyper- and hypo-perfusion between the infants studied depending upon time of 
study compared to time of injury and region of interest (159-161).  
 
Figure 1.20: Example of perinatal stroke: (a) Coronal midline ultrasound view of perinatal 
stroke noticed on admission scan. Note the bright echogenic circular region on the left 
temporal region (white arrow) in proximity to the Sylvian fissure. (b) Axial T1 weighted 
image of the same case depicting the area of infarction in keeping with the ultrasound 
imaging findings. Images from author’s personal file.  
Alternative neuro-investigating tools 
Magnetic resonance imaging (MRI) remains the gold standard in the diagnosis of both 
HIE (120) and perinatal stroke (157), and overall neonatal seizures (127). However, this 
is a non-portable, expensive technique requiring transport of infants away from the acute 
clinical area in most institutions and is rarely available out of hours.  
In addition to this, there are very few institutions with expertise to apply more 
advanced MRI techniques, as the above mentioned and/or MRS. The proximity to the 
scanner, the long duration of the scan, and the requirement for transportation decrease the 
possibility of serial and follow up scans. This has an impact on serial scans of preterm 
infants where not only transport but also equipment to maintain homeostasis and 
temperature during the scan is challenging. There are neonatal incubators specifically 
designed and built for MRI scanners, but these are not available universally.  Expertise in 
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neonatal neuroimaging is required for the interpretation of the acquired MR images. 
Although most tertiary hospitals have neuroradiology support on site there are few with 
specific neonatal neuroradiology experience support, and therefore, external advice is 
often sought. 
There is an ongoing requirement for the development of cost-effective automated 
cot-side brain monitoring and imaging tools which will ultimately improve clinical care 
and facilitate application of precision medicine. Near infrared spectroscopy (NIRS) and 
different NIR modalities can provide this alternative option as they permit non-invasive 
and continuous monitoring of cerebral haemodynamics and oxygenation at the cot side, 
by measuring changes in the concentration of oxy- and deoxy-haemoglobin (162-164). 
NIRS can augment monitoring of physiological parameters to inform perfusion status in 
cases of neonatal brain injury and may be highly valuable in clinical conditions such as 
HIE, where there is constant dynamic changes of brain oxygenation and metabolism over 
the course of the illness.  
Near-infrared techniques have been utilised in the study of infants with HIE and 
brain injury since the early eighties and in the next chapter a new approach of NIR 
methodology, diffuse optical tomography (DOT) combined with electroencephalography 
is presented. By combining DOT and EEG in monitoring and imaging infants with HIE 
or stroke, who originally presented with seizures, one may evaluate and begin to 
understand the constant dynamic changes in cerebral circulation. The aim of this study is 
to prove the feasibility of this imaging modality on a neonatal intensive care environment 
and to utilise this in the deeper understanding of the physiology of these morbidities from 
a combined neurophysiological and cerebrovascular perspective.   
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2.1 Electroencephalogram  
2.1.1 Origin of the EEG signal 
The mystery of brain electrical activity has for long been the focus of investigation for 
the world of physiology and neuroscience. The foundation of EEG is attributed to an 
English physiologist Richard Caton in 1875. He was the first to record the electrical 
activity from dog and rabbit brains with a primitive device (165). There follows numerous 
studies and descriptions of brain electrical response to electrical stimuli and seizure like 
activity in the 1800s and early 1900s (166-168). However, the first to describe the human 
EEG was Hans Berger with his report of human EEG recordings dating back to 1929 
(169). Since then, EEG has been widely used for the study of behaviour, wakefulness, 
and sleep states in research as well as for monitoring and detection of abnormal or 
epileptiform activity in clinical practice.  
The EEG measures the difference in electrical potential in the scalp. The human 
cerebral cortex contains billions of pyramidal neurons (nerve cells), which are electrically 
charged, forming complex connections and networks. This continuous neural 
electrochemical signalling gives rise to electric fields, which is what is detected via EEG. 
This activity, however, has a long distance to travel through different structural layers of 
non-neuronal tissue, such as the meninges, cerebrospinal fluid, skull, and skin, to reach 
the EEG electrodes. Hence many activated and synchronised neurons are required for the 
EEG signal to be produced, transmitted, and measured. For instance, it has been described 
that in cases of epileptiform discharges, up to 6 cm2 of neuron surface is required to 
exhibit synchronous neural activity in order for it to be detected by scalp EEG (170). 
Each neuron consists of axons, dendrites, and cell bodies (soma), (see Fig. 2.1.1). 
The nerve cells respond to stimuli and transmit information down the axons. The 
dendrites are either connected to axons or dendrites of other cells and are the recipients 
or transmitters of impulses between nerve cells. Neural activities in the central nervous 
system (CNS) are based on the synaptic currents travelling along these connections 
between dendrites and axons, called synapses (see Fig.2.1.2). 
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Figure 2.1.1: A neuron and its main parts. Adapted from reference (171). 
 
 
Figure 2.1.2: An electrical synapse and its components. Adapted from reference (171). 
The nerve cell membrane is usually negatively polarised at 60-70 mV, which is 
termed the resting potential. This potential differs in accordance to changes in synaptic 
activity. If a neuron is stimulated above a certain threshold (see Fig. 2.1.3) the polarity of 
its membrane potential is briefly reversed, and this is called an action potential.  If an 
action potential reaches an excitatory synapse, an excitatory postsynaptic potential 
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(EPSP) will occur and depolarise the following neuron. If an action potential reaches an 
inhibitory synapse, an inhibitory postsynaptic potential (IPSP) will occur and 
hyperpolarise the postsynaptic neuron accordingly. Essentially both EPSPs and IPSPs 
cause current to flow across the neurons but also amongst the neighbouring extracellular 
space. 
        
Figure 2.1.3: Action potential and electrical postsynaptic potential (PSP). The x axis in both 
graphs represents time in milliseconds (ms) and the y axis potential in millivolts (mV). The 
dotted line represents the negatively polarised threshold of the membrane (resting potential) 
beyond which the membrane of a neuron can be electrically stimulated (a) An action 
potential generated at one neuron causes an ionic current to flow into a second neuron (b) 
causing an electrical post synaptic current. Adapted from reference (171). 
It is the synchronisation of these electric fields generated by post-synaptic 
potentials (EPSPs and IPSPs) in pyramidal neurons which is thought to produce most of 
the actual EEG signal (172, 173). The EEG measures the difference in electrical potential 
between different locations over the scalp. The action potentials travelling along the 
neurons are higher in amplitude than post-synaptic potentials. However, the latter are 
longer in duration and occupy a larger surface of the membrane. This allows both 
temporal and spatial accumulation. Action potentials occupy a very small surface and are 
up to 30 times shorter in duration than synaptic potentials, factors which prevent their 
synchronisation on a neuronal basis. Thus, the electric fields resulting from asynchronous 
action potentials are not significant at the scalp. The duration of potentials in relation to 
their synchronisation also explains the association of frequency and wave amplitude seen 
on EEG. High frequencies produce lower amplitude EEG waves with a typical such 
example being the alpha frequency (α) (8-13 Hz), mostly associated with awake state in 
adults. On the other hand, low frequencies produce higher amplitude signal, with such an 
example being the delta waves (δ) with frequencies from 0.5 to <4 Hz.  
The pyramidal neuron resembles the behaviour of an electrical dipole (174), with 
either ends positively or negatively charged based on the type of input being applied. The 
a b 
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theory that best describes the conduction of the potential through the extra-cellular spaces 
and the association between the recordings and the distance from the source is one of 
volume conduction. The best mathematical approach to describing this is the solid angle 
theorem of volume conduction (173). The theorem provides a basic understanding of how 
the cortical pyramidal dipoles generate the waves seen on EEG, it states that the potential 
generated at an electrode (relative to a reference) will be proportional to the solid angle 
subtended by the poles of the dipole generator (173). 
In terms of size, shape and duration of EEG potentials, there are certain factors 
which play a crucial role. These are: (1) the distance of the recoding electrode from the 
source of the potential, (2) the duration of post-synaptic potentials (PSPs), (3) the number 
of simultaneously activated PSPs and (4) the anatomical orientation of the pyramidal 
neurons generating the potential (173). The electrical field produced by the pyramidal 
neurons is termed an open field.  The potential of an open field decreases inversely to the 
distance from each source. The architectural structure of neurons in other regions of the 
brain does not resemble the alignment of neuronal dipoles of the cortex. Therefore, the 
field potentials generated from the regions of the thalamus and the brain stem are called 
closed potentials and are not large enough to be detected on the scalp (173).  
It is often presumed that if an electrode is placed deeper than the scalp, more 
information will be gained. As briefly mentioned above, the potentials in an open field 
decrease in amplitude with the square of the distance from the generator. Due to this, 
when an electrode is placed near to one source over the cortex, it will be less sensitive to 
more distant regions because of the size of the signal at that location.  Whereas if the 
electrode is sampling from further away (the scalp) the signal strengths from the close 
and distant sources are both smaller, but closer to each other in amplitude and thus more 
likely to sample both.  Therefore, deeper electrodes detect higher potentials from a small 
surface-source and scalp electrodes detect from a large surface-source at a greater 
distance (175).  
The signal produced at an extracellular level has a certain distance to travel 
amongst different anatomical structures to be measured by scalp EEG. This distance (and 
the fact that these layers are semi-conductive) decreases the amplitude of the electric field 
and leads to loss of spatial information. Therefore, the EEG signal requires amplification 
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by a factor of approximately 106 for it to be effectively measured. This makes it vulnerable 
to noise interference and artefact.  
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2.1.2 EEG in clinical practice 
To perform EEG, one requires the following: (i) electrodes to detect the electrical activity 
placed over the scalp, (ii) an amplifier that magnifies the signal (as mentioned in section 
2.1.1, page 17), (iii) filters, (iv) a device to record the captured activity and (v) a video 
recorder to capture any simultaneous physical activity of the subject. 
In clinical practice, the EEG electrodes used are constructed from highly 
conductive, non-reactive metal such as gold or silver chloride coated. They are usually 
cup shaped and attached to insulated wires (see Fig. 2.1.4), which can be connected into 
the amplifier, which is then connected to the EEG recording device (see Fig. 2.1.5). In 
parallel with the EEG electrodes, other electrodes are often used to monitor cardiac 
rhythm, respiratory rate, and eye movements. These parameters, in association with video 
monitoring, allow the informed interpretation of the EEG trace and the distinction of 
various behavioural states as well as the identification of normal or abnormal activity. 
 
Fig. 2.1.4: A silver cup EEG electrode with a 10-mm diameter. Image adapted from 
www.cephalon.dk. 
 
2.1.2 EEG in clinical practice 
 
73 
 
 
Figure 2.1.5: Example of a complete video-EEG system. Image adapted from 
ww.micromed.eu. 
The arrangement of the electrodes over the scalp (array) is standardised according 
to the 10-20 international system of electrode placement (176). Each one of the electrodes 
is placed 10 or 20 per cent of the total nasion-inion (front–back) or right auricular to left 
auricular (right–left) distance of the skull, away from a neighbouring electrode (see Fig. 
2.1.6). Each electrode is identifiable by one to two initials and a number which represent 
the location on the scalp and the hemisphere they are placed on, respectively; for instance, 
F stands for frontal, C for central, T for temporal, P for parietal, O for occipital. The 
electrodes over the right hemisphere are represented by even numbers and the ones over 
the left with odd numbers. 
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Figure 2.1.6: The standardised 10-20 system for scalp-EEG application. Each one of the 
electrodes is placed 10 or 20 per cent of the total nasion-inion (front–back) or right auricular 
to left auricular (right–left) distance of the skull, away from a neighbouring electrode (see 
Fig. 2.1.6). Each electrode has identifiable one to two initials and a number which represent 
the location on the scalp and the hemisphere they are on. Even numbers represent the right 
hemisphere and odd numbers the left one. Adapted from reference from www.BCI2000.org. 
For infants, the standardised array of the EEG electrodes on the scalp follows a 
modification of the 10-20 system (177, 178), to accommodate for the infant’s immature 
frontal lobes which do not extend as anteriorly to the skull as in older children and adults 
(179). The recommended and widely accepted number of EEG electrodes for sufficient 
representation of the whole scalp activity is 21. One may create as sparse or dense of an 
array required as per clinical or research purposes. The minimum recommended electrode 
number for infant EEG is 11 with locations situated at Fp1, Fz, Fp2, T3, C3, Cz, C4, T4, Pz, 
O1, O2 (see Fig. 2.1.7). A carefully conducted study comparing the full 10/20 array and a 
reduced (9-electrode) array showed that 90% of 187 seizures detected by the full montage 
were also identified by the reduced version (178).  
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Figure 2.1.7: Example of the proposed reduced montage for neonatal EEG. Image from 
author’s personal file. 
In addition to the electrodes capturing the cortical electrical activity, the position 
of a reference electrode is important as all the variations in electrical potential difference 
are recorded relative to it.  The reference electrode can be placed on the scalp or away 
from the scalp (i.e. shoulder, chest). If the reference is placed too close to a sensing 
electrode, the signal recorded across that channel will be reduced as the electrical 
potential difference between the two electrodes will tend to zero. However, if the 
reference is placed away from the scalp, more noise components will be introduced.  
Another important factor during EEG recording is the impedance. This is the 
measure of the   resistance of a circuit to an alternating current when a certain voltage is 
applied. The use of abrasive gel and conductive paste prior to the application of the 
sensing electrodes aids the reduction of the impedance. A good contact impedance is 
usually defined as one lower than 5 kΩ. However, it is possible to obtain a good signal-
to-noise ratio with contact impedances higher than 5 kΩ and similarly to have a noisy 
EEG trace with good contact impedances. Electrical interference in the recording 
environment may affect the EEG signal, especially in an acute clinical environment with 
electrical infusion pumps or mechanical ventilators. 
The amplification of the EEG signal is essential for the recording and visualisation 
of the EEG trace. The EEG amplifiers are multi-channel differential devices arranged in 
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such a way that the signal at each active electrode is amplified relative to the reference 
electrode. The sampling rate is usually between 250 and 2000 Hz. Certain filters can be 
applied across a range of ~0.01 to 100 Hz to minimise noise effects. Most EEG systems 
have a 50 Hz notch filter to eliminate interference at mains frequency.  
The ways in which EEG electrodes are positioned and referenced is known as an 
EEG montage. Common forms include the referential and the bipolar montages. The 
referential montage measures EEG signals between each sensing scalp electrode and a 
single reference electrode, while the bipolar montage records the difference between 
neighbouring pairs of sensing scalp electrodes. The bipolar montages can be arranged in 
an orderly way in chains; front to back or side to side (see Fig. 2.1.8). 
 
Figure 2.1.8: Example of a typical bipolar montage (double banana). Image adapted by 
www.eegatlas-online.com. 
The EEG signal consists of a combination of transient waveforms and oscillatory 
features. The latter are categorised based on their frequency, measured as cycles per 
second (Hz) in four main frequency bands; delta, δ (<4 Hz), theta, θ (4-<8 Hz), alpha, α 
(8-13 Hz), and beta, β (>13 Hz). These rhythms are found in different ages and under 
different conditions. Most commonly there is a dominant frequency throughout the 
recording which is referred to background rhythm. In the awake state, the delta and theta 
activity are more characteristic of neonatal EEG, the theta more dominant in childhood 
and alpha in adulthood. Additionally, in adults, the predominant rhythm in REM sleep is 
theta activity, and delta activity in the non-REM sleep.  
Neonatal EEG recordings can be challenging. The basic clinical EEG requires a 
minimum of 20 minutes recording. Longer sampling periods (of at least one hour long) 
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can be more informative, in capturing a wide variability of different states which differ 
with gestational age and postconceptional age (180). However, in the instance of 
abnormal or suspected seizure activity continuous recordings will aid and inform clinical 
management (181). 
During recordings that take place in the clinical area, and particularly in a neonatal 
intensive care unit (NICU), there are certain precautions and considerations to be 
considered. The EEG device should be placed as close to the infant possible in a way that 
does not interfere with other devices and monitors (i.e. ventilators, intravenous pumps, 
other monitors). The electrodes should be placed onto the infant’s scalp appropriately and 
not interfering with any clinical care that the infant may be receiving (e.g. hats used to 
apply continuous positive airway pressure-CPAP mode of ventilation). The infant should 
be positioned ideally supine with head, face, trunk and both upper and lower limbs visible. 
Depending on the clinical circumstances and management this might not be possible and 
EEG recording should continue and be optimised based on the clinical requirements and 
not vice versa.  
Simultaneous video monitoring should be performed to capture any abnormal or 
seizure-like movement of the infant. The camera should be positioned in a way that 
captures the best possible view of the infant. It should capture any interventions (i.e. 
suctioning of the ventilated infant), but it should not video the personnel or conversations 
around the infant. Its purpose is exclusively to provide information for remote EEG 
interpretation. Most modern cameras will have a low light capability to record in ambient 
or dim light which is sometimes necessary in the NICU.    
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2.1.3 Amplitude integrated EEG in clinical practice 
In a neonatal intensive care environment, amplitude integrated EEG (aEEG) is frequently 
used as a simplified continuous monitoring system of the electrical cortical activity. This 
method was developed by Maynard in the 1960s for adult intensive care units in response 
to a requirement for ongoing neuro-monitoring (182) and evolved further in association 
with Prior (183, 184).  This method consists of a single or dual channel EEG recording 
which is filtered and time compressed (see Fig. 2.1.9) with the aim to monitor trends of 
the background electrocortical activity. The monitor is widely known in clinical practice 
as a ‘cerebral function monitor’ (CFM).  
 
Figure 2.1.9: A comercially available single channel aEEG-CFM system. The electrodes are 
applied onto the infant’s scalp and connected to the aEEG recording system via insulated 
wires. The aEEG monitor demonstrates the live continuous single channel EEG trace at the 
bottom of the screen and the amplified, time compressed aEEG signal at the top of the screen 
(adapted from the natus.com website). 
The single or dual-channel aEEG signals are derived from electrodes placed on 
the centro-parietal and parietal regions of the scalp. The recommended positions of the 
electrodes for the single channel is the bi-parietal placement (P3 and P4, see Fig. 2.1.10a) 
and for the dual channel, C3, P3, C4, P4 (see Fig. 2.1.10b) with the neutral electrode 
placed along the midline and away from the open anterior fontanelle. The bi-parietal 
region is the least likely to be affected by scalp muscle activity and eye movements.  
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Figure 2.1.10: Single and double-channel aEEG electrode placement: A) biparietal 
placement of electrodes in a single aEEG recording. This region is least likely to be affected 
by sweat, scalp muscle or eye movements, B) Electrode placement in double channel aEEG 
recording. Similarly this part of the scalp is less likely to produce artefacts deriving from 
eye movements or muscle. A neutral electrode completes the application of the aEEG, which 
is placed in the midline anteriorly or posteriorly to the anterior fontanelle. Image adapted 
from personal file.  
The aEEG monitor captures the background electro-cortical activity in real time 
for extended periods. The signal is amplified and passed through a pass band (with high 
pass band at 2 Hz and low pass band at 15 Hz). This essentially minimises interference 
from artefacts related to sweat, muscle activity, movements or surrounding electrically 
powered equipment. It also means that any normal EEG activity of slow frequency (<2 
Hz) is attenuated and not detected by aEEG. The second important component of aEEG 
processing is amplitude compression in a semi logarithmic manner (0-100 µV) and time 
compression (6 cm of trace are equivalent to one-hour recording) (185). This means that 
normal, variable activity will result in a narrow high amplitude signal (>10 µV), whereas 
minimal activity (i.e. discontinuous trace, low amplitude activity) will result in a broad 
signal of low amplitude. 
The interpretation of the signal is simple and does not require expert 
neurophysiology support. Any member of the attending team including; physicians, nurse 
practitioners and nurses can be trained in applying the aEEG leads and interpreting the 
signal accordingly to clinical practice and management. There are different aEEG signal 
classifications with main components being the morphology of the background activity, 
cycling between sleep and awake state and the amplitudes of the upper and lower margins 
of the trace (185-187). Any sudden brief or prolonged elevation above the bandwidth 
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should raise clinical suspicion. This should be inspected carefully in association with the 
underlying live single or dual channel EEG recording, the overall clinical context and 
nursing observations as to whether it is related to artefact or seizure activity.  
Overall aEEG is a useful monitoring tool in the NICU. However, low frequency 
activity may not be captured. Similarly, low frequency or short-lived seizure activity may 
not be detected. The restriction to single or dual channel offers very limited scalp 
coverage, which risks not detecting frontal or occipital abnormal activity. The 
differentiation between seizures and artefacts may also be difficult to decipher and 
requires careful overall monitoring of the infant and information input related to drug 
administration or other medical intervention. In any instance of uncertainty or possible 
seizure activity, the investigations should be completed by performing a formal EEG, 
which remains the gold standard for monitoring of the electrocortical activity. 
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2.1.4 Principles of neonatal EEG  
The human EEG goes through certain developmental trajectories, the features, and 
characteristics of which are best seen throughout the neonatal period. This makes 
interpretation of neonatal EEG dependent on the gestational age (GA) but also post-
conceptional age. Features which may be classified as pathological in older infants or 
children may classify as normal, age appropriate EEG features in the preterm and term 
infants.   
This section attempts to explain some of these features as it is essential for the 
understanding of the description and interpretation of pathological traces and EEG states 
in the neonatal period. The main EEG aspects covered below, as described by numerous 
studies (188-192), are the following: (i) states of sleep and wakefulness, (ii) background 
activity, (iii) synchrony, (iv) EEG provoked reactivity, and (v) other special EEG features.  
The evaluation of different behavioural states is a multifactorial process and 
various physiological and EEG components should be taken into consideration (193). In 
the normal term neonate, based on observation (i.e. open eyes, spontaneous movements), 
physiological parameters (eye movements, heart rate, respiratory rate) and EEG features, 
the following behavioural states can be identified: (i) wakefulness where the infant 
appears awake, vigorous with eyes open  (active wakefulness, AW) or quiet without 
agitation (quiet wakefulness, QW), (ii) active sleep (AS), where the infant appears asleep 
with the presence of rapid eye movements (REM-also known as REM sleep)  (iii) quiet 
sleep (QS) or non-REM sleep, where the infant appears asleep with the absence of REM 
(188, 194). A period between two discrete sleep states where the infant appears asleep, 
but the rest of the expected parameters are equivocal, is referred to as transitional sleep 
state. If this period is not between two distinct sleep states it is simply termed as 
indeterminate (195, 196) (see Fig. 2.1.11). The emergence of discrete sleep states occurs 
as early as 26-27 weeks of gestation. However, at this stage the EEG may still appear 
inconsistent with the infants’ behavioural state. It becomes clearer at gestations 28-29 
weeks where one may see distinct AS and QS with the presence of REM (190).  
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Figure 2.1.11: Example of polysomnographic digitized recording in a 34/40 weeks healthy 
premature baby. (LEOG: left electro-oculogram; REOG: right electro-oculogram; Eye: eye 
movements recorded using a piezo transducer; C3O1, C4O2 and C3C4: EEG recordings; 
ECG: electrocardiogram; RR: respiratory rate interval measurement; FLW: naso-buccal 
airflow (thermistor); THO and ABD: thoracic and abdominal respiratory movements 
(strain gauges); RH and ACT2: right hand (piezo transducer) and left leg (actimetry) 
movements; SaO2: oxygen saturation; s: seconds). Image adapted from reference (190). 
The background activity of the typical preterm neonatal EEG is characterised by 
discontinuity, and is known as discontinuous trace or tracé discontinu (TD) (197). In this 
state, the EEG consists of epochs of activity (short bursts of slow and fast rhythm) 
followed by epochs of inactivity (inter-burst intervals, IBIs). The amplitude of the signal 
during the inactive periods is <25 µV, where the trace appears as almost or on occasions 
completely flat (see Fig. 2.1.12). The duration of the inter-burst intervals classified as 
normal varies with gestational age from 46-60 seconds for extremely premature infants 
born at 24 weeks (198, 199), to 6-10 seconds for term infants (198, 200) (see Figures 
2.1.13 & 14).  
As the infant matures the IBIs shorten and the trace becomes more continuous 
(191, 200, 201). Specifically, at the gestation of 30 weeks the background EEG activity 
becomes continuous only during AS and progressively by 34 weeks this is also 
maintained during wakefulness. At this stage the continuous trace is characterised by the 
term activité moyenne (192). This is a poly-frequency state of low amplitude with mixed 
frequencies. Continuity is gradually established during QS by 36-37 weeks. However, at 
the same time a characteristic trace appears during quiet sleep of semi-periodic features 
of voltage attenuation (< 50 µV) up to 15 seconds, termed trace alternant (TA) (202). This 
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has been observed to emerge as early as 34 weeks of GA (198) and may persist up until 
45-46 weeks of CA.  
 
Figure 2.1.12: EEG of a 24/40 weeks infant. Discontinuous trace with no variability between 
sleep and awake state. Prominent burst like activity of slow δ frequency with intermixed 
higher frequencies (SATs). Adapted from reference (190). 
 
 
Figure 2.1.13: EEG of a 39/40 weeks infant. Quiet sleep with tracé alternant and slightly 
discontinuous background. Adapted from reference (190). 
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Figure 2.1.14: EEG of a 40/40 weeks infant: a) Quiet wakefulness. Polyfrequency activity 
(activite moyennne). b) Active sleep. Continuous activity with mixed frequencies. Low 
amplitude. Bilateral anterior dysrhytmia (normal developmental EEG feature). Adapted 
from reference (190).  
The extremely preterm infant EEG appears, paradoxically hypersynchronous with 
an observed absolute synchronisation of the bursts and IBIs. At the stage of 27-28 weeks 
of GA the EEG becomes asynchronous with the general rule of thumb that the greater the 
distance of the activity from the midline the greater the asynchrony between the two 
hemispheres (179). The maturity of the synchrony of the two hemispheres, likewise 
continuity of the background activity, first emerges in active sleep and then progresses in 
all states coming up to term CA.  
Another feature of the EEG examined during neurophysiological studies is the 
provoked EEG activity, otherwise known as the EEG reactivity to stimulation. Although 
one may observe some reactivity as early as 26-27 weeks (190) this is not always in 
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accordance with behavioural states and is quite inconsistent. It emerges more clearly at 
33-34 weeks of GA with consistency between clinical and neurophysiological state.  
The overall pattern of infant EEG is undergoing constant temporal and spatial 
reorganisation as functional connectivity between the two hemispheres is evolving. It 
changes from discontinuous to continuous and from asynchronous to synchronous. As the 
different behavioural states are established, more mature waveforms and frequencies 
replace the primitive features (see Fig. 2.1.15). The most important factor in EEG 
interpretation is the knowledge of the infant’s GA and/or postconceptional age. 
 
Figure 2.1.15: A simplified schematic representation for neonatal EEG intrepretation. This 
framework demonstrates how two prinicpal components of neonatal EEG; background 
cortical activity and SATs evolve in association with REM and non-REM sleep sates, from 
preterm to term GA. Adapted from reference (203).  
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2.1.5 Frequent EEG Artefacts 
In an intensive care environment, electrical interference from surrounding devices is very 
common. However, some of the most frequent artefacts seen in an EEG recording usually 
derive from the infant themselves.  
One of the most common EEG artefacts is the electrode-pop artefact (see Fig. 
2.1.16). This is a result from a sudden decrease in electrode contact (increase in 
impedance). It appears as a sharp feature, isolated to one electrode, which in a bipolar 
montage will lead to a mirror image across two or more channels. The recognition of this 
artefact is significant as it might be mistaken as a spike or epileptic-form activity.  
 
Figure 2.1.16: Example of the electrode-pop artefact related to the P3 electrode. Note that 
in the beginning of the trace over the fronto-temporal region there is also EMG artefact. 
(adapted by emedicine.medscape.com). 
Another frequently seen artefact is the one arising from muscle activity also 
known as the electro-myogram (EMG) artefact (see Fig. 2.1.17). Muscle contraction 
produces high frequency (20-100 Hz) and high amplitude (up to 100 µV) potentials which 
appear as sudden onset of activity with no equivalent to any meaningful cortical 
waveform. This can typically derive from muscle contraction from and around the head 
with frontalis and temporalis muscles being the principal contributors. 
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Figure 2.1.17:  Example of an electromyogram (muscle) artefact mostly pronounced over 
the left temporal region. ECG artefact also is present, best observed in the posterior region 
(adapted by emedicine.medscape.com). 
The electro-cardiographic (ECG-cardiac) artefact is also invariably seen in EEG 
recordings (see Fig. 2.1.17). The heart beat produces a high amplitude 
electrophysiological signal, which can appear in the EEG recording. The key feature is 
that its frequency is identical to that of the patient’s heart rate. A single channel ECG 
alongside the EEG recording facilitates the identification and rejection of the ECG 
artefact.     
The eye movement artefact (see Fig. 2.1.18) occurs because the eyeball acts as an 
electrical dipole with the retina negatively charged and the cornea positively charged. 
This electrical potential can infiltrate the EEG recording. Lateral, vertical, and blinking 
eye movements can be identified based on the polarity and symmetry of the changes in 
electrical potential difference as detected by the frontal EEG electrodes. They are rarely 
apparent posterior to the mid-temporal region. This artefact is quite common in EEG 
recordings but can be difficult to identify in the absence of recorded eye movements. In 
this respect an electro-oculogram (EOG, where additional electrodes are placed in the 
outer canthus of the eyes) can facilitate the identification of eye movement artefact (204), 
as well as REM sleep state.  
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Figure 2.1.18: Example of an eye movement artefact mainly observed in frontal electrodes 
and not further posteriorly than the mid-temporal region (adapted by 
emedicine.medscape.com). 
Normal respiration can produce two types of artefacts; slow, rhythmic waves in 
synchrony with body movements during respiration, which typically affects the 
impedance of one electrode or slow or sharp waves in synchrony either with inspiration 
or expiration, which affect the electrodes upon which the infant is lying. Many 
commercially available devices couple the respiration monitoring with ECG and EEG. 
This is performed with a band over the infant’s abdomen and a sensor detecting the 
movements in inspiration and expiration. 
Other significant artefacts include those due to movement of the mouth and tongue, and 
artefacts due to equipment such as intravenous pumps, mechanical ventilators.  
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2.1.6 Abnormal EEG features and rhythms 
The interpretation of EEG requires the expertise of a clinical neurophysiologist. Pattern 
recognition and detection of abnormalities in a neonatal EEG can only be achieved with 
good understanding of the developmental features in different GA and postconceptional 
age, which have been described previously. For monitoring and prognostic purposes, the 
first EEG in at risk infants should be performed within the first 24 hours of life or after a 
significant event such as a brain insult (179). Similar electroencephalographic 
abnormalities are seen in both preterm and term neonatal EEG. In this section, the main 
aim is to briefly describe some of these patterns but not to exhaust the wide range of 
variations seen in neonatal EEG. 
One of the things that one may comment on whilst reviewing an infant’s EEG is 
the maturity of the trace compared to the infant’s GA and postconceptional age. However, 
in cases where the EEG does not contain the expected developmental features for the 
equivalent GA or postconceptional age, the EEG is characterised as dyschronous. If the 
features are absent in all states then there is external dyschronism, whereas if appropriate 
features are seen in the awake state but not in the quiet sleep state, that is termed internal 
dyschronism. 
Some maturational abnormalities observed may be transient, especially in clinical 
situations such as HIE. At a later stage, as the infant is recovering from the initial hypoxic-
ischaemic insult, the observed EEG activity may normalise completely. It is therefore 
always important to repeat an EEG study in the recovery or even healthy state as it may 
appear that these abnormalities are no longer present. Similarly, an EEG feature which 
may be affected by a cerebral insult but may also reflect the use of sedative medications 
(205) is the prolongation of IBIs. In the acute phase of HIE faster frequencies in the 
electrocortical activity tend to be depressed or absent. It is as if the cortex regresses to a 
more primitive low energy activity, the trace becomes less variable or more 
discontinuous.  
Another finding of abnormal cortical function is the recurrence of either 
generalised or localised amplitude attenuation. Along the same lines, depression, or lack 
of differentiation in the cortical activity may be a sign of cortical dysfunction in cases 
such as HIE, where there is partial or complete absence of the normally expected poly-
frequency activity (206). Therapeutic hypothermia (TH) applied to infants with HIE may 
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also have an added effect on the EEG activity. As the infant recovers and TH is gradually 
discontinued these features may persist or may be replaced by the emergence of 
continuous trace, poly-frequencies, and multifocal sharp waves or even seizures (207, 
208). However, if the EEG remains undifferentiated and depressed in the recovery phase, 
this is a sign of poor prognosis.  
Burst suppression (BS) is a pathological EEG trace that may be seen in the 
neonatal period. This electroencephalographic pattern is defined as a constant alternation 
between high-voltage slow, occasionally sharp waves (bursts) and depressed or 
suppressed low-voltage activity (IBIs) (209) (see Fig.2.1.19).  This abnormal EEG pattern 
is described in more detail in section 2.1.8. 
 
Figure 2.1.19:  Burst-suppressed pattern of a 42/40 weeks post-term infant with HIE. Image 
adapted from www.emedicine.medscape.com. 
A more severe form of cerebral dysfunction is electrocortical silence (see 
Fig.2.1.20). It is important to note that an isoelectric EEG trace represents absence of 
activity over the cortex but does not exclude activity in deeper brain structures such as 
the brainstem, which may sustain vital functions for prolonged periods in the absence of 
higher cerebral function.  
There are certain generalised EEG patterns typical of certain syndromes or clinical 
entities. Gibbs and Gibbs described the pattern of hypsarrhythmia, which is closely 
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associated to the condition of infantile spasms and is characterised by high amplitude and 
irregular waves and spikes in a background of chaotic and disorganized activity (210) 
(see figure 2.1.21). Another example is that of holoprosencephaly, a congenital 
developmental defect, where the EEG appearance consists of multiple features occurring 
randomly with abrupt changes from one pattern to another, and consist of multifocal spike 
and polyspike activity, monorrhytmic activity, asynchrony, iso-electric or low frequency 
activity, and overall lack of normal organisation (179, 211). 
 
Figure 2.1.20: EEG showing electrocortical silence. Note the presence of regular 
electrocardiographic cardiac rhythm. Image adapted from reference (212). 
In other cases of abnormal EEG patterns there can be focal or generalised features. 
For instance, there can be sustained rhythmic alpha and theta activity, or sustained 
rhythmic delta activity especially in the bifrontal regions, which are all considered 
pathological. Other focal abnormalities consist of periodic complexes, which are closely 
associated with neonatal herpes simplex encephalopathy (213, 214). The presence of 
central positive sharp waves in an infant’s EEG recording has also been associated with 
neonatal brain injury. These are not epileptiform discharges, but their natural progress 
and physiological process is not well understood. The rate of their occurrence (more than 
2 per second) has been proven to be associated with poor outcome (215, 216). Central 
positive sharp waves have been linked to severe intraventricular haemorrhage, 
periventricular leukomalacia, haemorrhagic parenchymal infarct and  periventricular 
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echodensities, and are considered more specific to white matter necrotic lesions than to 
intraventricular haemorrhage (217). Temporal sharp waves may also be noted in an 
infant’s EEG, and it is often difficult to differentiate whether they are normal or abnormal. 
Overall, random sharp waves with infrequent recurrence (less than 2-3 per hour), with 
negative polarity of their initial component and arising from any location of the scalp 
without specific focality are considered normal with unclear clinical significance.  
Focal slow activity that is persistent over a certain brain region is suggestive of a focal 
lesion such as infarction, haemorrhage, or even specific congenital anomalies. Similarly, 
unilateral attenuation of the background activity can be associated with focal 
intraparenchymal lesions such as cerebral infarction. A certain degree of asymmetry of 
the background activity between the two hemispheres is expected in the neonatal EEG, 
particularly during non-REM sleep.  
 
Figure 2.1.21: Hypsarrhythmic EEG pattern. Note the characteristic high-voltage, 
disorganized, chaotic, and asynchronous slow waves with superimposed multifocal spikes 
or sharp waves. Periods of generalized electro- decrement are seen throughout the 
recording and may be associated with clinical spasms.  The above pattern is often more 
pronounced during non-REM sleep with the background activity during wakefulness even 
being normal. Image adapted from www.acns.com. 
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2.1.7. Neonatal Seizures 
Seizures occur secondary to an excessive synchronous depolarisation of neurons within 
the central nervous system (218-220). Clinically, a seizure is defined as a sudden, 
stereotypical and repetitive episode of abnormal electro-cortical activity with a peak-to-
peak amplitude of at least 2 μV, a minimum duration of 10 seconds, and dynamic 
evolution over time with clear beginning, middle, and end (221). 
A series of studies have explored the potential pathophysiological trajectories 
behind the genesis of neonatal seizures. It is fair to say though that neonatal seizures are 
still not clearly well understood. As described and summarised by Volpe, neonatal 
seizures can be secondary to: i) disruption in energy production, affecting the energy 
based Na+-K+-pump, ii) excess of excitatory versus inhibitory neurotransmitters, iii) 
deficiency of inhibitory versus excitatory neurotransmitters; the latter two both resulting 
in excessive rate of depolarisation, and deficiency of calcium and/or magnesium which 
play a significant role in the balance of the neuronal membrane permeability to Na+ (222).  
Neonatal seizures are a separate clinical entity compared to those of older children 
and adults and may also vary when comparing preterm with term infants. This is primarily 
due to a series of neuroanatomical and neurophysiological maturing processes of the 
developing brain. From an anatomical perspective, the main developmental features are 
the migration, orientation, and alignment of cortical neurons, the development of axonal 
and dendritic ramifications and creation of synapses. From a neurophysiological 
perspective, the most crucial role is played by the neurotransmitters: gamma-
aminobutyric acid (GABA) and glutamate in terms of their levels, activation or 
inactivation (223).  
Neonatal seizures, more recently reported as occurring in 0.5 to 3 infants per 1,000 
live births, with their incidence increasing in preterm infants (4). This might appear as a 
relatively rare occurrence, but when centres deal with up to 6,000 births a year and regions 
up to 80,000 births a year, it translates to a relatively frequent clinical problem. 
Additionally, most of the epidemiological studies include only clinical seizures with the 
incidence of purely electroencephalographical seizures not yet known. The requirement 
for early identification, diagnosis and effective treatment lies in the significant association 
of neonatal seizures with disability in life. In up to 50% of cases, there will be some form 
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of neurological sequelae, such as epilepsy, cerebral palsy, and/or intellectual disability 
(224, 225).  
Variations in reported incidence of neonatal seizures can be explained by different 
diagnostic definitions and methods used. Most neonatal seizures occur on the first day, 
and 70% of all cases eventually recognised have been diagnosed by the fourth day. 
Humans are more likely to present with a seizure in the neonatal period than any other 
point in their lifetime. Subtleties, such as equivocal clinical manifestation, electroclinical 
dissociation with ongoing epileptiform electrical activity without any clinical association, 
and the lack of equipment and trained staff for 24-hour service in EEG readings, make 
the diagnosis of seizures challenging. In a recent study in which members of a clinical 
team were shown 20 video recordings of infants with seizure or seizure-like activity, only 
50% were correctly identified, with poor inter-observer agreement and no difference 
between medical and non-medical staff in the interpretation of the videos (226). 
Seizures are clinically subdivided into clonic, tonic and myoclonic. They can also 
be focal or generalised. Generalised tonic-clonic seizures are rare in the neonatal period. 
They can be very difficult to differentiate from spontaneous normal movements, with 
variable EEG correlation and associated autonomic phenomena (226). An additional type 
of neonatal seizures, where the described paroxysmal movements and changes in the 
behaviour of the infant are neither of the above, nor normal (see Table 2.1). These are 
termed as subtle seizures, and are associated with a variety of abnormal movements, such 
as eye flickering, staring, chewing, lip smacking, cycling movements of the lower 
extremities with autonomic phenomena (most usually referring to increase of systemic 
blood pressure) (227). Their correlation to electroencephalographic activity is variable 
(227). They are more frequent in premature infants (228), but can also be noted in term 
infants with variable EEG correlation (229).  
Clonic seizures are most frequently associated with time-synchronised EEG 
seizure activity (229, 230). They are rhythmic and rather slow compared to other seizure 
types. They can be focal, multifocal, or generalised. Focal clonic seizures are most 
frequently associated with cerebral infarction but can also occur in the background of 
metabolic encephalopathies. Tonic and myoclonic seizures are less likely associated with 
time-synchronised abnormal electrical activity (229). Tonic seizures are usually focal or 
generalised and involve sustained posturing of limbs or trunk and neck. Horizontal 
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deviation of the eyes has been described as a type of focal tonic seizure (229). Myoclonic 
seizures are differentiated from the rest and especially clonic seizures by the fact that they 
are more rapid and preferably involve flexor muscle groups. They can be focal, 
multifocal, or generalised. Knowledge of the different types of seizures is crucial in 
determining underlying pathologies and strategic approach in their management.  
TYPE CLINICAL MANIFESTATION  FREQUENCY AND EEG 
CORRELATE 
Subtle Eye flickering, eye deviation, stare, 
blinking. Apnoea. Cycling, boxing, 
stepping, swimming movements of the 
limbs. Mouthing, chewing, lip smacking, 
smiling.  
~50% of neonatal seizures; EEG 
correlation is variable; EEG changes 
occur most likely with ocular 
movements. 
Tonic Stiffening, decerebrate posturing ~5% of neonatal seizures; EEG 
correlation is variable. 
Clonic Repetitive jerking, distinct from 
jitteriness. May be uni- or multifocal.  
25-30% of neonatal seizures; EEG 
correlation highly likely especially if 
focal. 
Myoclonic Myoclonic jerks; sleep myoclonus can be 
benign. 
15-20% of neonatal seizures. EEG 
normal if focal or if sleep myoclonus. 
Table 2.1: Types of neonatal seizures. Table adapted from reference (231). 
Neonatal seizures tend to occur during active sleep, if sleep-wake cycle is 
preserved (232). The average seizure duration is from 1 to 5 minutes (221, 233, 234). 
However, more recent studies with the added benefit of continuous EEG monitoring have 
shown a high incidence of seizure activity lasting up to 30-40 minutes (235-237). For 
seizures to be considered as distinct phenomena there needs to be at least a 10 second 
inter-ictal interval between one seizure to the next (238).  
Neonatal seizures have been categorised as local, lateral, diffuse or unifocal, 
multifocal, and bilaterally independent (239). This categorisation is done based on the 
location, the focal point of seizure onset and the region involved during the maximal 
spread of the seizure activity as observed on EEG recordings. Most commonly neonatal 
seizures are initially focal and then spread to become generalised. It is very rare that they 
are originally diffuse or generalised (240). What is of great interest is that the focus of 
seizure activity can shift from one hemisphere to the other, known as the flip-flop 
phenomenon (241). Identifying the focal onset of seizures is of utmost importance in 
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aiding clinical diagnosis as focal seizures can be associated with focal injury, while 
generalised events are more often associated with widespread injury, such as infection 
(242). However, it is important to note that in the neonatal period, generalised injury can 
also present as focal seizures (243). 
Diagnosis of neonatal seizures is further complicated by the fact that infants may 
present with stereotypical, rhythmic movements with no EEG correlate. It is unclear as 
to whether these events arise from subcortical structures (i.e., brainstem, hippocampus) 
impossible to capture with conventional EEG and as to whether one should treat with 
anticonvulsant medications (5). On the other hand, what is frequently seen especially in 
immature infants or infants who have already received anticonvulsant treatment, is the 
presence of electrographic seizures in the absence of clinical seizure activity. This is 
widely known as electroclinical dissociation, a phenomenon well described in the 
literature (10, 244-246). One hypothesis supports that the electro-clinical dissociation 
could be due to the excitatory as opposed to inhibitory role of the GABA neurotransmitter 
in the neonatal period. This is mediated by the efflux of chloride ions (Cl-) (secondary to 
expression of two membrane co-transporters of Cl- at the perinatal period), which 
eventually depolarises the neuronal membrane causing excitation (247-249). Frequently 
used anticonvulsant agents such as benzodiazepines and phenobarbital act as GABA 
agonists which may be an explanation for the fact that despite cessation of the clinically 
observed seizure there is ongoing electrographic seizure activity.   
Another challenge in managing neonatal seizures is the clinical significance of 
electrical seizures with no clinical manifestation, termed subclinical seizures. Previous 
studies assessing continuous video-EEG monitoring amongst children admitted in 
intensive care units have identified subclinical seizures in up to 46% and status epilepticus 
in as many as 23% (250-252). Similar results have been shown in studies of critically ill 
neonates with subclinical seizures (18, 210). Most of these seizures would go undetected 
without the presence of continuous video-EEG recordings. Their effect on ongoing brain 
injury has long been debatable (252), with increasing evidence to support an association 
between subclinical seizures and poor neurodevelopmental outcome (19, 253). 
The question that naturally arises is why is it important to monitor these events if 
we do not yet fully comprehend their clinical relevance? Furthermore, should we only 
treat clinically obvious seizures and not EEG-only seizures? Such questions have 
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tormented clinical neurophysiologists and neonatologists for years and clear answers are 
yet to be established. However, continuous EEG monitoring increasingly reveals that 
exclusive clinical judgement on seizure detection is a poor and incomplete approach 
which can lead to over or underestimation of the seizure incidence, morphology, and 
evolution.  
There are extensive animal-based research studies showing the direct effect of 
seizures on brain injury. Recurrent seizures in infants may affect their ventilation and lead 
to periods of prolonged hypoxia and hypercapnia that precipitate brain injury, especially 
in an already insulted cerebral region. However, there are clinical ways to support and 
improve ventilation and oxygenation. Studies in paralysed adult animals showed that the 
recurrence of seizures results in a point where the increase in energy supply can no longer 
maintain the decrease in energy reserves. It was shown that failure in energy supply leads 
to further prolongation of the seizures with irreparable injury to the brain tissue (254-
256). Other studies have shown that severe seizures result in excessive secretion of 
excitatory amino acids, such as glutamate; a principal excitatory neurotransmitter in the 
central nervous system. This appears to occur preferentially in areas involving the 
hippocampus and limbic structures leading to neurotransmitter mediated post-synaptic 
damage and eventually neuronal death (254-258). Although, most studies suggest that the 
neonatal brain is more resilient to seizure mediated neuronal necrosis than that of the 
adults (259), it is worthwhile noting that critically-ill infants will most likely present with 
EEG-only seizures rather than clinical seizures (243, 260). Therefore, close, continuous 
monitoring and a careful clinical approach is required for the neonatal groups most at risk 
of seizures and brain injury. Examples of neonatal seizure patterns may be seen in the 
following figures (2.1.22-24). 
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Figure 2.1.22: EEG trace in epileptic encephalopathy with continuous spike-and-wave 
appearance during sleep. Adapted from reference (261).  
 
 
Figure 2.1.23: Example of rhythmic right delta occipital epileptiform discharge at a 
suppressed electrical background. This trace was not associated with any clinical seizures. 
Image adapted from reference (262). 
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Figure 2.1.24: Example of rhythmic sharp wave activity over the left hemisphere. This was 
clinically associated with clonic jerking of the right arm and of the leg. Adapted from 
reference (262).
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2.1.8 Burst Suppression 
Burst suppression (BS) is a pathological EEG trace defined as the periodic alternation 
between high amplitude waves (bursts, 150 -350 μV) and depressed or suppressed cortical 
activity (inter-burst intervals, IBIs, <25 μV). It is considered as a state of profound brain 
inactivation (263) (for example see Fig. 2.1.19). It is an indication of global brain 
dysfunction and inactivation. Many studies have shown an association between the 
recovery rate from a burst-suppressed to a continuous EEG trace and long-term prognosis, 
and outcome post HIE in the neonatal period (113, 264). The presence and persistence of 
such electrocortical activity (or inactivity) is therefore associated with poor prognosis and 
adverse neurodevelopmental outcome (111, 265, 266).  
In stricter neurophysiological terms, though, the IBI activity seen on a BS pattern 
is minimal to non-existent with amplitudes of less than 5 μV. When the IBI amplitude 
ranges above that threshold but remains less than 25 μV it is referred to as a discontinuous 
trace. There are other sources, that have used different upper thresholds of IBI amplitude 
to define BS, including 10 μV (267), 20 μV (180) or 25 μV (268). The BS pattern in the 
neonatal EEG is associated with poor outcome. However, this serious abnormal pattern 
constitutes only a small proportion of discontinuous neonatal EEGs (264).  
The term discontinuous EEG is invariably used to describe the preterm EEG of 
different postconceptional ages as well as different sleep states (see section 2.1.4). 
Conversely, a discontinuous EEG pattern in the term-age infant, with no variability over 
the sleep-wake cycle is representative of neuropathology. In this instance, we are referring 
to the pathological discontinuous pattern which shows no variability between the awake 
and sleep state and is characterised by the quiescence of bursts; high voltage waves with 
intermixed, disorganised frequencies and IBI periods of suppressed activity (with 
amplitude of <25 μV). 
Burst suppression can be secondary to a variety of conditions, such as hypoxia 
and ischaemia (269), coma (269), specific encephalopathies with neonatal presentation, 
such as Ohtahara syndrome (270), anti-epileptic medications, deep anaesthesia (271), and 
hypothermia (272, 273) and is observed across all age groups. Chapter 5 focuses on these 
EEG states of infants, secondary to HIE. This clinical entity is characteristic of the term 
infant who has experienced a severe perinatal deficit in the cerebral oxygen delivery 
leading to the disruption of the cerebral energy metabolism (222) (see section 1.1.2).  
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In infants with HIE, the severity and persistence of such abnormal EEG changes 
has traditionally been one of the markers directly related to the severity of the insult, the 
risk of ongoing neuronal damage and poor long-term prognosis. Several studies have 
shown that the rate of recovery of the electro-cortical activity is closely related to outcome 
and that the longer the EEG remains abnormal the higher the risk of an adverse 
neurodevelopmental outcome (111, 113, 114, 265, 274). In a study looking at aEEG 
background tracings in the first 6 postnatal hours in infants with HIE, it was shown that 
80% of the infants presenting with BS either died or had severe disability at follow up 
(111). Another study looking at term infants with excessively discontinuous EEGs, 
showed that when infant’s EEG contains a predominant IBI duration of more than 30 s 
there is 100% probability of severe neuro-disability or death and an 86% chance of 
developing epilepsy (264).  
More recent EEG work has focused on developing more objective mathematical 
metrics for prediction of outcome in HIE infants. This has demonstrated that certain 
parameters of the BS trace such as the distributions of burst area (area under the curve) 
and burst duration predict later clinical outcome comparable to structural neuroimaging 
and neurodevelopmental assessment (267). Japaridze et al., identified different neuronal 
networks in the burst and suppression phases in human infants with BS, by applying 
dynamic imaging of coherent sources (DICS) on EEG segments (268). 
Despite the extensive EEG work, certain aspects of the BS pathophysiology, its 
behaviour and characteristics remain unclear. Its unified appearance and presentation in 
different age groups and under different conditions suggest a common pathophysiological 
process. It appears as the brain becomes inactive, entering a low energy phase in response 
to brain injury in the same way that a chemical agent (such as an anaesthetic agent) would 
induce BS.  
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2.2 Near-Infrared Diffuse Optical Imaging 
2.2.1 Basic Principles of Biomedical Optics 
Biomedical optics is a broad term which incorporates the various approaches and methods 
of using light to study biological tissue. Diffuse Optical Imaging (DOI) is one of these 
methods, which have evolved from near-infrared (NIR) spectroscopy, originally 
described in the 1970’s (275). The description of the properties of NIR light and the 
physical principles of tissue spectroscopy is therefore essential to the understanding of 
DOI.  
Visible light exists at wavelengths in range of 450 to approximately 700 nm and 
is strongly attenuated by biological tissue. As a result, it is difficult to transmit visible 
light more than a few millimetres through tissue. However, biological tissue is relatively 
transparent to NIR wavelengths of light, whose spectrum is just beyond the visible, 
ranging from approximately 700 to 1000 nm. Near infrared spectroscopy (NIRS) 
therefore, uses variations in the intensity of back-scattered NIR light through a region of 
tissue to determine the changes in the optical properties of that tissue. These changes or 
variations in tissue optical properties are dependent upon changes in concentration of 
tissue chromophores. Chromophores (optical absorbers) are compounds within biological 
tissue that absorb light in the NIR spectrum. The most important such chromophores are 
the oxygenated and deoxygenated forms of haemoglobin, referred to as oxy-haemoglobin 
(HbO2) and deoxy-haemoglobin (HHb). Haemoglobin carries oxygen to tissue via the 
circulatory system. Changes in the levels of haemoglobin indirectly suggest changes in 
oxygen supply to and consumption by the tissue. By using simple models with regards to 
how NIR light is absorbed and scattered through tissue one can calculate changes in the 
tissue concentration of HbO2 and HHb.  
Absorption of light 
Understanding the principles of how light is absorbed by the chromophores and scattered 
within the tissue, and how it provides a way of measuring the changes in oxy- and deoxy-
haemoglobin concentrations is complex. However, the description of what happens when 
light is transmitted through a simple, one-dimensional medium aids in the understanding 
of the basics of light interactions.  
If we assume that NIR light is transmitted through a non-scattering medium that 
contains an absorbing compound of concentration (c), the intensity of that light will fall 
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exponentially with distance through this medium. Each absorbing compound has specific 
absorbing properties, described by its absorption coefficient, μa, which is related to the 
probability of a photon being absorbed per unit length of travel through a medium 
containing that compound alone. The mathematical description of this fall in light 
intensity, is expressed by the Lambert-Bouguer Law: 
       I/I0 = e -μa.d                              Equation 2.1 
In the above equation, I is the transmitted light intensity, I0 the incident light 
intensity and d, the optical pathlength, which is the distance traversed through the 
medium, μa expresses the absorption coefficient of the absorbing compound at a given 
wavelength (See Fig. 2.2.10). 
Equation 2.1  originates from Bouguer (276), and was adopted by Lambert who 
stated that when light travels through a layer of a substance, the fraction of the radiation 
absorbed is only dependent on the thickness of the layer (pathlength) (277). Beer was the 
first to describe the relationship between the absorption coefficient and the concentration 
of the absorber. He stated that: ‘for an absorbing substance dissolved in a non-absorbing 
medium, the optical density is proportional to the concentration of the absorber.’ (278). 
The following equation mathematically expresses this: 
                 μa = α.c                                  Equation 2.2 
Where α is the specific absorption coefficient for that compound, and c is the 
molar concentration of the specific compound. The specific absorption coefficient 
represents the level of absorption per mole of absorber per litre of solution per unit 
distance of optical pathlength. It is related to the probability of a photon being absorbed 
per unit length. This was adapted and expressed as the Beer-Lambert Law: 
I/I0 = e-a.c.d                                        Equation 2.3 
The negative logarithm of the intensity ratio on the left-hand side of Eq. 2.3 is 
known as optical attenuation and is measured in the units of optical density.  The higher 
the attenuation, the lower the ratio of transmitted light to incident intensity, i.e. the higher 
the absorption of light by the medium. Essentially attenuation is the decrease in light 
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intensity whilst light is travelling through an absorbing, non-scattering medium, and is 
expressed by the following equation:   
    A=ln[I/I0] = a.c.d                            Equation 2.4        
The transmitted light intensity, I is dependent on both the absorbing properties of 
the absorbing compound (given here by the specific extinction coefficient) and upon the 
wavelength of the light that is incident upon it; the absorption spectrum of the compound 
describes this wavelength dependent absorption.  
Absorbers in tissue 
The principal medium of interrogation in biomedical optics is the human tissue, within 
which the main compound of interest is haemoglobin. However, it is also important to 
have a basic understanding of the optical properties of other chromophores within human 
tissue, such as water, lipids, melanin, and cytochrome oxidase. 
Water 
Water is one of the principal components of human tissue, with 80% of the adult brain 
tissue mainly comprising water (279). The light absorption by water is higher at 
wavelengths above 900 nm (see Fig. 2.2.1). Between wavelengths of 200 to 900 nm, water 
exhibits a window of transparency (280) within which human tissue can be investigated. 
 
Figure 2.2.1: Representation of the absorption coefficient of water. Adapted from reference 
(280). 
2.2.1 Basic principles of Biomedical Optics 
 
105 
 
Haemoglobin 
Within this window of transparency, haemoglobin is the chromophore which is absorbed 
in the NIR spectrum, between 600 and 900 nm. It is worth noting that there is a 
differentiation in absorption properties between HbO2 and HHb. The difference in the 
absorption levels between these two compounds in the visible part of the spectrum 
explains the appearance of blood; where oxygenated blood (arterial) appears bright red, 
and deoxygenated blood (venous) appears more purple or blue (see Fig. 2.2.2). Similarly, 
light at 850nm will be absorbed more by HbO2 and less by HHb; conversely light of 
750nm will be absorbed predominantly by HHb (see Fig. 2.2.2 & 2.2.3). An isosbestic 
point, where the specific extinction coefficients of both haemoglobin compounds are 
equal exists at 800 nm. Before and after this point the absorption of the spectra differs for 
HbO2 and HHb. This difference allows spectroscopic separation of the two compounds 
by only using a few sample wavelengths. By illuminating tissue with two or more 
wavelengths, the changes in the absorption of those two wavelengths of light can be used 
to calculate the relative concentration changes of both HbO2 and HHb.  
 
 
 
Figure 2.2.2: Representation of the absorption (molar extinction) coefficients of HbO2 (blue 
line) and HHb (pink line) for different wavelengths between 400 to 1000 nm. The spectrum 
of visible light is overlaid on the x axis. The black square indicates light in the NIR range 
with the isosbestic point of HbO2 and HHb. Adapted from reference (281).  
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Figure 2.2.3: Representation of the absorption spectra for HbO2 and HHb in the NIR range. 
Note the significant differentiation in absorption before and after 800nm, where the specific 
absorption coefficient is equal for both compounds. This is the isosbestic point at which the 
concentration of the two chromophores can be estimated independent of the oxygen 
saturation. Before and after this point the differences in absorption of the spectra are 
significant and consistent. Therefore, the changes in the absorption of two wavelengths of 
light on either side of the isosbestic point can be used to calculate the relative concentration 
changes of both oxy- and deoxy-haemoglobin. Adapted from reference (281). 
 
Lipids 
Although the distribution of lipid in tissue may vary based on different types of tissue, it 
can also be considered as a constant absorber, the concentration of which is unlikely to 
change during an experiment. The absorption spectrum of lipid is like the one of water.  
Cytochrome c 
Cytochrome c oxidase (CtOx) is the last enzyme of the cellular respiratory electron 
transport chain, within the mitochondrial membrane. It receives an electron from each of 
four cytochrome c molecules, and transfers them to one oxygen molecule, converting 
molecular oxygen to two molecules of water. The concentration of CtOx in tissue is 
approximately a tenth of that of haemoglobin and consequently has a relatively small 
effect on the total absorption coefficient of tissue. It is worth mentioning that the relative 
amount of CtOx in a reduced or oxidised state can provide an indirect measure of the 
metabolic demand of a region of tissue. As the total concentration of cytochrome oxidase 
is a constant which does not vary, it is the difference in the absorption coefficient of 
reduced and oxidised CtOx which is relevant to spectroscopic measurement. Its 
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concentration, however, is relatively low compared to haemoglobin and unless using 
specific broadband spectrophotometers it is difficult to measure (282). 
Scattering of light 
Scattering is the other main way in which light interacts with tissue. The term scattering 
includes a variety of light-matter interactions which maintain the existence of the 
incoming photon but may alter its direction of travel (elastic scattering) or degrade the 
photon’s kinetic energy (inelastic scattering).  Scattering is the dominant light-matter 
interaction in biological tissue at visible and NIR wavelengths. In most cases, when a 
photon travels within a scattering medium, the different compounds will change its 
direction of travel but not its kinetic energy. Inelastic scattering is generally neglected in 
biomedical optics. In the same way that the absorption coefficient (µa) describes the 
absorption properties of a certain compound, the scattering coefficient (µs) describes its 
scattering properties.  
Because of the effect of scattering and unlike the controlled example above, light 
does not travel in a straight line through biological tissue. The biological tissue per se is 
a scattering medium with its compounds constantly changing the direction of light (see 
Fig. 2.2.4), forcing to follow a random path. This is where the term, diffuse, often used 
to describe imaging methods (see section 2.2.4), derives from. The direction in which the 
scattered photon will travel is dependent on the size of the scattering compound, the light 
wavelength, and the refractive indices of the scattering medium.   
 
Figure 2.2.4: The effect of light scattering through a medium containing a scattering 
component.  
The probability of any given photon being absorbed will no longer be a simple 
function of the thickness of the medium as originally described by Bouguer. As a photon 
is undergoing a great number of scattering events, it must travel a greater distance to 
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traverse the medium, thus increasing the probability being absorbed. The revision of the 
model for the attenuation of light intensity whilst travelling through biological tissue, is 
known as the modified Beer Lambert law:      
  
A = log10[I/I0] = a.c.d.B+G            Equation 2.5                                          
                    
A stands for attenuation of light intensity, Io for intensity of light incident upon an 
absorbing and scattering medium, I intensity of light transmitted through the medium, a 
for the specific extinction coefficient of the absorbing compound measured, c for 
concentration of the absorbing compound in the solution, d geometrical distance that the 
light travels, B for differential pathlength factor (DPF) and G as the additive term to 
account for scattering losses (i.e. photons that are scattered away from the detector). The 
DPF accounts for the expected increase in average pathlength due to scattering events 
(283), and is dependent upon the reduced scattering coefficient, the absorption coefficient 
and the geometry of source and detector.  
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2.2.2 Measurements using near-infrared light 
The modified Beer-Lambert law is the most important equation in biomedical optics and 
it allows us to calculate several physiologically important characteristics. However, in the 
same manner the original Beer-Lambert law did not account for the scattering effect, there 
are certain limitations within the modified version of the law regarding these 
measurements.  
The factor which is the most difficult to calculate is the geometrical loss due to 
scattering events, G, as this is dependent upon the geometry of the tissue, as well as the 
scattering coefficient of the tissue under investigation. Without knowledge of G, the 
calculation of the absolute concentration of a compound, c, becomes impossible. 
However, if one assumes that the factor G, remains constant and does not change between 
two, it then becomes possible to calculate the changes of concentration of a compound 
from the measured change in attenuation between the experiments.  
Imagine light of intensity Io, illuminating a highly scattering medium that contains 
an absorber (chromophore) with a concentration c1. The light attenuation is measured as 
A1, but c1 is not possible to determine due to the unknown contribution of scattering 
losses, G. Similarly, if we repeat the experiment with the exact same medium and incident 
light intensity, Io, but change the concentration of the absorber within the medium to c2, 
we will be able to measure the light attenuation, A2.  
 
A1 = c1.a.d.B + G                            Equation 2.6 
A2 = c2.a.d.B + G                            Equation 2.7 
 
Note that in both equations 2.6 and 2.7, and following certain assumptions, we can 
calculate the absolute changes in chromophore concentration based on the absolute 
measurements of light attenuation as shown in equation 2.2.8. 
 
        ΔA = A2 - A1 = (c2 - c1).a.d.B                    Equation 2.8 
 
As noted above, factor G is eliminated in Eq. 2.8. Therefore, based on 
measurements of the change in attenuation one could determine the changes in absorption 
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coefficient. However, prior to that, there remain the DPF and optical pathlength (B and d 
respectively) to be calculated.  These two values together represent the average time taken 
by photons to travel through a medium. By calculating the mean time in which photons 
travel through a medium and knowing the optical properties of the medium, one may 
determine the DPF. The latter can also be approximated based on the optical properties 
of the medium (284, 285). In NIRS applications, the DPF is often taken as a fixed, 
constant value, based on previous measurements according to type of tissue and subject 
being interrogated.  
As mentioned in section 2.2.1, there are many chromophores in biological tissue, 
but only those which vary in concentration over the timescale of an experiment, as well 
as absorb light in the NIR spectrum, will contribute to the absorption coefficient. 
Therefore, the ones of most physiological interest are the changes in concentration of 
HbO2, HHb and CtOx to provide any measured variation in absorption coefficient.  
Combining the above knowledge with the basis of Eq. 2.8, by measuring at two 
different wavelengths simultaneously it is possible to calculate the concentration changes 
in HbO2 and that of HHb, as shown in Eq. 2.9 and Eq. 2.10. The standard approach to 
performing NIRS is by measuring the changes in attenuation at two light wavelengths 
over the same volume of tissue. The concentration changes of the chromophores are 
subsequently calculated by solving equations 2.9 and 2.10. By adding a third wavelength 
it becomes possible to measure another chromophore, i.e. CtOx. 
 
Δμa (λ1) = εHbO2(λ1).ΔC HbO2 + εHHb(λ1).ΔC HHb              Equation 2.9 
Δμa (λ2) = εHbO2(λ2).ΔC HbO2 + εHHb(λ2).ΔC HHb            Equation 2.10 
  
Δμa (λ1) and Δμa (λ2) represent changes in absorption coefficient, whereas εHbO2(λ1) 
and εHbO2(λ2) represent the specific extinction coefficient for HbO2 at the relevant 
wavelengths λ1 and λ2 (and similarly for HHb - εHHb(λ1) and εHHb(λ2)). 
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2.2.3 Neurovascular coupling 
NIRS is an ideal tool for measurements of changes in the chromophore concentration of 
a given medium, and it is thus mostly applied to experiments where a stimulus invokes a 
change in the chromophore concentration. An ideal such medium is the human cortex, 
which is rich in both neuronal and vascular activity.  
During a purposeful movement or a cognitive task there is a natural increase in 
electro-cortical activity which leads to increased metabolic demands and energy supply 
at a cellular level (286, 287). The principal molecule in energy production or consumption 
on a cellular level is adenosine tri-phosphatase (ATP), which is the end-product of cellular 
respiration. Repeated neuronal activation results in a constant re-polarisation of the 
neuronal membrane back to its resting potential state, a highly energy consumptive 
process. The ion transporters across the neuronal membrane are fuelled by ATP and their 
increased activity leads to high ATP requirements and therefore, increase in cellular 
respiration. The latter process is driven by both O2 and glucose supply, which is provided 
by the flow of regional vasculature (see Fig. 2.2.5).  
Cerebral blood flow (CBF) is vital to the brain, and there is a constant baseline 
flow for maintaining all basic functions (288). Within the cerebrovascular system there 
are heterogenous mechanisms which maintain cerebral blood flow at a level which meets 
the energy requirements and prevents sudden fluctuations due to changes in systemic 
arterial blood pressure. The control of blood supply to the brain is tightly regulated at 
both a global and regional level. Global cerebral autoregulation, which maintains CBF 
over a range of perfusion pressures is regulated by smooth muscle cells in the cerebral 
arterioles (289). Local supply of blood to meet metabolic demand of neuronal tissue is 
regulated both by smooth muscle cell activation as well as local metabolic factors. In this 
way, a constant supply of oxygen and glucose is provided to the neuronal tissues in an 
activity-dependent manner. 
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Figure 2.2.5: Representation of the interactions between neuronal and vascular activity. The 
above shown cell types are thought to contribute primarily in the cerebro-vascular control 
with vasoactive interneuron and astrocyte processes being transmitted to both the principal 
neurons (in grey) and the arterioles (in red). Image adapted from reference (286).  
 
This link between transient neuronal activity and the corresponding increase in 
cerebral blood flow (CBF) is called neurovascular coupling (NVC). It was initially 
thought that this increase in CBF, described as functional hyperaemia, was a result of a 
regional decrease in oxygen concentration (290). However, more recent studies have 
indicated that NVC is mediated by a combination of vasoactive agents (291, 292).  
Studies have also shown that mediated by the release of glutamate (an excitatory 
neurotransmitter), astrocytes directly affect local CBF (293). Under the effect of 
glutamate substances such as nitric oxide (NO) and arachidonic acid (AA) are released 
and play a significant vasomotor role in the cerebral microvasculature, with NO being a 
primarily vasodilating substance, while AA is vaso-constricting. Further studies have 
shown that the final effect of these agents depends on local oxygen concentration and may 
differ between brain regions (292, 294). 
Arteriole and 
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As previously discussed NIRS can measure fluctuations in the concentrations of 
HbO2 and HHb. Hence, the NIRS signal reflects the balance between the oxygenated CBF 
and the rate at which O2 is consumed (known as the cerebral metabolic rate of oxygen, 
CMRO2). Logically, one would anticipate that increased localised neuronal activity 
would lead to a localised decrease in HbO2 and increase in HHb secondary to increased 
CMRO2. However, the classical anticipated NIRS response is the result of a decrease in 
HHb and an increase in HbO2 concentration.  
The change in CMRO2 and the corresponding change in CBF are poorly balanced. 
With CBF being an indirect measure of oxygen supply, it has been shown that CBF may 
increase 6 times more for a given increase in CMRO2 following a somatosensory stimulus 
(295). However, although the actual figure remains debatable through the literature, 
similar studies have shown that stimulation of changes in the neuronal activity does lead 
in CBF over-compensation (296, 297). It is this signal that forms the foundation of 
research in the field of investigating the functional cortical activation using NIR optical 
techniques and MRI, known as functional NIRS (fNIRS) and blood oxygen level 
dependent (BOLD) fMRI. 
The classic NIRS functional response in the adult brain is represented by an 
increase in HbO2 concentration, accompanied by a decrease in HHb concentration on a 
micro-molar scale (see Fig. 2.2.6). This has consistently been demonstrated by adult 
NIRS based studies (298-303). As discussed above, it is thought that the decrease in HHb 
is secondary to oxygen delivery in excess of oxygen consumption in response to 
functional activation of the brain (295). This activity-induced vascular response is known 
as the haemodynamic response function (HRF). Normally the HRF to a stimulus is 
typically quite slow; it begins at approximately 3 seconds post stimulation and reaches its 
crescendo within 20 seconds (304). The shape of the HRF and its time-course will 
naturally differ depending upon the type of stimulus (different amplitudes in the signal 
have been noted to brief or long-lasting stimuli) (305), the subject, age group, the region 
of the brain interrogated and the underlying neuronal activity.   
Research studies in adults suggest that the observed haemodynamic response 
measured by NIRS is comparable to the BOLD response observed in functional MRI. The 
superiority of NIRS is that it is based on the intrinsic blood light absorption and therefore 
provides separate measurements of changes in HbO2, HHb, and HbT concentrations. 
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Functional MRI is based on the paramagnetic properties of HHb and therefore the BOLD 
signal derives from local changes in the HHb concentration (306, 307). In that respect, 
studies that have compared the two techniques in experiments of functional activation 
have shown better correlation of the BOLD signal to the changes in HHb concentration 
(308-311). However, Yamamoto and Kato, and Strangman et al. showed a better 
correlation of the BOLD signal to the changes of the HbO2 concentration, as measured by 
NIRS (312, 313), whereas Punwani et al., and Chen et al., showed that the BOLD signal 
is similar to the NIRS one without specifying for which type of haemoglobin that was 
(314, 315). Huppert et al., tried to overcome some of the challenges of previous 
experiments, by using BOLD fMRI and NIRS with a high signal to noise ratio, to 
investigate the haemodynamic changes in a short-lived motor task. They reported that the 
obtained BOLD signal correlated to the NIRS measured changes of the HHb 
concentration and not those of the HbO2 (316). 
 
 
Figure 2.2.6: A typical HRF to cortical activation by showing an increase in HbO2 and 
decrease in HHb (blue)along the y axis over time, along the x axis. Graph adapted from 
reference (317). 
 
In infants the haemodynamic response to stimuli appears to have a less consistent 
pattern in comparison to adult studies. Functional NIRS studies in infants have shown an 
increase in HbT and HbO2 with a simultaneous, smaller amplitude increase in HHb, which 
contradicts the anticipated decrease (318-323). Figures 2.2.7 and 2.2.8 are typical 
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examples from two different studies showing this pattern in the HHb signal during 
functional NIRS studies on infants. Hoshi et al., have suggested that the observed increase 
in HHb following the increase in HbT and HbO2 over the investigated area of the neonatal 
cortex, may be attributed to venous dilatation, and that this may vary with different 
developmental stages (319). Age or developmental stage could be a factor influencing the 
balance between oxygen supply and demand, in addition to other factors such as region 
of interest, sleep states, level of anaesthesia  (324-327). Similarly, studies using BOLD 
fMRI have shown the variable scale of the HRF to somatosensory stimuli between adults, 
term, and preterm infants (see Fig. 2.2.9), with the response to functional activation 
becoming more brisk and greater in scale with maturation (328).  
Finally, most infant fNIRS studies employ HbO2 as the preferred measure of 
cortical activation. This is most likely because HbO2 has the highest signal to noise ratio. 
Generally, the direction of its change is consistent amongst different subjects and different 
paradigms. However, HbO2 signals are more heavily influenced by systemic 
physiological changes (such as the cardiac cycle, and blood pressure etc.). 
 
Figure 2.2.7: Changes in the HbT, HbO2, and HHb with visual stimulation of the occipital 
cortex averaged and smoothed over nine cycles in the same infant. Note the increase and 
subsequent decrease in all the parameters at a different scale and over a slightly different 
time. Image adapted from reference (320). 
 
 
[HbT] 
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Figure 2.2.8: Example of functional activation. Changes in oxygenated haemoglobin (oxy-
Hb), deoxygenated haemoglobin (deoxy-Hb), and total haemoglobin (t-Hb) over one channel 
in one infant during the (A) first and (B) second stimulation. Note the increase in deoxy-Hb 
in Figure A and its decrease in Figure B. Image adapted from reference (319). 
 
 
Figure 2.2.9: Time-series plots of the BOLD signal change post somatosensory stimulus for 
different age groups: the (a) adult; (b) term equivalent infant; (c) preterm infant groups. 
(d) Note the decrease in the time to peak of the HRF, and the increase in peak amplitude 
with increasing age. Graphs adapted from reference (328). 
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2.2.4 Types of near-infrared techniques 
NIR techniques are classified in three main categories: continuous wavelength, time 
domain and frequency domain modalities. This classification mainly derives from the 
type of instrumentation, type of tissue illumination and type of information acquired at 
the end of each recording. Figure 2.2.10 provides an idea of the different measurements 
obtained by these three fundamental NIR techniques.  
 
Figure 2.2.10: Demonstration of the three different NIR techniques. (a) CW emits light at a 
constant intensity and then only measures the changes in the intensity of the light travelling 
through tissue. (b) The frequency domain technique modulates the emitted light intensity 
and subsequently measures the intensity of the detected light and the phase shift, equivalent 
to the time of flight. (c) The time domain technique emits a short pulse of light (in 
picoseconds) into the tissue and calculates the time of arrival of each emerging through 
tissue pulse of photons. (I0: incident light signal, I: transmitted light signal, d: thickness of 
the medium, μa: absorption coefficient, μs: scattering coefficient, φ: phase delay, and I(t): 
temporal point spread function of the transmitted light signa). Image adapted from 
reference (329).  
 
Continuous Wavelength 
The term ‘continuous wavelength’ (CW) essentially means that the device is exclusively 
based upon a light intensity measurement. For example, NIR light illuminates tissue and 
the intensity of the re-emerging light is measured. Continuous wavelength systems 
measure back-scattered light and are characterised by light emission at a constant 
intensity, allowing detection of variations in attenuation from different regions of tissue. 
These fluctuations in attenuation provide information on the chromophore concentration 
changes, which are calculated either based on the modified Beer-Lambert law or more 
advanced models of light transports (see section 2.2.5). These constitute most of the 
commercially available NIRS systems and can be single or multi-channel systems (see 
Fig. 2.2.11). They are overall inexpensive, safe, wearable, and portable (305, 330). 
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Figure 2.2.11: Different end-products using CW NIR systems. This is dependent on the 
number of channels and the arrangements of the sources and detectors across the scalp. 
Adapted from reference (331). 
Continuous wavelength, single channel NIRS systems utilise one source location 
and one detector location to investigate a chosen region of tissue. The source and detector 
are typically coupled to the body via optical fibres. However, single-channel NIRS 
systems can only sample and provide information for a small volume of tissue.  
Multi-channel CW NIR systems employ an array of multiple sources and 
detectors to investigate the haemodynamics of a broader area of tissue. The use of 
multiple sources creates an engineering challenge, because it is critical that the origin of 
any detected light is known. There are several methods that allow sources to be 
distinguished including time multiplexing (i.e. you turn them on one at a time) and 
frequency multiplexing (where each source is modulated at a known frequency) (332). 
However, still, simple multi-channel, CW NIRS only provides a series of spectroscopic 
measurements across different areas of the tissue investigated.  
Continuous wavelength, diffuse optical imaging (DOI) systems have been widely 
used in the investigation of the haemodynamic changes of the cortical surface of the brain. 
Mainly dependent upon the arrangement of channels used, they offer the possibility of 
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reconstructing 2-dimensional (2D) and 3-dimensional (3D) images of the observed 
haemodynamic changes of the interrogated tissue. In the literature 2D imaging systems 
are called diffuse optical topography or mapping or imaging and similarly 3D imaging 
systems are called diffuse optical tomography or mapping or imaging. The term diffuse 
optical imaging in this thesis is used to describe both these techniques. The device used 
in the study is a diffuse optical tomography device, which will be described in detail in 
chapter 3.  
Optical topography is also a multi-channel CW NIRS method. As mentioned 
above, it produces two-dimensional (2D) maps of the captured cortical haemodynamic 
changes (see Fig. 2.2.12). This is achieved by interpolating the signal measured from 
different channels across the area of investigation (333). This approach has aided the 
study of cortical activation to visual stimulation, sound, and speech through the different 
neurodevelopmental stages of infancy (334-339).   
 
Figure 2.2.12: Optical topography of the cortical haemodynamic response to sound stimuli. 
17 Japanese infants were studied with a 72-channel whole head NIR device whilst four 
different types of language were played (maternal and foreign language, both forward and 
backward played). (A) Graph showing the grand average for all channels and all infants of 
haemoglobin signals in response to sound. (B) Topographic maps of the grand average 
activation with common activation channels amongst the infants over the posterior part of 
the left temporal cortex and anterior part of the right temporal cortex (indicated with red 
circles).  Image adapted from reference (340).  
However, optical topography has limitations regarding the anatomical registration 
of the channels and critically provides no depth information. Diffuse optical tomography 
(DOT) can allow for increased spatial resolution and provides full three-dimensional (3D) 
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images (341). Diffuse optical tomography uses multiple overlapping channels with 
multiple source-detector distances (usually ranging from 1.5 to 4 cm) to increase spatial 
resolution and improve haemodynamic information deriving from different layers of 
depth within the cortex (342, 343) and essentially enables the acquisition of 3D images 
(344).  
The source-emitted NIR light penetrates tissue in a banana-shaped fashion and the 
transmitted light is measured by a neighbouring detector (see Fig.2.2.13). The intensity 
of light travelling from a source to a detector through tissue decreases exponentially with 
source-detector distance. The source-detector distance is significant as it determines the 
sampling depth and the spatial resolution of the final image acquired. A large distance 
allows greater sampling depth into the cortex, whereas a short distance provides better 
spatial resolution. In infants, a separation of 3 cm typically penetrates 1–1.5 centimetres 
into the cortex (281), reported as 0.5 to 2 cm in human adults (345). 
 
Figure 2.2.13: The banana shaped trajectory of NIR light at different source-detector 
separations in DOI.  The sensitivity distribution of light has a banana shape. The areas 
proximal to the source and the detector have the greatest effect on the captured light. 
Depending on the depth of the tissue, the spatial sensitivity varies. Hence, by using multi-
distances between sources and detectors, the depth spatial sensitivity increases. Image 
adapted from reference (281). 
The quality of the images is dependent upon the number of channels, which in 
practice is modulated by the weight and number of available optical fibres, as well as the 
age of the subject under investigation. Most commercial systems provide 10-20 sources 
and 10-20 detectors respectively. Users must choose to cover a wide area sparsely at the 
expense of lower resolution, patchy sensitivity, less depth discrimination, or a small area 
densely with better resolution and better 3D images, but small field of view (346).  
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Frequency Domain 
In contrast to CW NIR systems that only provide intensity measurements, frequency, and 
time domain NIR techniques provide additional information about the transmission of 
photons through tissue.  
The frequency domain system, in addition to light attenuation, also measure the phase 
shift by using a sinusoidally modulated input intensity. By comparison of the phase of the 
modulated signal going in to the tissue and that coming out, it is possible to measure the 
phase shift caused by the tissue. The principal advantage of this method is that from phase 
shift, one can calculate the mean optical pathlength. As a result, it is no longer necessary 
to estimate the DPF, significantly reducing errors in the measurement of absorption 
coefficient. It also allows the effects of absorption and scattering to be studied separately, 
something which cannot be achieved by CW NIR systems. Frequency domain systems 
have been designed to perform spectroscopic measurements, optical topography, and 
optical tomography (333, 347, 348). 
Time Domain  
The time domain systems are the most sophisticated amongst the NIR techniques as they 
measure the time that individual photons take to travel across a volume of tissue. Time 
domain systems employ sources that emit very short duration pulses (a few picoseconds), 
and extremely sensitive detectors that can pick up the difference between the time of the 
pulse, and the arrival time of a photon at the detector. Because of scattering effects, the 
input pulse of light is stretched in time: some photons travel in a near straight line to the 
detector and thus have a short time of flight, while others experience many scattering 
events and take a longer time to reach the detector. The distribution of photon flight times 
is called a temporal point spread function (TPSF), which typically has a width of several 
nanoseconds. The TPSF represents a histogram of the time of flight of pulses of photons 
between source and detector (349). The information within this histogram includes 
measurement of the intensity of detected light (like a CW system would). Additionally, 
the Fourier transform of the TPSF provides measures of phase shift at every frequency. 
Time domain systems provide the same information as both the CW and frequency 
domain systems as well as absolute measurements of changes in HbO2 and HHb 
concentrations, and the potential to study the separate effects of absorption and scattering.   
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Time domain systems, therefore, offer the richest dataset of all forms of NIR imaging 
(see Fig. 2.2.14).  
In summary, CW NIR systems cannot fully describe the optical properties of the 
biological tissue being investigated. They can, however, provide measurements of the 
relative changes in HbO2, HHb and HbT. On the other hand, time resolved systems can 
provide both qualitative and quantitative measurements. However, the latter are much 
more expensive systems, with a lower overall temporal resolution. Furthermore, time of 
flight can be a noisier parameter to measure as opposed to intensity. Nevertheless, what 
appears to be more important in neuroscience is the demonstration of a qualitative, 
statistically significant change in brain activity, rather than one that is necessarily a 
quantitative one. These measures can be obtained by CW NIR systems (329).  
 
Figure 2.2.14: A time domain image. (a) coronal cranial ultrasound section of a preterm 
infant showing a left intraventricular haemorrhage with corresponding haemorrhagic 
parenchymal infarct. (B) A coronal section of the same preterm infant of regional blood 
volume. Note the increase in regional haemoglobin concentration over the corresponding 
pathological lesion outlined in the cranial ultrasound view. Image adapted from reference 
(350). 
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2.2.5 Image reconstruction 
As mentioned in section 2.2.4 multi-channel CW NIR systems that employ multi-distance 
overlapping channels can measure haemodynamic changes in the cortical area monitored, 
which can be reconstructed into images. Therefore, this section focuses on the process of 
image reconstruction.  
Diffuse optical image reconstruction requires three main components; an 
anatomical head model, a mathematical model of light transport in tissue and the data 
which contain the haemodynamic changes. With these components, it is possible to 
produce 4-dimensional (three spatial dimensions plus time) structurally registered images 
of changes in HbO2 and HHb concentration. 
Near-infrared light is highly scattered in tissue and does not travel in a straight 
line (see section 2.2.1, fig. 2.2.4). Therefore, the first stage of image reconstruction is to 
provide a mathematical model of light travelling through cerebral tissue. The most widely 
used model of light transport in DOI is based on the diffusion equation, which derives 
from the radiative transport equation (that models the transport of a variety of particles 
through a variety of media). The diffusion equation is used to estimate where light travels 
in a head model and thus identify which areas of this head model are sensitive to light. 
From this, it is possible to determine the spatial distribution of light that leaves a given 
source and reaches a given detector (332), and calculate the sensitivity matrix (J).  
The sensitivity matrix is then used to solve the forward problem as seen in Eq. 3.1 
below: 
Δy = J * Δx                       Equation 3.1   
where: 
J = a sensitivity matrix  
Δy = changes in measurements of light intensity 
Δx = changes in the optical properties of a volume of tissue 
The changes in light intensity (Δy) represent the obtained optical signal in a given 
volume of tissue with changes in optical properties (Δx) for a given arrangement of 
sources and detectors. However, numerical modelling techniques such as the finite 
element method (FEM) are needed to model the diffuse transmission of light within 
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complex geometries such as the brain (341). The FEM approach involves producing a 
mesh to separate the volume of brain tissue into a finite number of tetrahedral elements 
labelled by tissue type (i.e. skin, bone, CSF, etc). Solving the diffusion equation within 
the FEM will provide an estimate of the photon density within each finite element for a 
given source. Using this information results in a sensitivity matrix, which relates the 
changes in optical properties of brain tissue (Δx-image) to the changes in light intensity 
(Δy) at a given channel. It therefore provides a solution to what is known as the forward 
problem.    
The changes in optical properties within a given head model represents the desired 
image. For the reconstruction of an image (i.e. the calculation of Δx), the sensitivity 
matrix (J) must be inverted. This is described as the inverse problem and is defined in Eq. 
3.2 below. The inverse problem is described as the process of calculating from a given 
set of measurements the elements that produced them.  
Δx = J-1 * (Δy)                   Equation 3.2  
 
where: 
J-1 = the inverse of the sensitivity matrix 
Δx = the desired image (changes in the optical properties of tissue) 
Δy = the measurements of change in light intensity 
A software package, “time-resolved optical absorption and scatter tomography” 
(TOAST++) (351), developed by the Centre for Medical Imaging Computing at 
University College London.  This software package uses FEM approaches to solve the 
diffusion equation for a given mesh geometry, which can be used to calculate J (thus 
solving the forward problem, as mentioned above-see Eq. 3.1). 
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2.3 Diffuse Optical Imaging and EEG 
In this section, the use of the terms diffuse optical topography and tomography are used 
interchangeably according to the different studies. Therefore, the term DOI is used as a 
generic term characterising both topographic and tomographic methodologies.   
The unique properties of DOI have been employed in the investigation of the 
human cortex. In 1993 different research groups demonstrated the possibility of non-
invasive investigation of the brain with functional NIRS (162, 301, 352-354). In 1998, 
Chance et al., produced the first diffuse optical images of haemodynamic changes in 
response to sensorimotor stimuli in premature infants (see Fig. 2.3.1) (352). 
Continuous wave DOI systems cannot fully determine a tissue’s optical properties 
or provide absolute measurements, but with certain assumptions, it can quantify changes 
in HbO2 and HHb concentration. Depending on the allocation of NIR light sources and 
detectors these systems can provide good spatial resolution (~1cm) in combination with 
a good temporal resolution (~10Hz) and measuring haemodynamic fluctuations across 
different cortical regions. This, along with their low cost and the ability to position these 
systems at the patient’s bedside allows their application in the investigation of a variety 
of neurological conditions. 
 
Figure 2.3.1:  Diffuse optical topographic illustration of the increase in phase shift following 
sensorimotor stimulation of the brain. Whilst stroking the left and subsequently right finger 
of a preterm infant born at 26 weeks of GA, studied at CGA of 30 weeks, there is significant 
haemodynamic response in the contralateral parietal region (A for left finger stimulation 
and B for right finger stimulation respectively) lasting up to 30 seconds. Image acquired 
from reference (352). 
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Liao et al., employed a continuous wavelength, high-density system to study the 
haemodynamic response to visual stimuli of the neonatal occipital cortex (346). Eleven 
term newborn infants were studied between day one to two of life, postprandially and 
whilst resting or asleep for up to two hours. A screen at 20 cm distance from the infant’s 
face would alternate a repetitive 10s visual stimuli, from a checkerboard to a flat pattern 
of different luminance. Since the infants had their eyes closed during the study, the visual-
evoked response obtained was secondary to the variation in the luminance. A consistent 
distinct increase in the HbO2 concentration, peaking between 10 to 14s post stimuli over 
the visual cortex was noted in 7 out of the 11 infants (see Fig.2.3.2) (346). Sato et al. 
produced diffuse optical images demonstrating the cortical spatiotemporal 
haemodynamic changes in 17 Japanese newborn infants to the sound of their native 
language (Japanese) played forward and backwards as opposed to a foreign language 
(English) similarly played forward and backwards. A whole-head array was used and 
overall 72 channels were representing cortico-vascular changes over the neonatal cortex. 
There was significant haemodynamic response to all the sound stimuli over both temporal 
and frontal regions with significantly more pronounced response to forward-played 
Japanese language as opposed to backwards-played Japanese, forward-played or 
backwards-played English (340).  
Another group investigating the functional organisation of the brain and its 
intrinsic activity by using a highly dense continuous wave DOI technique, produced the 
first diffuse optical images of bilateral occipital resting state connectivity in newborn 
infants (355). The existence of resting state connectivity networks in adults (356) and in 
infants (357-359) has previously been demonstrated with BOLD fMRI. 
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Figure 2.3.2: Diffuse optical topographic illustration of visual stimulation in infants: (a) 
images showing the spatiotemporal haemodynamic response for HbO2 to 10s long visual 
stimulus on a single infant. Note the marked bilateral increase in HbO2. (b) and (c) average 
traces for the cortical region with the maximum response to stimulus versus single channel 
measurement over five stimulus blocks. (d) and (e) block average time trace of the peak 
region of interest versus single channel measurement. Image adapted from reference (346).  
The EEG has an excellent temporal resolution in monitoring changes of the 
electro-cortical activity (sub-millisecond), monitoring the continuous 
electrophysiological cortical activity and detecting distinct phenomena (e.g. seizures). It 
does, however, lack in spatial resolution compared to imaging. It is thought that main 
components contributing to this are the various layers the electrical cortical activity needs 
to go through to reach the EEG scalp electrodes (360) with the skull being the main one 
(361). Therefore, any scalp electrode detects the activity from the underlying brain layers 
including the cortical activity (362). The use of a reference electrode in EEG recordings 
also contributes negatively in the degree of spatial resolution.  
Combining DOI and EEG facilitates the study of functional activation, and 
neurovascular coupling of either spontaneous oscillations (363), evoked potentials (364), 
or abnormal electrical activity such as seizures (365). These two modalities of brain 
monitoring complement each other in a fashion that maximises the overall temporal and 
spatial resolution; thus, making simultaneous DOI-EEG a unique tool for functional 
imaging. For example, during the study of functional activation (e.g. associated with the 
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movement of an arm), one may obtain parallel information via event related potentials 
across time (EEG) and the haemodynamic response (DOI) to the event (stimulus). The 
signals from the two techniques can provide a map of what the haemodynamic changes 
look like in different cortical regions in response to neuronal activation (see Fig. 2.3.3).  
 
Figure 2.3.3: Diffuse optical topographic illustration of functional activation in adults. 
Representation of the block average cortical haemodynamic response of HHb 10s after the 
onset of left and right hand electrical stimulation on an adult patient. The study showed a 
consistent increase in HbO2 and decrease in HHb (as shown in the image above) over the 
contralateral cortical side compared to the stimulation. Image adapted from reference 
(364). 
Diffuse optical imaging can similarly offer information on changes of cortical 
haemodynamics in cases of neonatal brain injury. There are however, very few studies 
exploring this field. In the study of newborn infants presenting with seizures in the 
neonatal period using EEG and DOI, transient haemodynamic events of small increase 
followed by profound sustained decrease in HbO2 concentration were identified. This was 
consistent amongst the subjects and not seen in the healthy controls, suggesting altered 
cortico-vascular activity associated with affected brain tissue (366). For further details of 
this work please see section 6.1.  
A case study of a term infant with severe HIE and electrophysiological seizures 
by Singh et al., using simultaneous EEG and DOI (as described in section 3.2.1), showed 
significant changes in HbO2 following seizures (see Fig. 4.1.3 in chapter 4) (365). Seven 
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distinct seizures were detected lasting from 30 to 90s. Although there was a degree of 
variability during the separate episodes, the reconstructed diffuse optical images revealed 
a consistent increase in HbT and HbO2 concentrations related to the seizure activity. The 
diffuse optical images revealed an initial small increase in the HbO2 concentration 
followed by its dramatic decrease. The latter persisted for several minutes after the end 
of the seizure activity (see Fig. 4.1.3 in chapter 4).  
This work by Singh et al., constitutes the initial pilot study that gave rise to this to 
this MD research project and lays the ground for the investigation of acquired neonatal 
brain injury with video-EEG and DOT. The improved spatial resolution provided by DOT 
enhances the information obtained during interesting neurological phenomena as 
captured by EEG, in situations of neonatal brain injury. The principal aim of the MD 
project presented in my thesis was to understand the physiological haemodynamic 
changes of the neonatal brain in response to pathological events (evident in the EEG) in 
the context of acquired brain injury.  
The main pathological events studied included seizures and burst suppression in 
the context of HIE, and perinatal stroke. The results of each topic are presented in chapters 
4 to 6. The following chapter broadly describes the study designs, recruitment, data 
acquisition, and methodologies. As each condition explored is different, additional 
methodological details are provided in each of chapters 4 to 6. 
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3.1 Patients  
3.1.1 Ethics 
The National Research Ethics Service Committee East of England (REC reference 
09/H0308/125) approved the conduction of this study and allowed patient recruitment 
under the regulations of the Declaration of Helsinki (DoH) as developed by the World 
Medical Association (WMA) (367). 
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3.1.2 Recruitment 
Following informed parental consent, infants were recruited to the study upon their 
admission to the Neonatal Intensive Care Unit (NICU) at the Rosie Hospital of Cambridge 
University Hospitals NHS Foundation Trust.   
The patients recruited in the study are divided in three categories; the healthy term, 
the preterm and the infants presenting with seizures. The data selected during the 
conduction of the pilot study, prior to the commencement of my project, have been 
included in the analyses of this thesis.  
The number of patients recruited during the conduction of the pilot study from 
January 2013 until August 2014 was 28: 
• Healthy term infants: 9 
• Preterm infants: 6 
• Infants presenting with seizures: 13 (with data acquired from 12) 
During the conduction of the pilot study, the research nurse, Andrea D. Edwards 
(ADE) was responsible for patient recruitment. In the beginning of the study she was 
supported by Dr Chuen Wai Lee (CWL), clinical research fellow at the time. The data 
acquisition was performed by Dr Harsimrat Singh, a post-doctoral research associate in 
medical physics with the clinical support of ADE. During that period a total of 51 patients 
with presentation of suspected or confirmed seizures were screened. A total of 18 patients 
were approached, out of which 13 were consented in the study (see Table 3.1).  
My study was completed over a course of two years from September 2014 until 
August 2016. Having received training to perform the EEG-DOT scans independently, I 
actively started recruiting patients in December 2014. The number of patients recruited 
from December 2014 until August 2016 was 34: 
• Healthy term infants: 1 
• Preterm infants: 17 (data acquired from 14) 
• Infants presenting with seizures: 16 
During this period, a total number of 34 patients with presentation of suspected or 
confirmed seizures were screened. 5 of these patients were deemed inappropriate for 
recruitment due to co-existing neurosurgical entities, and one due to redirection of cares 
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being considered and discussed. Eventually 19 patients were approached, out of which 
16 were consented and recruited in the study (see Table 3.1). The total number of infants 
(both controls and patients) recruited in conjunction with the preliminary pilot study was 
62. The clinical details of all 62 infants are presented later in this chapter, in tables 3.2, 
3.3 and 3.4.  
Healthy term and preterm infants 
The eligibility of the healthy term and preterm infants was determined upon clinical 
evaluation and discussion with the medical team. The infants had to be either with their 
mothers on the postnatal ward or on the NICU receiving minimal clinical input (mainly 
requiring help with establishing feeds). Exclusion criteria for the recruitment of healthy 
infants were the existence of antenatally diagnosed congenital anomalies or obvious 
postnatal dysmorphic features and/or other anomalies. The presence of skull trauma, such 
as a cephalohaematoma, caput and/or a skull fracture, and/or abnormal findings on cranial 
ultrasound scan (if clinically indicated during their stay) were also considered as 
exclusion criteria for the healthy control population. Amongst the preterm population 
recruited by me, 7 patients had significant abnormal findings on serial cranial ultrasound 
scans. These were recruited and enrolled in the study at a later stage and not in the first 
week of life.  
Infants presenting with seizures 
The infants presenting with seizures and/or HIE were recruited as soon as possible after 
their admission to the unit. Most of these patients were transferred in by the neonatal 
transport service from other district hospitals, rather than from the Rosie Maternity and 
Delivery Unit in Cambridge. This meant that occasionally the parents were still in the 
referring hospital. On other occasions, the father would accompany the infant but 
depending on their marital status with the mother, consenting the infant was not an option. 
This posed significant difficulty in recruiting these patients during their most acute phase, 
when they were most likely to seize.  
The eligibility for recruitment of seizure/HIE patients was again evaluated based 
on the patients’ clinical presentation and the severity of their condition. Following 
discussion with the medical team, I would approach the parents for consent and 
participating to the study. In situations where consent was granted, but an acute clinical 
procedure was required (e.g. insertion of percutaneous long line, transfer to MRI), the 
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study would be deferred for much later in the day or the following day. Infants with an 
antenatal diagnosis of congenital anomalies, or those with a strong clinical suspicion of 
skull fracture and/or a neurosurgical diagnosis (e.g. subgaleal haemorrhage, subdural 
haemorrhage) were excluded from the study.  
 
Table 3.1: Consort diagram demonstrating the recruitment of the patients presenting with 
seizures in the intensive care unit at the Rosie Hospital. As it appears on the diagram, the 
occurred between January 2013 and August 2014 by a research nurse and a postdoc 
researcher prior to my involvement in the project as part of a pilot study. After my 
involvement in the project, the recruitment continued between September 2014 and August 
2016. The main reasons for patients not being approached for recruitment were the 
following: not meeting eligibility criteria (i.e. neurosurgical co-morbidities); clinical team 
not happy for recruitment into studies; redirection of cares; not available research staff.   
 
Jan 2013-Aug 2014
Assessed for 
eligibility 
n=51
not meeting criteria 
n=7                        
other reasons n=26
Approached 
n=18  
Enrolled  
n=13
Sep 2014-Aug 2016
Assessed for 
eligibility  
n=34
not meeting criteria 
n=5                        
other reasons n=10
Approached
n=19
Enrolled  
n=16
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3.1.3 Clinical details 
The healthy term infants were recruited in the study in the first few days of postnatal life 
and required minimal clinical input. The study was conducted in the postprandial phase 
to minimise motion-related artefact.  
The preterm infants recruited in the study likewise were receiving low 
dependency care. Few of them were receiving non-invasive ventilatory support in the 
form of high flow nasal cannula oxygen. The rest of the infants were breathing in air 
unaided and were enterally fed. The scans were again performed in the postprandial 
phase. 
The near term or term infants with seizures were recruited in the acute phase of 
their presentation to the unit. This meant that they were receiving intensive neonatal care 
in the form of mechanical ventilation, potential inotropic support, multiple intravenous 
infusions, intravenous antibiotics, and potentially anticonvulsant treatment. The nature of 
these admissions limited the timing of the study. Apart from gaining parental consent, the 
fact that most infants were transferred in from another hospital, meant that the infants had 
already received one or more anticonvulsant medications in the referring hospital.  
Most of the infants presenting with seizures had a suspected primary diagnosis of 
HIE, based on their condition at birth, neurological examination, and clinical examination 
as described by the Sarnat classification (34). In the instance of strong clinical suspicion 
of HIE the infants would be reviewed as to whether they were eligible for total body 
therapeutic hypothermia (TH) with target core body temperatures between 33-34 oC. This 
clinical evaluation is based upon the TOBY (TOtal BodY, whole body hypothermia for 
the treatment of perinatal asphyxial encephalopathy) cooling criteria (43, 368). These 
clinical criteria reflect the condition of the infant at birth and their neurological 
presentation/examination; if fulfilled, therapeutic hypothermia can be commenced within 
the first 6 hours of postnatal life. In the cases of infants delivered elsewhere and 
transferred in, passive cooling was commenced from the referring hospital within 6 hours 
and active cooling was initiated by the transport services and continued upon arrival to 
the NICU at the Rosie Hospital. Most of the patients, 23 out of 29, had a diagnosis of 
HIE, 19 of which received a 72-hour course of TH. The other three (patients 1, 12, and 
28) presented with seizures at a later stage outside the window of the first 6 hours of life. 
Their condition and clinical evaluation at birth and in the first few postnatal hours did not 
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warrant initiation of TH. In one patient (patient 20), TH was discontinued, although 
cooling criteria were fulfilled as there was co-existing group B streptococcal meningitis 
which was felt to be the main contributing factor in the clinical condition of the infant 
and that it would not benefit further from TH.  
Within the cohort of patients recruited, however, some presented with seizures in 
the first 48 hours of life without any clinical indication or suspicion of a hypoxic-
ischaemic insult in the perinatal period. These patients numbered 5 in total. Patients 16, 
25 and 29 had a primary diagnosis of perinatal stroke and presented as previously 
asymptomatic, low risk infants with seizures. Patient 23 presented with seizures with 
suspected sepsis on the background of maternal varicella infection close to the delivery. 
The CSF tested negative for the Varicella-Zoster virus and the MRI showed a mild to 
moderate dilatation of the ventricles with a small co-existing intraventricular 
haemorrhage (IVH) and mild changes in the cortical appearance of unclear clinical 
significance. Patient 27 had poor perinatal adaptation and a seizure at 30 minutes of life, 
which was attributed to co-existing hypoglycaemia. The MRI showed small foci of 
restricted diffusion in the posterior periventricular white matter and otherwise a normally 
formed brain.  
All the infants presenting with seizures had an MRI of the head within the first 10 
days of life. This was part of their standard clinical care. The local neuro-radiologist 
reported the MRI scans. They were also reviewed and reported by Professor Mary 
Rutherford, expert in perinatal neuroimaging at Kings College London. All the MRI 
reports mentioned in this thesis are the official reports given by Professor Rutherford.  
The clinical details of all the infants recruited in the study can be seen in the 
following tables 3.2-4. Additional clinical details are also provided in the separate 
chapters 4, 5 and 6.  
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Subject 
ID 
GA Day 
of 
Life 
at 
Scan 
Mode of 
Delivery 
Mode of 
Ventilation 
Background 
activity of EEG 
Clinical Background 
Patient 1 38+1 10 Vaginal 
Ventouse 
SVIA Continuous HIE II, TH, seizures, 
phenobarbitone 
Patient 2 40+1 5 SVD SVIA Continuous HIE I, TH, self-limiting seizures 
Patient 3 - - - - Discontinuous Not scanned 
Patient 4 40+4 5 SVD HFOV Discontinuous 
with seizures 
HIE III, TH, seizures, 
phenobarbitone, clonazepam, 
phenytoin 
Patient 5 40+4 6 SVD SVIA Discontinuous HIE II, TH, seizures, 
phenobarbitone 
Patient 6 40+4 5 EmLSCS SVIA Discontinuous HIE II, TH, seizures 
Patient 7 39+3 4 SVD HFOV Discontinuous HIE III, TH, seizures, 
phenobarbitone 
Patient 8 41+6 5 Ventouse SVIA Continuous HIE III, TH, seizures, 
phenobarbitone 
Patient 9 35+6 2 EmLSCS SVIA Continuous HIE II, TH 
Patient 10 41+3 3 SVD SIMV Vg Continuous HIE III, TH, seizures, 
phenobarbitone, clonazepam, 
phenytoin 
Patient 11 40+5 19 SVD HFNC Continuous HIE II, TH 
Patient 12 34+5 1 EmLSCS SIMV Vg Continuous HIE III, TH, seizures, 
phenobarbitone 
Patient 13 41+5 4 SVD SVIA Mild 
discontinuity 
HIE III, TH, seizures, 
phenobarbitone, clonazepam 
Patient 14 38+6 7 EmLSCS SIMV Vg Mild 
discontinuity 
HIE III, TH, phenobarbitone, 
clonazepam 
Patient 15 40+6 1 SVD SIMV Vg Discontinuous 
with seizures 
HIE III, TH, phenobarbitone 
Patient 16 38+4 2 SVD HFNC Continuous Neonatal stroke: Lt temporal lobe 
infarct, seizures, phenobarbitone 
Patient 17 41+6 1 EmLSCS SIMV Vg Continuous HIE II, TH, phenobarbitone, 
midazolam 
Patient 18 37+2 1 EmLSCS SIMV Vg Discontinuous 
with seizures 
Feto-maternal haemorrhage, Lt 
MCA infarct, HIE II, TH, 
phenobarbitone  
Patient 19 37+5 1 EmLSCS SIMV Vg Continuous HIE II, TH, midazolam 
Patient 20 41+3 1 SVD SIMV Vg Continuous with 
seizures 
GBS meningitis, B/L stroke, HIE 
III, TH, phenobarbitone, 
midazolam 
Patient 21 39 2 EmLSCS SIMV Limited 
interpretation 
HIE II, TH, seizures, 
phenobarbitone, clonazepam 
Patient 22 38+6 2 SVD SIMV Vg Discontinuous HIE II, TH, seizures, 
phenobarbitone, phenytoin 
Patient 23 37+5 3 SVD SVIA Continuous Apnoea, maternal varicella, none 
Patient 24 42 7 EmLSCS HFNC Continuous with 
seizures 
HIE grade III, TH, seizures, 
phenobarbitone 
Patient 25 40 3 Vaginal 
Forceps 
SVIA Continuous Rt MCA, seizures, 
phenobarbitone 
Patient 26 40+3 3 Vaginal 
Ventouse 
SVIA Discontinuous HIE I, TH, seizures, 
phenobarbitone 
Patient 27 37+5 3 EmLSCS SVIA Discontinuous Neonatal Hypoglycaemia, 
seizures, none 
Patient 28 37+4 3 EmLSCS SVIA Continuous HIE I, TH, seizures, 
phenobarbitone, clonazepam 
Patient 29 41+3 3 EmLSCS SVIA Continuous Lt MCA, seizures/phenobarbitone 
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Table 3.2: Clinical details of recruited patients presenting with seizures. (GA: gestational 
age, SVD: spontaneous vaginal delivery, EmLSCS: Emergency low segment Caesarean 
section, SVIA: self-ventilating in air, SIMV: synchronised intermittent mandatory 
ventilation, Vg: volume guarantee, HFOV: high frequency oscillatory ventilation, HFNC: 
high flow nasal cannula, HIE: hypoxic ischaemic encephalopathy, TH: therapeutic 
hypothermia, Lt: left, MCA: middle cerebral artery, GBS: group B streptococcus).  
 
Subject ID GA GA at 
scan 
Mode of 
Delivery 
Mode of 
Ventilation 
Clinical 
Background 
Control 1 36+1 39 EmLSCS SVIA Establishing feeds 
Control 2 37+0 37+3 EmLSCS SVIA Establishing feeds 
Control 3 38+0 38+4 SVD SVIA Establishing feeds 
Control 4 37+5 38+0 Forceps SVIA Establishing feeds 
Control 5 35+1 36+2 EmLSCS SVIA Establishing feeds 
Control 6 41+5 42+2 EmLSCS SVIA Establishing feeds 
Control 7 36+0 36+5 EmLSCS SVIA Establishing feeds 
Control 8 40+1 40+2 Forceps SVIA Establishing feeds 
Control 9 38+5 40+2 Forceps SVIA Establishing feeds 
Control 10 37+2 37+3 SVD SVIA Establishing feeds 
 
Table 3.3: Clinical details of the healthy controls recruited in the study. Abbreviations as in 
table 3.2. (IVH: intraventricular haemorrhage, PVL: periventricular leucomalacia) 
 
Subject ID GA GA at scan Mode of 
Delivery 
Mode of 
Ventilation 
Clinical Background 
Preterm 1 31+5 34+3 Forceps SVIA Normal 
Preterm 2 30+2 32+2 EmLSCS SVIA Normal 
Preterm 3 30+6 32+3 EmLSCS SVIA Normal 
Preterm 4 30+0 35+0 EmLSCS HFNC Normal 
Preterm 5 30+4 32+4 EmLSCS SVIA Normal 
Preterm 6 23+3 35+3 SVD HFNC Normal 
Preterm 7 28+3 34 EmLSCS HFNC Cystic PVL 
Preterm 8 28+3 34+2 EmLSCS HFNC Rt IVH 
Preterm 9 28 32+4 SVD HFNC Normal 
Preterm 10 27+5 29+3 SVD HFNC Normal 
Preterm 11 27+5 29+6 SVD HFNC Normal 
Preterm 12 29 30+4 EmLSCS HFNC Normal 
Preterm 13 28+1 31+3 SVD HFNC Lt Grade II IVH 
Preterm 14 24+6 Not scanned  EmLSCS N/A B/L IVH Grade II 
Preterm 15 30 32+3 EmLSCS HFNC Normal 
Preterm 16 29+6 30+3 EmLSCS SVIA Normal 
Preterm 17 28+2 34+3 SVD SVIA Normal 
Preterm 18 25+1 Not scanned EmLSCS N/A Lt Grade III IVH with HPI 
Preterm 19 29+6 36+2 SVD SVIA B/L cystic PVL 
Preterm 20 32+1 38+1 SVD SVIA B/L cystic PVL 
Preterm 21 29+4 30+4 SVD HFNC Normal 
Preterm 22 28+3 34+2 SVD SVIA Normal 
Preterm 23 27+1 Not scanned SVD HFNC Normal 
Table 3.4: Clinical details of the preterm infants in the study. Abbreviations as in able 3.2. 
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3.2 Equipment and Study Conduction   
3.2.1 Simultaneous video-EEG & DOT 
The Cambridge Centre for Perinatal Neuroscience (CCPN) has a long-term collaboration 
with the University College London Biomedical Optics Research Lab (UCL BORL), 
collectively known as neoLAB. The UCL BORL have developed their own in-house 
diffuse optical tomography (DOT) system, the NTS Optical Imaging System (369), which 
is also commercially available (see Fig. 3.2.1).  
Continuous wave DOT data were acquired using the UCL NTS Optical Imaging 
System. This device employs 16 dual-wavelength laser diode sources operating at 780 
nm and 850 nm, and 16 avalanche photodiode detectors (APDs). Each source is 
modulated at a different frequency between 2-4 kHz. The amount of light which can be 
coupled into the scalp is limited for safety reasons, and thus the device maintains an 
output intensity below that of the eye safety limit (10 W/m2 for NIR wavelengths in 
continuous operation (British Standard EN 60825-1:2007)). The sources are illuminated 
simultaneously, and a Fourier transform of the transmitted light recorded at each detector 
determines the modulation frequency and thus the origin of the detected light. The 
arrangement of source-detector positions on the head determines the spatial resolution of 
the final image. The sampling frequency rate of the device is 10 Hz. 
Video-EEG data were obtained using a BrainVision V-Amp system (Brain 
Products GmbH, Germany). During the conduction of the pilot study, for the first few 
patients recruited, the Micromed SystemPlus clinical EEG system (Micromed S.p.A., 
Italy) was used. The sampling frequency of both systems is 250 Hz.  
To allow simultaneous DOT-EEG recordings with full scalp coverage, an 
integrated infant head-cap was employed. The sources and detectors were coupled to the 
infants’ heads using 32 optical fibre bundles (Loptek GmbH & Co. KG) attached to a soft, 
flexible head cap (EasyCap, Germany) (see Fig. 3.2.2). Caps of different sizes in 
circumference were manufactured by EasyCap to match the age and size of each infant’s 
head. The range in head circumference during my study was 28-38cm, in 2cm intervals. 
The optical fibres were positioned within the cap at a subset of locations taken from the 
10–5 system (370). These locations were chosen to maximize the density of DOT source–
detector pairs (channels) with optimal separations between 20 and 40 mm while also 
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covering the whole scalp. This distance is large enough to sample brain tissue and small 
enough for enough light to be detected. A relative experimental rule-of-thumb, is that a 
source-detector pair separated by a distance d will only be sensitive to a depth of 
approximately d/2 (371). The array design, which provides a total of 58 dual-wavelength 
DOI channels, is shown in figure 3.2.2 and was designed by Laura Dempsey (LAD) 
(MPhil student in Cambridge at the time) and Dr Chuen Wai Lee (CWL) (clinical research 
fellow at the time) in 2012 prior to the onset of the pilot study.  
For the EEG recordings, 13 ring Ag/AgCl EEG electrodes were coupled to the 
head cap in the initial studies and following that ring EEG electrodes were coupled to the 
head cap (see Fig. 3.2.2). The positions of the EEG electrodes conformed to the standard 
neonatal EEG montage (Fp1, Fp2, Fz, T3, T4, C3, Cz, C4, Pz, O1, O2) with reference 
and ground electrodes at AFpz and FC1 respectively (see Fig. 3.2.2).  
As mentioned before DOT is a safe and non-invasive technique that uses light in 
the near-infrared spectrum relying on two principal phenomena, (i) the relative 
transparency of biological tissue in this region of the spectrum and (ii) the presence of 
compounds in tissue whose absorption of light is oxygen concentration dependent.   
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Figure 3.2.1: The combination of systems used for the study on a portable trolley: (A), the 
EEG V-Amp (B), and the UCL NTS optical imaging system (C). Image from personal file. 
 
Figure 3.2.2: DOT-EEG whole head array and cap: (A) The design layout of the DOT 
sources and detectors (blue) and EEG electrodes (red and black) defined using the 
international 10-5 positions, (B) DOT-EEG flexible cap with DOT sensors (red: sources, 
yellow: detectors) and EEG electrodes (clear rings) on an infant control subject during a 
study (following parental permission). Image from personal file. 
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3.2.2 Data Acquisition 
The data acquisition was performed in the NICU, by the infants’ cot side. The only 
exception to this was that some of the healthy control infants in the pilot study were 
recruited in the postnatal ward. For dimmer lighting and a relatively noise-free 
environment, these infants were scanned in the baby scan room, in the Evelyn Perinatal 
Imaging Centre (EPIC).  
Following informed parental consent, the equipment was prepped and the right 
size head cap per infant was selected. This was according to the occipital-frontal 
circumference (OFC), right to left auricular distance (AA) and the nasion to inion distance 
(NI). Note that prior to approaching the parents for consent, with permission by the 
medical team, the infant would be examined with special focus on the inspection of the 
head for any areas of oedema, soft tissue swelling (e.g. haematomas, caputs, etc.). The 
anterior and posterior fontanelle, as well as the sutures, were palpated to ensure a normal 
head examination without suspicion of fractures or haematomas. If the exact sized head 
cap was not available, the nearest smaller size would be selected; for instance, if an 
infant’s head circumference was 33 cm, the head cap with a 32-cm head circumference 
rather than the 34-cm one would be used. Once the correct size head cap was selected, 
the optical fibres based on the whole-head array were attached onto it (see Fig. 3.2.2(A)). 
At the surface of the optical fibres adhesive foamy circular pads were applied to achieve 
a better fit over the infant’s head and avoid trauma, as the surface of the optical electrode 
is a flat, hard disc (see Fig. 3.2.3). The EEG leads were attached last and connected to the 
V-Amp.  
The above preparation would take place in the lab and subsequently the equipment 
was taken to the infant’s cot side (see Fig. 3.2.1(A)). The infant’s head was cleaned with 
sterile gauze soaked in sterile water, and then dried. The cap was applied and the NTS 
and EEG systems would be switched on. Soft straps attached to the head cap would be 
strapped underneath the infant’s mandible. Abrasion gel and conductive paste were 
applied to ensure EEG electrode impedances were kept below 5 kΩ. ECG leads would 
also be applied to monitor the HR trace and to also facilitate artefact recognition in the 
EEG trace.  Once the NTS was warmed up, checks of the source light emission would be 
performed and checks of the EEG electrodes impedance would be checked on the separate 
EEG system. The camera would be attached or stabilised at an optimum position around 
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or inside the infant’s cot (see Fig. 3.3.3 (A)) and linked to the EEG system. Once all 
checks were done, the data acquisition would start with the simultaneous onset of both 
systems. The DOT and EEG systems were synchronised using a custom-made external 
trigger generator, developed by UCL BORL. 
Preparation of the head gear required at least 15 minutes. Application of the head 
gear onto the infant’s head and initiation of the study required 10 to 20 minutes. There 
was only one occasion where the head gear prepared was not fitting well and a different 
size head cap had to be prepared, causing a 20-minute delay. No adverse events were 
noted around or during the studies. There was great acceptance of the research study by 
the medical and nursing stuff showing support and facilitating its conduction. Parents had 
the option of being present throughout the conduction of the study with the only limitation 
not to stimulate (i.e. stroke) their infant during the scan. On the contrary, they were 
encouraged to pacify their infant in the beginning of the study if they appeared overly 
alert or unsettled. Approaching the infants in the postprandial phase, making a 
cocoon/nest, and swaddling them aided in acquiring better quality data with fewer 
motion-related artefacts. The latter mostly applied to the healthy term or preterm infants, 
whereas the patient cohort group were less active.  
Throughout the conduction of the scans, clinical care continued undisturbed. The 
duration of the recordings varied from 45 to 240 minutes. I was present throughout the 
recordings, monitoring the infant, overseeing the quality of the signal, making any 
necessary adjustments, and noting any significant events (e.g. seizures, desaturation, 
cares being given by the nurse, suction). 
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Figure 3.2.3: Images of infants during the study conduction. (A) Preterm infant breathing 
in air unaided. (B) Term infant with HIE presenting with history of perinatal asphyxia and 
seizures, ventilated and whilst receiving therapeutic hypothermia (note the cooling blanket 
the infant is wrapped in). Images have been acquired following parental permission. Images 
from author’s personal file. 
A 
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3.2.3 Data Analysis 
The EEG recordings were assessed by using the BrainVision Analyser (Brain Products 
GmbH) and EEGLAB software packages (372). Part of simple pre-processing steps were 
the application of a high pass filter at 0.5 Hz and a low pass filter at 70 Hz, with an added 
notch filter at 50 Hz. The ones with an abnormal trace or seizure-like activity were 
reviewed by Dr Andrew Michell (AWM), Clinical Neurophysiologist, who reported on 
the quality of the recording, the background state (e.g. continuous, discontinuous, or burst 
suppressed), the presence of any asymmetry between the two hemispheres, presence of 
cyclicity (between awake and sleep state) and detection of any abnormal rhythmic activity 
or seizures.  
Using MATLAB and a synchronisation algorithm developed by RJC, the EEG 
and DOT datasets were synchronised, and events were marked (for instance in the 
presence of burst activity: burst onset and offset, seizures: seizure onset and offset). The 
synchronised and marked DOT data were then loaded on Homer2, a NIRS processing 
toolbox (www.homer-fnirs.org) for visual inspection. Homer2 is a MATLAB-based 
toolbox with a graphical user interface that offers a variety of options including 
visualisation of the NIRS signal, artefact rejection and extraction of the haemodynamic 
response to a specific stimulus (373). First, channels were excluded from each dataset 
based on a simple optical intensity threshold, and on visual inspection of their frequency 
content (this was necessary due to the impact of high-frequency oscillatory ventilation, in 
infants that required this for ventilatory support).  If more than 15 (of 58) channels were 
excluded from any one DOT dataset, that dataset was excluded from any further analysis. 
The raw intensity data were then converted to optical density, and periods of motion 
artefact were identified using a combination of visual inspection and Homer2 motion 
artefact detection approaches (374). The latter was not applied in all paths of the analysis 
but mainly for the burst suppression analysis (see Chapter 5). The final steps of the 
processing differed for the different parts of the analysis. Please see the relevant chapters 
4, 5, and 6 for details of the analysis in the group of infants with seizures, burst 
suppression, and stroke, respectively.  
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Figure 3.2.4: Graph of the different pre-processing and processing steps.  
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4.1 Optical methods and EEG on neonatal seizures 
Near-infrared spectroscopy (NIRS) has been used in the investigation of seizures to 
understand the associated haemodynamic phenomena and develop early detection tools. 
As mentioned previously (section 2.2.3 of chapter 2), an increase in neuronal activity 
leads to increase in metabolic demand, thus causing local vasodilatation, increased CBF 
and oxygenation, via a process known as neurovascular coupling. This mechanism is not 
fully understood but it is believed that vasoactive neurotransmitters, released during 
neural activity, trigger the contraction or dilatation of the cerebral blood vessels 
depending on localised energy demands (375). The combination of EEG and NIR 
techniques allows the study of neurovascular coupling, especially in the occurrence of 
overt electrical phenomena such as seizures.  
Steinhoff et al., demonstrated that coupling NIRS and video-EEG in the pre-
operative assessment of two patients of temporal-originating intractable focal epilepsy, 
can aid targeted neurosurgery. They showed marked desaturations in accordance with the 
seizures. These were particularly observed in the postictal phase on the ipsilateral region 
with inconsistent findings on the contralateral side (376). Sokol et al., showed that data 
from combining a single sensor NIRS and EEG could differentiate complex partial 
seizures from rapidly evolving secondary generalised seizures. They demonstrated that 
there was an increase in cerebral oxygenation during partial seizures with no change of 
peripheral oximetry. In contrast they observed a decrease in cerebral oxygenation during 
the generalised seizures with a concomitant decrease in peripheral pulse oximetry (377). 
This was a study based on a single probe NIRS system (InvosTM system, cerebral/somatic 
oximeter, Covidien AG, USA) which provides a single measurement of cerebral 
oxygenation from the forehead. 
  In 2007, Zhao et al., measured intrinsic optical signals from human cortex intra-
operatively during focal seizures. They showed an increase in both cerebral blood volume 
(CBV) and HHb concentration preceding and during seizure activity, suggesting an 
inadequate supply to meet the metabolic demands (378). The group used optical imaging 
in two wavelengths to achieve these measurements but in an alternating pattern rather 
than simultaneously, which introduces potential variations between measurements and 
artefact, ultimately affecting the calculations of Hb concentrations.  
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Although there is supporting literature on the neurovascular coupling in 
asphyxiated neonates from the early nineties (162, 379), Wallois et al., were the first to 
demonstrate evidence of  haemodynamic changes in association with seizure-like activity 
in the neonatal period combining NIRS and EEG (380). The group used a device with a 
limited number of NIRS channels over the parietal areas emitting light simultaneously at 
two wavelengths (using a frequency domain spectrophotometer device) for the 
measurement of the haemodynamic changes in combination with EEG. They noted a 
paradoxical increase in HHb prior to the onset of the event followed by its decline and an 
increase in HbO2 and HbT concentration during the seizure-like activity (see Fig. 4.1.1). 
This could be explained by a regional increased metabolic rate driving a rapid increase in 
CBV, which is insufficient to achieve the expected washout of HHb, as the one noted in 
functional activation studies (328). This haemodynamic pattern has also been 
demonstrated on the rat neocortex in correlation to inter-ictal activity using multi-
wavelength NIR methodologies (optical recording of intrinsic signals-ORIS) (381). 
 
Figure 4.1.1: Representation of the changes in tissue oxygenation index (TOI), HbT, HbO2 
and HHb in response to seizure activity in the neonatal period. This graph shows the 
different phases in relation to seizure activity: phase (I) corresponds to no haemodynamic 
changes right after the seizure onset, phase (II) to the increase in HbT, HbO2 and HHb, and 
decrease in TOI, (III) to a plateau of HbT, HbO2 and HHb, and further decrease in TOI 
and (IV) to a plateau and gradual return to the baseline following the seizure offset. Adapted 
from reference (380). 
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Figure 4.1.2: Graph showing the average changes relative to the changes of HbO2 (red), 
HHb (blue) and HbT (green) concentrations (y axis) during seizure activity (grey shaded 
area) over time (in 3,600 s, x axis), for one-hour recording. Adapted from reference (365). 
Based on the pilot study conducted prior to my MD project, the first ever diffuse 
optical tomographic images of the cortical haemodynamic response to neonatal seizures 
were reported (365). This study of an infant in the first few days of life with severe HIE 
used the combined EEG and DOI methodology described in chapter 3. Seven discrete 
seizures were identified on the EEG during the recording. The relative changes in 
concentration of the HbO2, HHb, and HbT were calculated and utilised for the 
reproduction of images (see figures 4.1.2 and 3). On average, across all channels, there 
was a consistent increase in all three haemodynamic parameters in response to the seizure 
activity. There was variation in the magnitude of changes per type of haemoglobin. Clear 
spatial variation was also apparent across different cortical locations, and this spatial 
pattern remained consistent across most seizure events (365).  
C
o
n
ce
n
tr
at
io
n
 c
h
an
ge
s 
(µ
M
) 
4.1 Optical methods and EEG on neonatal seizures 
 
 
154 
 
 
Figure 4.1.3: A series of DOT images showing the changes in HbT observed at different 
phases of a single neonatal seizure 50-seconds long in duration. The top of the image is 
showing the changes in concentration of the oxy (red), deoxy (blue) and total (green) 
haemoglobin before, during and after the seizure. The lower part of the image demonstrates 
the spatial distribution of the changes across the cortex. Note the characteristic rise in all 
three parameters 10 s prior to the seizure onset, the peak at 10 s into the seizure and the 
beginning of their decrease prior to the offset of the event. A marked decrease in HbT lasts 
for several minutes after the offset of the seizure. (Numbers 1 to 7 on the graph and over the 
DOT images signify the following: 1-30 s prior to seizure onset; 2-10 s prior to seizure onset; 
3-10 s after seizure onset; 4-25 s after seizure onset; 5-25 s after seizure offset; 6-85 s after 
seizure offset; 7-175 s after seizure offset). Image adapted from reference (365).  
 The aim of this part of the project was to explore the cortical haemodynamic 
changes observed during electrical seizure activity in the term neonatal population.  
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4.2 Patients and Methods 
4.2.1 Patients and Data Acquisition 
Newborn infants presenting with seizures in the first 72 hours of life were recruited to the 
study following informed parental consent as described in section 3.1.1 of chapter 3. The 
video-EEG and DOI device were used in combination to scan the infants whilst receiving 
acute neonatal clinical care. The recording period varied from 45 to 240 minutes. 
Depending on the day of recruitment and their clinical status, some infants had more than 
one scan, performed on consecutive days. No adverse events were recorded during the 
study and the scans were well tolerated throughout without interfering with the clinical 
management and treatment being delivered.  
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4.2.2 EEG Data Analysis  
During the conduction of the study, there was continuous monitoring of the infant and the 
quality of the data being recorded. Simultaneously, the EEG trace was being reviewed 
throughout its recording for the detection of any artefact, abnormal rhythm, or seizure-
like activity. A detailed timesheet was kept, reporting all the important events during the 
recording from a clinical and data-quality point of view. In the instance of any abnormal 
EEG trace detection, the rest of the observations and physiological parameters, such as 
peripheral pulse oximetry, mean blood pressure, heart or respiratory rate were noted. 
Additionally, any abnormal or unusual infant behaviour, such as unusual breathing 
pattern, stereotypical movements (i.e. lip smacking, hiccups, cycling movements of lower 
limbs) were noted.  
The EEG recordings of the infants with a pathological clinical background were 
routinely reviewed and reported by Dr Andrew Michell (AWM), Clinical 
Neurophysiologist. The EEG data containing suspected abnormal rhythms (as identified 
during data acquisition), were brought to his attention for reporting. In the instance of 
identified seizures, the duration, the onset and offset, and the change in frequency during 
the seizure activity were noted. The exact timings of the events were then used as markers 
on the DOT signal for further processing as described in the following section.  
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4.2.3 DOT Data Analysis 
Using MATLAB, the EEG and DOT datasets were synchronized to the first point in time 
of parallel data acquisition and the seizure onset and offset markers were transformed to 
the DOI time-base. Using functions from the Homer2 NIRS processing toolbox 
(www.homer-fnirs.org) (373) and MATLAB, the DOT data were pre-processed prior to 
extracting the haemodynamic response to seizure activity. The seizure onset and offset 
timings were marked against the DOT signal. The DOT data were low pass filtered at 1 
Hz to eliminate heart rate and high frequency interference, which could be generated by 
equipment in the clinical area, such as the ventilator and/or intravenous pumps. The raw 
optical intensity data were then converted to optical density for further visual inspection 
and artefact rejection processing (374). For channel-wise visual inspection and analysis, 
the optical density data were converted into changes in concentration of HbO2, HHb and 
HbT using the modified Beer-Lambert law and a pathlength factor of 4.9 (382). The 
fluctuations in the haemodynamic signal were then inspected for any obvious deviation 
from the baseline in association with the seizure activity.  
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4.3 Results  
4.3.1 Clinical Details 
The total number of infants presenting with seizures and recruited into this study was 29. 
Amongst these, 5 infants were studied whilst having seizures. These were patient 4, 15, 
18, 20 and 24. The clinical details and the results showing the haemodynamic response 
to seizures in patient 4 had already been described and published prior to this MD project, 
as a pilot study (please see reference (365)).  
Patient 15 
Patient 15 was a female infant born unexpectedly in a very poor condition, following 
induced vaginal delivery at 40+5 weeks of gestation in a local district hospital. Her birth 
weight was 3216 grams. This was a low risk pregnancy with no antenatal concerns and 
the first baby to this mother. She was born unresponsive with no respiratory effort or heart 
rate. The cord was wrapped around her neck. She was given full resuscitation including 
intubation, ventilation, cardio-pulmonary resuscitation with three rounds of Adrenaline, 
O negative blood and bicarbonate. The APGAR scores were very poor: 0 at 1 minute, 0 
at 5 minutes and 2 at 10 minutes. The initial lactate was 20 and pH 6.6. She started seizing 
right after being resuscitated and was loaded with intravenous phenobarbitone (20 
mg/kg). She was urgently transferred to the Rosie NICU and therapeutic hypothermia 
was commenced as a follow up of passive cooling since birth. 
 On admission, she was ventilated and exhibited abnormal neurology; hypotonia, 
posturing, absent gag reflex and fixed, dilated pupils. Her aEEG showed burst suppressed 
pattern. On day 2 of life she continued to have seizures associated with profound 
desaturations and bradycardias, for which she received a further dose of phenobarbitone.  
In view of poor condition at birth, ongoing intractable seizures, no improvement 
in neurological status, fixed, dilated, non-responsive pupils, a joint decision with the 
family was made for re-direction of care. Following this, she was transferred to a hospice 
and intensive care was withdrawn. The MRI showed severe abnormalities within the basal 
ganglia, thalami, posterior limb of the internal capsule (PLIC), brainstem and cortex 
consistent with a severe acute hypoxic ischaemic insult. These imaging findings were 
reported to be in keeping with a likely very severe global neurodevelopmental 
impairment.  
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Patient 18 
Patient 18 was a female infant born at 37+2 weeks of gestation, following an emergency 
low segment Caesarean section (LSCS) due to irregular foetal heart rate. Labour was 
induced prior to this due to gestational diabetes mellitus (GDM) and was progressing. 
There were otherwise no antenatal concerns and the mother was primigravida. The infant 
was born slightly compromised with irregular breathing and heart rate of 80 bpm (beats 
per minute). Ventilation support was offered, but she remained pale with the haemoglobin 
on the gas being extremely low, 25 gr/dl (normal value for a newborn >120 gr/dl) and the 
blood glucose level of 1.8 (normal value >3.5). A dextrose bolus and O negative 
emergency blood were administered via an umbilical venous catheter during 
resuscitation. In view of persistent desaturations, she was eventually intubated and 
ventilated and was transferred to the Rosie NICU. She required further blood transfusions 
for anaemia secondary to significant feto-maternal blood loss (Kleihauer test positive), 
and inotropic support to improve cardiac function. On her neurological examination, she 
was hypertonic with reduced tendon reflexes, pupils were symmetrically and equally 
reactive. reacting and equal. She continued to have subclinical seizures on aEEG for 
which she received Phenobarbitone.  
The MRI showed a large stroke in the left middle cerebral artery with involvement 
of the basal ganglia, thalami and PLIC on the left, and abnormal diffusion in the left 
cerebral peduncle; findings suggestive of a possible right sided motor impairment.  Her 
examination prior to transfer back to referring hospital revealed a weak palmar grasp and 
poor head control, but otherwise normal. 
Patient 20 
Patient 20 was a female infant born at 41+3 weeks of gestation, following a spontaneous 
vaginal delivery after a low risk pregnancy. There was background of maternal 
intrapartum pyrexia >39.0 degrees with suspicion of prolonged rupture of membranes. 
The maternal c-reactive protein (CRP) was markedly raised, 107 and she was commenced 
on antibiotics. The infant was born in poor condition and was intubated at 8 minutes of 
age. She made a quick recovery and was extubated shortly after. However, at 4 hours of 
life, she started exhibiting back arching posturing followed by clonic movements of all 
limbs, cycling of lower limbs and eye flickering. Each episode was associated with 
desaturations and on several occasions, she required bag-valve mask inflation breaths to 
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recover. Most episodes lasted up to 2 minutes (the longest one lasted 10 minutes) with 
less than 10-minute inter-ictal periods. She received Phenobarbitone and was put on a 
Midazolam infusion. She was intubated and ventilated for stabilisation. Subsequently, a 
decision was made to start passive therapeutic hypothermia and to transfer to the Rosie 
NICU for advanced neonatal care. A lumbar puncture performed prior to the infant’s 
transport was suggestive of meningitis and the infant was already on appropriate 
antibiotic cover. She was intubated and ventilated for transfer. She continued to have 
seizures, detected on aEEG monitoring. The Midazolam infusion rate was increased and 
a further dose of Phenobarbitone and Phenytoin were administered.  
In view of a positive initial blood culture for group B Streptococcus (GBS) and 
the positive lumbar puncture result, the principal working diagnosis was GBS sepsis and 
meningitis. Therapeutic hypothermia was discontinued. The MRI showed a normally 
formed brain with bilateral infarction of both posterior parietal, temporal and occipital 
white matter, and cortex. There was some sparing of the left visual cortex but involvement 
of both optic radiations. There was additional involvement of the body and posterior 
aspects of the corpus callosum and abnormal high signal intensity in the posterior thalami. 
The prognosis based on the MRI findings was that the affected tissue would atrophy with 
head growth possibly being suboptimal and at increased risk of visual impairment, and 
later cognitive and behavioural impairments, potentially within the autistic spectrum 
disorders. On discharge, her neurological examination appeared normal and she was 
demand breastfeeding. 
Patient 24 
Patient 24 was a female infant born at 42 weeks of gestation, following an emergency 
LSCS due to irregular foetal heart rate. She was born in good condition with APGARS 
of 8 at 1 minute and 10 at 5 minutes. At 3 hrs of age, however, she started having multiple 
apnoeic episodes with posturing and significant desaturations, highly suggestive of 
seizures. She was, therefore, transferred to the Rosie NICU for therapeutic hypothermia. 
Seizures were managed with Phenobarbitone, Phenytoin, and Midazolam.  
All investigations including a metabolic screen, blood cultures, CSF cultures 
(cerebro-spinal fluid), TORCH screen (screen for congenital infections; Toxoplasma, 
Rubella, Cytomegalovirus, Herpes Simplex Virus) were negative. In view of ongoing 
persistent seizures, she was put on maintenance Phenobarbitone and had a trial of 
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Pyridoxine. The MRI revealed widespread abnormal signal intensity within the white 
matter (involving the PLIC, thalami and corpus callosum) and cortex with an additional 
focal haemorrhagic lesion over the left occipital lobe. The prognosis given, based on the 
MRI findings, was that the insulted brain tissue would atrophy with subsequent 
suboptimal head growth and likely later cognitive and probably some motor impairment. 
The findings were consistent with a chronic hypoxic ischaemic injury rather than typical 
of isolated acute hypoxic ischaemic injury. Upon discharge, there was truncal hypotonia 
and she was still requiring nasogastric tube feeds as unable to complete all bottle feeds. 
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4.3.2 Seizure detection 
Patient 15 was studied on day 2 of life, whilst being ventilated, for approximately one 
hour. Discrete electroencephalographic seizures were noted during the recording with 
associated desaturations and bradycardias. They were four in total with minimum 
duration of 35 seconds and maximum of 76 seconds. The focus of electrographic activity 
appeared to be the right anterior quadrant cortical region with the seizures becoming 
generalised soon after their onset.  
Patient 18 was recruited and studied on the day 2 of life, whilst being ventilated, 
for approximately 4,500 seconds. During the study, she was noted to have 5 discrete 
episodes of seizures which remained purely electro-graphical with no clinical correlation. 
She received Phenobarbitone towards the end of the study due to seizure identification on 
the simultaneous aEEG monitoring. The seizure activity during the recording was quite 
prolonged with a minimum duration of 60 seconds and a maximum of 639 seconds. In 
total, the infant was exhibiting electrical seizure activity for one third of the period during 
EEG and DOI data acquisition (1,387 seconds out of 4,500 seconds).  
Patient 20 was recruited and studied on day 2 of life for approximately 7,650 
seconds. The patient was mechanically ventilated during the scan. During the study, there 
were 5 discrete seizures in the space of 2 hours. The minimum seizure duration was 29 
seconds and the maximum 1,189 seconds (equivalent to almost 20 minutes). In total, there 
was seizure activity (principally subclinical) for one fifth of the period of data acquisition 
(1,731 seconds in total out of 7,650 seconds). The ictal activity commenced either from 
the right hemisphere or the midline and then became generalised involving all channels 
and both hemispheres. All the events were subclinical with no change in any of the 
physiological parameters, such as heart rate or peripheral pulse oximetry. She was on a 
Midazolam infusion at the time. After the study, the infusion rate of Midazolam was 
increased and a further dose of Phenobarbitone and Phenytoin were administered. An 
example of the seizure activity detected in patient 20 can be seen in figure 4.3.1.  
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Figure 4.3.1: An EEG snapshot of patient 20. This EEG segment represents part of the 5th seizure 
detected whilst studying this patient. One can notice the fast, rhythmic activity across the scalp over 
a 20-second epoch (from the 7070 to 7090 seconds into the EEG recording).  
Patient 24 was recruited and studied on day 7 of life for approximately 5,100 
seconds. Prior to the onset of the study the infant was on aEEG continuous monitoring. 
The trace at the time was being reported as exaggerated sleep wake cycle with no clear 
evidence of seizure activity. No clinical concern regarding any abnormal or stereotypical 
movement resembling seizure activity had been raised at the time. However, during the 
study, 15 discrete seizures were identified on the EEG. There was no associated change 
in physiological parameters. However, during each episode, the infant would start 
grunting, which was followed by swallowing movements. Towards the end of each 
seizure, she would become agitated and cry. Saturations were self-maintained throughout 
whilst she was breathing in air unaided. The minimum seizure duration was 22 seconds 
and the maximum 114 seconds. There was at least a 100-second inter-ictal period with 
only two occasions where seizures occurred with only a 20-second recovery phase in 
between ictal activity. Despite the frequency of the seizure activity, most of the seizures 
were very short and the overall burden over one hour was 12%. Interestingly in this case 
the seizures were multifocal and of various frequencies, with seizures on one occasion 
starting over one hemisphere and a different ictal activity of different frequency starting 
Time (s) 
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on the other hemisphere shortly after. An example of the seizure activity detected in 
patient 24 can be seen in figure 4.3.2.  
 
Figure 4.3.2: An EEG snapshot of patient 24. This EEG segment represents part of the 1st seizure 
detected whilst studying this patient. There is on-going rhythmic activity over the right anterior 
region, demonstrated in this graph over a 40-second epoch (from 175 to 215 seconds into the EEG 
recording).  
A summary of some of the clinical details as well as the exact timings of the 
seizures for each patient can be seen in the following tables from 4.1 to 4.5.  
Subject 
ID 
Background 
EEG activity 
No of 
Seizures 
Focus Medications  Underlying Clinical 
Condition 
Patient 15 Discontinuous 4 Right anterior 
quadrant 
Phenobarbitone HIE III, TH 
Patient 18 Discontinuous 5 Anterior midline Phenobarbitone Feto-maternal haemorrhage, 
Neonatal stroke: Lt MCA 
infarct, HIE, TH 
Patient 20 Continuous 5 Right 
hemisphere/midline 
Phenobarbitone, 
Midazolam 
GBS meningitis, B/L stroke, 
HIE III, TH  
Patient 24 Continuous 15 Multifocal  Phenobarbitone HIE grade III, TH 
 
Table 4.1:   Clinical and EEG details for patients 15, 18, 20 and 24. Further clinical details 
can be seen in table 3.1, chapter 3. (HIE: hypoxic ischaemic encephalopathy, TH: 
therapeutic hypothermia, Lt: left, MCA: middle cerebral artery, GBS: group B 
streptococcus). 
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Patient 15  
Seizures Seizure onset (s) Seizure offset (s) Duration of event (s) 
1 27 103 76 
2 925 978 53 
3 1,346 1,419 73 
4 2,119 2,154 35 
 
Table 4.2: Timings and duration for each seizure event in seconds for patient 15.  
 
Patient 18  
Seizures Seizure onset (s) Seizure offset (s) Duration of event (s) 
1 176 338 162 
2 1,788 2,019 231 
3 2,109 2,427 318 
4 2,689 2,749 60 
5 3,000 3,526 526 
 
Table 4.3: Timings and duration for each seizure event in seconds for patient 18. 
 
Patient 20  
Seizures Seizure onset (s) Seizure offset (s) Duration of event (s) 
1 3,527 3,572 45 
2 4,233 4,262 29 
3 4,927 5,055 128 
4 5,582 5,922 340 
5 6,360 7,549 1,189 
 
Table 4.4: Timings and duration for each seizure event in seconds for patient 20.  
 
Patient 24  
Seizures Seizure onset (s) Seizure offset (s) Duration of event (s) 
1 170 216 46 
2 558  596 38 
3 807  859 52 
4 1,165  1,210 45 
5 1,400 1,489 89 
6 1,877 1,899 22 
7 2,512 2,563 51 
8 2,711 2,825 114 
9 3,782  3838 56 
10 3,958 3,980 22 
11 4,162 4,186 24 
12 4,366 4,400 34 
13 4,422 4,476 54 
14 4,868 4,895 27 
15 4,920  5,020 100 
 
Table 4.5: Timings and duration for each seizure event in seconds for patient 24.
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4.3.3 Cortical haemodynamic changes in response to seizure activity 
Patient 15 
The raw optical signal obtained for patient 15 can be seen in figures 4.3.3 and 4.3.4. These 
present the optical intensity prior to any processing or artefact rejection steps. Any abrupt 
change of the signal, usually rapid rise from the baseline, is considered as artefact and not 
a physiological change.   
 
Figure 4.3.3: The raw optical signals for patient 15, demonstrating the optical intensity 
changes in µV (y axis) over time (x axis in ms). The different colours correspond to the 
different optical channels. The black arrow indicates a sudden increase of the signal from 
the baseline, attributed to movement artefact. 
 
Figure 4.3.4: Close-up of the optical signal for patient 15 showing global, ongoing high 
frequency interference. 
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At a first glance, the signal appears good. However, upon closer inspection, there 
is ongoing high frequency interference, most likely of mechanical origin (see Fig. 4.3.3). 
Further inspection of the signal and a fast Fourier transform (FFT) analysis to investigate 
the power spectra of the data was used to assess whether the data captures the expected 
physiological range of frequencies. This analysis showed the same superimposed 
oscillation with multiple harmonic peaks in frequencies which cannot be explained 
physiologically (see Fig. 4.3.5).  
 
Figure 4.3.5: A sample for the power spectra plot for channels 1, 2 and 3 for patient 15. 
Apart from the peak in the power between 2 and 2.5 Hz which corresponds to heart rate, 
most of the features are not physiological and appear as repetitive and stereotypical in the 
power spectrum, suggesting a non-physiological origin. The graph on the right top hand 
side is showing the whole head array-design of 16 sources (letters A to P) and 16 detectors 
(numbers 1 to 16).  
Following processing in Homer and MATLAB the haemodynamic response to 
each seizure event for patient 15 was obtained, despite the issue of high-frequency signal 
contamination. In total, 16 out of 58 channels were excluded due to either low optical 
intensity or artefact corruption throughout the recording. By using a lower pass filter of 
0.5 Hz instead of the standard 1.0 Hz, the changes in the HbO2 concentration in relation 
to seizure event 4 (see Table 4.2) are shown in figure 4.3.6A. These changes related to 
three randomly selected channels (channels number 27, 43, and 51). Across all 3 channels 
there is an obvious increase in HbO2 starting almost 12 s (marked as -1 on the graph in 
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figure 4.3.6A) prior to the onset of seizure activity (marked as 0 on the graph in figure 
4.3.6A)  which lasts up to 20 s (marked as 1 on the graph in figure 4.3.6A)  and is followed 
by a more pronounced decrease which lasts for 30 s and essentially returns to baseline in 
approximately 5 s after the offset of the seizure. However, figure 4.3.6B highlights the 
ongoing increase and decrease in HbO2 in-keeping with the background ongoing 
oscillation independent of seizure activity.  
 
 
Figure 4.3.6: The relative changes of HbO2 concentration (y axis in µM) in relation to the 
seizure activity over time (x axis in seconds), using a lpf of 0.5 Hz for patient 15: (A) shows 
the increase in HbO2 concentration (time point -1) prior to the seizure onset (time point 0), 
lasting for 20 s (time point 1) followed by a decrease and return to the baseline few seconds 
after seizure offset seen in all randomly selected three channels (right hand side), whereas 
(B) shows the ongoing HbO2 fluctuations during the recording independent to the seizure 
activity (light blue vertical line for seizure onset; red vertical line for seizure offset; right 
hand side for whole-head array 16 sources (A-P) and 16 detectors (1-16).  
No meaningful results were obtained in the extraction of the haemodynamic 
activity in relation to the seizure episodes noted in patient 15. Overall, there was an 
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ongoing oscillation of the optical trace irrelevant of seizure activity throughout the 
recording. The extracted HRFs for each seizure event returned an almost identical pattern, 
heavily corrupted with artefact (as seen in Fig. 4.3.7). 
 
Figure 4.3.7: Graph showing the changes in HbO2, (red line) HHb (blue line) and HbT (green 
line) concentration (over the y axis in µM) during the seizure event 1 on patient 15 over time 
(x axis in seconds) for all 42 channels. Time 0 signifies the seizure onset. The duration of the 
seizure was 35 seconds.  
Patient 18 
The raw optical signal acquired for patient 18 (see Fig. 4.3.8), prior to any processing or 
artefact rejection steps, was characterised by a rhythmic almost step-wise superimposed 
elevation of the trace. Its presence interfered with the onset and offset of the co-existing 
ongoing seizure activity. An example of the returned results for seizure event 5 which 
lasted approximately 9 minutes (526 s) (see Table 4.3 for details) can be seen in figure 
4.3.9. The observed decrease in all HbO2, HHb and HbT concentrations which become 
more pronounced 200 s into the seizure activity and continue until the seizure offset can 
only be attributed to artefact rather than any meaningful physiological change. In the 
analysis of this signal 16 channels were excluded either due to low intensity levels or 
excessive noise interference.  
HbO2 
HHb 
HbT 
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Figure 4.3.8: Graph showing the raw optical signal for patient 18, demonstrating the optical 
intensity changes in µV (y axis) over time (x axis in ms). The different colours correspond 
to the different optical channels. Note the black arrow showing the consistent rhythmic 
interference with the background signal.  
 
Figure 4.3.9: Graph showing the changes in concentration of all HbO2, (red line) HHb (blue 
line) and HbT (green line) (over the y axis in µM) during the seizure event 5 on patient 18 
over time (x axis in seconds) for all 36 channels. The abrupt nature of the change suggests 
superimposed artefact.  
Patient 20 
The optical signal acquired for patient 20 (see Fig. 4.3.10), prior to any processing steps, 
was also characterised by a rhythmic, step-wise superimposed elevation of the trace. After 
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further processing, 22 channels were excluded mainly due to motion related artefact. 
Similarly, its presence interfered with the onset and offset of the co-existing seizure 
activity (see also Fig. 4.3.11), and therefore no meaningful results in terms of the relative 
changes in any of the HbO2, HHb and/or HbT concentrations were obtained.  
  
Figure 4.3.10: Graph showing the raw optical signal for patient 20, demonstrating the 
optical intensity changes in µV (y axis) over time (x axis in ms). The different colours 
correspond to the different optical channels. The black arrows point to the onset of the step-
wise rhythmic elevation of the trace independent to seizure activity.  
This elevation in the trace (see Fig.4.3.10, arrows) was persistent throughout the 
recording and as mentioned before was also present in the optical signal of patient 18. It 
was occurring approximately every 13 minutes and was 8 to 8.5 minutes long in duration. 
This was not obvious at the time of data acquisition. The elevation from the baseline is 
quite dramatic but one may notice that it is not as abrupt as the standard motion-associated 
artefact (see Fig. 4.3.11). 
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Figure 4.3.11: Close-up of the raw optical signal for patient 20. Note the changes in optical 
intensity in µV (y axis) over time (on the x axis, in milliseconds). The different colours 
correspond to the different optical channels. Note the black arrow showing the consistent 
rhythmic interference with the background signal.  
Patient 24 
The optical signal acquired for patient 24 (see Fig. 4.3.12), prior to any processing steps, 
was characterised by significant motion-related artefact. Following further processing 
steps, 6 channels were excluded due to low signal to noise ratio (SNR). During this 
recording, the patient had 15 seizures of variable duration (see Table 4.5 for details), all 
of which were both clinical and electrographic. In the onset of the seizure the infant would 
go quiet followed by a change in the breathing pattern with audible grunting associated 
with swallowing movements. Towards the end of each episode, the infant would cry and 
become very unsettled. This led to excessive motion artefact throughout the recording 
and almost invariably coinciding with the end of each seizure. Analysis of the trace was 
thus challenging, and all channels were affected by the excessive motion during the 
recording. One example of an attempt to extract the HRF during seizure event 3 can be 
seen in figure 4.3.13. This oscillatory pattern seen in figure 4.3.13 is secondary to 
excessive artefact and was present during all seizure episodes.  
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Figure 4.3.12: Graph showing the raw optical signal for patient 24, demonstrating the 
optical intensity changes in µV (y axis) over time (x axis in ms). The different colours 
correspond to the different optical channels. The black arrows are pointing to some of the 
significant motion artefacts in the recording.  
 
Figure 4.3.13: Graph showing the changes in concentration of all HbO2, (red line) HHb (blue 
line) and HbT (green line) (over the y axis in µM) in relation to the seizure event 3 on patient 
24 over time (x axis in seconds) for all 52 channels. Time 0 signifies the seizure onset. This 
seizure was 52 s long in duration. Note a decrease in HbO2, HHb and HbT 7 s prior to the 
seizure offset.  
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4.4 Discussion and Conclusions 
The results for this part of the study are not enough to draw any significant conclusions 
regarding the cortico-vascular changes in association to seizure activity. Although for 
some of the seizures there was a subsequent increase in the concentration of HbO2 and 
HbT, followed by a decrease, this was not consistent across the patients or amongst the 
different seizures of the same patient. There were multiple barriers and challenges during 
the study which may explain why the results were not as expected or comparable to the 
original case study (365).  
Most of the patients recruited in the study were transferred to the recruiting unit 
rather than being inborn. This meant that most patients already had some definite or 
suspected seizure activity with subsequent treatment prior to their admission to the unit 
and recruitment to the study. Additionally, patients transported in, often may not have 
travelled with the mother or guardian with parental rights, thus delaying the consenting 
process. In that respect, most patients were recruited and studied beyond the acute phase 
of their seizure activity. Most frequently, when the patients were recruited to the study, 
they had already received one or multiple anticonvulsant agents leading to seizure control. 
The EEG trace would appear as either burst suppressed, discontinuous, or normalising, 
depending on the severity of the initial insult and overall clinical condition.  
In study populations of HIE patients receiving TH a wide range of electrographic 
seizure onset has been demonstrated. Wusthoff et al., studied 26 infants receiving TH and 
showed electrographic seizure onset of 35 hours with more than half of the patients 
exhibiting seizure activity in less than 24 hours (383). Glass et al., in a larger cohort across 
three centres (n=90) reported a median age of seizure onset at 18 hours with the latest at 
62 hours (207). This makes it hard to know exactly when to study the patients in the 
absence of continuous multi-channel EEG monitoring. The overall aim was to study the 
patients in the acute phase, first 48 to 72 hours. However, the intermittent periods of 1-4 
hours of data acquisition rather than continuous (as per granted ethics permission at the 
time) limited the detection rate of seizure activity. Furthermore, most of the HIE patients 
were receiving TH at the time of data acquisition, which has been reported to contribute 
to decreasing seizure burden and altering seizure characteristics (208, 236, 384).  
Nevertheless, the patients with seizures during data acquisition, were amongst the 
most critically ill infants recruited in this study and approaching the parents was time-
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critical. It was also challenging as there were situations, where redirection of care was 
being considered. The consenting process needed to not interfere with the delivery of the 
best clinical care and not pose any added burden to the parents. Regardless of the difficult 
circumstances, most families were often happy that their infant’s condition could 
contribute to research and potentially help future patients.  
On reviewing the optical signal, it becomes apparent to the naked eye as to 
whether there are any obvious changes in cortical Hb concentrations in response to seizure 
activity. One may also establish by visual inspection whether these changes appear 
physiological or artefact related. In the instance of co-existent electrical events on the 
EEG trace, multiple artefact correction processes of the optical signal may distort the 
presumed neurovascular coupling response. While methods for artefact correction exist 
(374), their application was not appropriate for this study. As the interest lies in the 
changes of the trace from the baseline any artefact interference leads to multiple 
assumptions about the change in trace on removing the artefact. This is a limitation of the 
system in collecting meaningful data during a seizure, especially if a patient is exhibiting 
physical manifestations during this, as such was the case in patient 24.  
It is quite evident from section 4.3 that there were significant issues regarding 
artefact in the raw optical signal of all patients (see figures 4.3.3, 4.3.4, 4.3.8, 4.3.10-12). 
In patient 15, there was an ongoing oscillatory type of activity superimposed on the signal 
throughout the recording (see figures 4.3.3 and 4.3.4). This could be electrical 
interference from the equipment around the patient, such as the ventilator. For patient 18 
and 20, apart from occasional motion related artefact there was a slow periodic rise and 
subsequent fall in the baseline of the optical signal throughout the recording (see figures 
4.3.8, 4.3.10, and 4.3.11). This periodic feature appeared to have no temporal correlation 
with the seizure events, as it was present at different points during each of the identified 
seizures in these infants.  Because this feature had a large amplitude, it was impossible to 
separate any haemodynamic features related to the seizures themselves.  
On reviewing the traces and considering other contributing factors to these 
periodic features, the most logical explanation was that the observed repetitive events 
could be due to the periodic inflation and deflation of the cooling mattress. The cooling 
mattress was wrapped around the patients whilst receiving therapeutic hypothermia 
during data acquisition. The mattress used on the unit inflates approximately every 13 
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minutes and the actual inflation lasts up to 10 minutes. During the study, the cooling part 
of the mattress around the head was removed and the cap was applied while the rest of 
the trunk, upper limbs and lower limbs remained wrapped within the mattress. It is 
possible that the inflation of the mattress caused an elevation of the body compared to the 
head, which created a head-tilt or slow-motion artefact effect that was apparent in the 
DOT trace (see figures 4.3.8, 4.3.10, and 4.3.11).  
An interesting observation was that out of 15 patients that were being cooled 
during data acquisition, this periodic feature was noted in only 4. One possible 
explanation for this phenomenon is that the inflation of the mattress constricts the limbs, 
causing an increase in arterial blood pressure. This would not matter in a healthy infant 
but in a critically ill infant with altered or absent cerebral autoregulation it may have an 
immediate effect on cerebral haemodynamics; increasing the cerebral arterial blood 
pressure; increasing the concentrations of HbO2 and HbT in the cortical vasculature; 
observed as an elevation of the baseline in the raw optical trace (see figures 4.3.8, 4.3.10, 
and 4.3.11). To prove this, however, continuous measurement of the arterial blood 
pressure and an accelerometer applied on the head gear (used for scanning the patients) 
are required.  
In retrospect, the absence of continuous recording of the patients’ physiological 
parameters (i.e. heart rate, respiratory rate, mean blood pressure) limits further analysis 
of electro-cortical phenomena. As mentioned before, there was continuous observation 
of the patients during recording and any change or abnormal activity was noted and 
documented, however, subtle trends or changes may well have been missed. For 
continuous blood pressure measurement, invasive monitoring (via umbilical arterial or 
peripheral arterial catheter in situ) is required. This requirement would limit the 
recruitment criteria further and hence it was not pursued. 
In view of the excess in noise in the optical signals obtained in patient 15, a lower 
lpf was also applied to extract the HRF (see Fig. 4.3.6). The standard approach was to 
apply no hpf and to set the lpf at 1.0 Hz. This allowed the exclusion of heart rate (usually 
2-3 Hz), and respiratory rate (0.5-1.0 Hz). It also allowed the study of physiological 
frequencies associated with resting state (355, 356), smooth muscle cell activity and 
cerebral autoregulation (385-387) potentially affected by seizure activity. At a lower lpf 
of 0.5 Hz, a naturally smoother HRF was obtained (see Fig. 4.3.6), but that did not alter 
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the overall appearance of the HRF as a harmonic oscillation was still present throughout 
the recording.    
Therapeutic hypothermia is considered to decrease cerebral perfusion (388, 389). 
Existing studies considering the effect of TH with NIRS and MRI have shown that the 
expected brain reperfusion/hyperperfusion is still occurring in infants with moderate and 
severe HIE whilst receiving TH (390, 391). These are small sample size studies and have 
primarily investigated arterial spin labelled-MRI and NIRS in the assessment of cerebral 
perfusion in HIE patients during TH. There are few in vivo studies on newborns to 
investigate how TH directly affects cerebral perfusion to understand how this may have 
affected the patients studied in this thesis. Existing research currently supports that the 
anticipated haemodynamic phenomena in HIE patients should be observed despite TH.  
Due to noise interference and motion-related artefact, the results of the extracted 
HRFs in relation to seizure activity were inconclusive and not consistent with the results 
published during the conduction of this research as a pilot study; decrease in HbO2 and 
HbT following onset of seizure activity lasting for several seconds after the offset of the 
event (365). Zhao et al., noted an associated increase rather in CBV related to seizure 
activity. By performing optical imaging and EEG intraoperatively in the exposed cortex 
of adult human subjects, an increase in CBV and HHb preceding the seizure onset was 
identified, indirectly suggesting inadequate tissue perfusion (378). Cortico-vascular 
activity preceding the neuronal activity has been repeatedly observed (392, 393).  
The phenomenon of cortical spreading depression (CSD), which is characterised 
by disrupted cortico-electrical activity secondary to loss of ion homeostasis (394) and is 
associated with brain injury (395-397), could be an association to the observed sustained 
decreases in perfusion seen in similar studies. Most certainly the results demonstrated by 
Singh et al. (365), suggest that the pattern of the response to seizure activity could be 
associated to CSD and needs to be investigated further.  
Due to the inconsistencies in the data and the excessive artefact, no meaningful 
HRFs were obtained. Therefore, it was not possible to reconstruct any images of the 
spatial variation of the observed haemodynamic phenomena. Upon reflection of 
improving similar studies in the future, both from observation and existing literature it 
appears that prolonging the study period alongside continuous multi-channel EEG and 
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aiming for early DOT monitoring in the first 48 hours maximises the chances of capturing 
seizures. NIRS-based studies have demonstrated that neurovascular coupling in different 
conditions is not altered under the effect of different anaesthetic drugs, amongst which 
phenobarbitone was also tested (398). The effect of TH on seizure activity should be 
encountered more carefully in the sense that the seizure burden may be lower or the 
electrographic semiology of the seizures different than the expected; subtle; of slower 
frequency; of short duration. The direct effect of TH on cerebral perfusion as assessed by 
NIRS methodologies is yet to be defined and should be considered in the analysis of 
neurovascular coupling in patients with seizures whilst receiving TH. Finally, further 
work is required to refine the technique of data acquisition. In that respect, collection of 
continuous physiological parameters, such as invasive arterial mean blood pressure, 
saturations, heart rate may aid the interpretation of the data in relation to cortical blood 
volume changes. Furthermore, a possible way to improve motion artefact correction in 
the future would be to adjust an accelerometer on the recording cap. Thus, by capturing 
the movements of the head, motion related artefact can safely be rejected from the optical 
signal. 
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5.1 Functional imaging of burst suppression  
The actual interaction between abnormal electrical activity and the cortico-vascular 
circulation is under-investigated and poorly understood. There is a paucity of studies 
investigating cortical haemodynamics in critically ill adults, let alone infants with 
pathological EEG tracings. There are some animal studies which combine EEG and 
functional neuro-imaging techniques, such as BOLD fMRI. These studies have presented 
results on neurovascular coupling in burst suppression and types of epilepsy under the 
effect of certain anaesthetic drugs (399-401).  
Other animal studies using functional neuroimaging techniques in the form of 
BOLD fMRI have shown the existence of spontaneous fluctuations in the BOLD signal 
even during BS, in the deepest forms of anaesthesia, suggesting that these may be a 
reflection of an inner functional brain organisation (402). One of the first studies to use 
EEG and fMRI on a porcine model to investigate changes in functional brain activity at 
different levels of thiopental-induced anaesthesia, showed that the intensity of the signal 
changes was more prominent in the thalamic as opposed to the cortical regions of interest 
(399). In 2011, Liu et al., used simultaneous epidural EEG and double channel laser 
Doppler to measure cerebral blood flow (CBF) at different depths of isoflurane-induced 
anaesthesia on the rat model. Under the same conditions of neuronal status, they 
performed BOLD fMRI independently. They showed strong neurovascular coupling 
between the EEG bursts of the BS trace and CBF ‘bumps’ in the Doppler trace, which 
varied per level of anaesthesia. These were similarly identified as BOLD ‘bumps’ during 
the fMRI, which were also dependent on the degree of anaesthesia (401). In 2014, Sutin 
et al., used simultaneous NIRS and EEG to investigate the haemodynamic responses 
associated with isoflurane-induced BS in the rat model, similarly showing the existence 
of neurovascular coupling between burst activity and the oxy- and deoxy-haemoglobin 
fluctuations (403). These studies are the closest to identifying neurovascular coupling in 
BS but still refer to animal models. Prior to this investigation there were no in-vivo 
functional neuroimaging studies of burst suppression in humans. 
Multi-modality neuroimaging approaches (such as DOT-EEG) have the potential 
to elucidate the fundamental physiological, neurovascular, and neuro-energetic 
characteristics of the BS and discontinuous EEG state. One added advantage is that they 
allow the investigation of the spatial characteristics of these states. We conducted this 
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part of the study with the principle aim to investigate the haemodynamic events associated 
with the BS and discontinuous EEG in critically ill infants with HIE, using DOT and 
video-EEG.  
The working hypothesis was that there are cortical haemodynamic changes in 
response to EEG bursts and therefore to the neuronal activity. 
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5.2 Patients and Methods 
5.2.1 Patients and Data Acquisition 
Infants selected for the burst-suppression investigation phase of this work presented with 
seizures and/or a clinical diagnosis of HIE. They were recruited as mentioned in section 
3.1.1 and were scanned during or after having received therapeutic hypothermia. They 
were selected in this part of the analysis as they presented with either BS or a 
pathologically discontinuous EEG trace during the recording period which ranged from 
approximately 60 to 120 minutes. No adverse events were recorded during the study and 
the scans were well tolerated throughout without interfering with the clinical input or 
management required.  
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5.2.2 EEG Data Analysis 
The definition used for identification of a BS trace within these datasets, was the 
recurrence of high amplitude, occasionally sharp burst activity alternating with inactive 
periods of low amplitude < 25 µV (IBIs). Another criterion for the selection of EEGs 
studied was that there was no variability in the trace, with no identified changes due to 
sleep states and no seizure activity during the recording.   
Once the EEGs were identified as burst suppressed or discontinuous, the Clinical 
Neurophysiologist, Dr Michell (AWM, co-author to the relevant published paper) would 
review them for confirmation of diagnosis and identification of any other abnormal 
activity, such as seizures. Using the BrainVision Analyser and EEGLAB toolbox within 
MATLAB, I then proceeded to further spectral analysis and manual artefact rejection. 
Both the raw and filtered data were reviewed for artefacts. The EEG datasets were 
bandpass filtered with a high pass filter at 0.5 Hz and low pass filter at 70 Hz, with a 
notch set at 50 Hz. The last step in the EEG spectral analysis was the marking of the 
bursts and for this, the onset and offset of each burst were identified based on the strict 
criterion that prior to each burst there should be an IBI of ≥ 2 seconds in duration. Both 
discrete bursts and IBIs themselves were marked.  As a more objective way of burst 
identification, a second observer, Dr Lee (CWL, PhD student and co-author to the 
relevant paper) independently marked the bursts in a subset of EEGs. The inter-observer 
comparison indicated that for every burst onset identified by me (MC), a burst onset was 
independently identified by CWL within an error of 1.5 seconds in 84 % of cases.     
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5.2.3 DOT Data Analysis 
Using the MATLAB toolbox, the EEG and DOT datasets were synchronised, and the 
burst onset and offset markers were transformed to the DOT time-base. Using functions 
form the Homer2 NIRS processing toolbox (www.homer-fnirs.org), the DOT data were 
first pre-processed using the standard pipeline described in detail in section 3.2.3.  Further 
project-specific processing consisted of the raw intensity data being converted to optical 
density. Periods of motion artefact were identified using a combination of visual 
inspection and Homer2 motion artefact detection approaches (374) prior to band-pass 
filtering in the range 0.01 to 1 Hz. 
To extract the haemodynamic response to the EEG bursts in each dataset, the 
bursts were first sub-divided based on their duration into 2-second wide bins over the 
range from 0 to 30 s.  Bins containing less than 5 bursts were excluded.  The burst onset 
markers associated with each bin were then treated as separate conditions in an event-
related general linear model of the DOT data (such that the model contained a 0-2 s burst 
condition, a 2-4 s burst condition etc.).  The general linear model is a generalization of 
multiple linear regression model in the instance of more than one dependent variable. The 
general linear model was constructed using a series of Gaussian basis functions (with a 
standard deviation of 2 s and separated by 1s), to model the haemodynamic response 
function (HRF) associated with each burst duration.  In this instance, the different 
variables are the scale of each basis function used to model the HRF to burst of different 
durations.  The time range of the modelled HRF was set to -10 to 40 s relative to the burst 
onset markers.  This approach resulted in an HRF for each accepted DOT channel, burst 
duration bin and infant.   
To provide an objective representation of the morphology of the spatially-varying 
haemodynamic response to bursts in each infant (instead of arbitrarily selecting a channel 
to display or taking an average), the principal component analysis (PCA) method was 
used. This type of analysis entails finding the linear relationship of a set of variables that 
has maximum variance, removing its effect, and repeating this successively. PCA was 
performed across the accepted channels in each dataset. An HRF was then produced for 
each infant and each burst duration by combining the components required to account for 
80 % of the signal variance.   
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To ensure that any extracted HRF was not an artefact of the data processing 
procedure, and was directly temporally correlated with the EEG bursts, additional HRFs 
were computed using 10 randomly generated dummy onset vectors in place of the burst 
onset markers for each dataset.  These dummy vectors contained the same number of 
‘events’ as the largest number of bursts in any one bin for each infant.  A one-tailed, 
Bonferroni-corrected t-test was then performed to identify channels in which the 
haemodynamic response to EEG bursts is statistically distinguishable from a vector 
produced by concatenating the 10 dummy HRFs. 
The algorithms for the synchronization of the DOI-EEG datasets and the HRF 
extraction were developed by my co-supervisor and physicist, Dr Cooper (RJC). The 
image and video reconstruction of the HRFs were accomplished based on the 
methodology described in section 3.2.5.  
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5.3 Results  
5.3.1 Clinical Details 
Between March 2013 and September 2015, 9 infants presented with either BS or a 
discontinuous EEG trace as defined in section 5.3.2 (patients 2, 4, 7, 10, 12, 14, 18, 19, 
21). Three infants were excluded due to excessive noise or artefact within the DOT 
datasets (>15 DOT channels were rejected in each dataset), leaving a total of 6 datasets 
suitable for analysis.  Further clinical information regarding the 6 infants included is 
provided in Table 5.1. The median gestational age at birth was 38+6 weeks (range from 
34+5 to 40+1 weeks).  The median age of the infants at the time of the study was 3.5 days 
(with a range from birth to 7 days of life).  The length of the DOT-EEG recording ranged 
from 47 to 115 minutes with a median period of 59 minutes. 
All infants presented with seizures in the first 48 hours of life and received either 
one or three types of anticonvulsant treatment prior to (or in one case during), the study 
(see Table 5.1). All infants were receiving respiratory support during the study in the form 
of conventional mechanical ventilation, apart from patient 7, who was receiving high 
frequency oscillatory ventilation and patient 2 who was breathing spontaneously in air. 
All infants had stable levels of carbon dioxide partial tension (PCO2) within the normal 
range (4.7-6.0 kPa) 34 throughout the study. Two of the infants were receiving inotropic 
support during the study to maintain a stable systemic arterial blood pressure (patients 7 
and 21).  Each infant underwent a structural MRI between 7 to 10 days of life as per the 
standard clinical care protocol and all received a final diagnosis of HIE grade III, apart 
from patient 2 who received a final diagnosis of HIE grade I (please refer to section 1.1.2 
for further details on HIE grading). The MRIs were provisionally reported locally and 
were further interpreted by Professor Mary Rutherford as an external expert on neonatal 
MRI, as part of the standard clinical care (see Table 5.1). All 6 infants survived and were 
either discharged back to the referring hospital or to home.  
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Infant GA 
 
CGA  
 
Neurology Anticonvulsant 
treatment 
(hours prior to study) 
MRI findings 
Patient 2 40+1 40+6 Self-limiting 
seizures 
None required  Normal findings. 
Patient 7 39+3 40+2 Clinical 
seizures 
Phenobarbitone (40) Diffuse multiple  
haemorrhagic lesions. 
Patient 12 34+5 34+6 Clinical 
&electrical 
seizures 
Phenobarbitone (24) Abnormal signal intensity within 
the WM, BG, thalami & cortex. 
Thrombosis within the TS and SSs. 
Patient 14 38+6 39+6 Clinical 
&electrical 
seizures 
Phenytoin (4), 
Phenobarbitone (22) 
 
Multiple areas of cortical 
highlighting Left>Right. Lesions 
within the BG and thalami. 
Patient 19 37+5 37+6 Clinical 
seizures 
Midazolam (5) Diffuse abnormal signal intensity 
within the BG and thalami. Bilateral 
increased signal intensity along the 
cortex & central sulci. Bilateral 
swollen medial temporal cortex. 
Possible haemorrhagic lesion 
within the right parietal lobe. 
Patient 21 39 39+2 Clinical 
&electrical 
seizures 
Midazolam (12), 
Phenobarbitone (2),   
Clonazepam (infusion) 
Abnormal signal intensity within 
the BG, thalami, PLIC and superior 
cortex. 
 
Table 5.1: Clinical details of the study subjects for the investigation of neurovascular 
coupling in BS. The information regarding their neurological status refers to the clinical 
presentation of the infants prior to the initiation of the recording. The anticonvulsant 
medications reported also reflect treatment which was administered prior to the recordings 
(as indicated in hours in the brackets) except for the ones indicated as infusions, which the 
infants were receiving during the study. The MRI findings refer to structural MRI, T1 and 
T2 weighted images obtained after day 7 of life (GA: gestational age at birth, CGA: 
corrected GA at time of study, WM: white matter. BG: basal ganglia. TS: transverse sinus. 
SSs: sagittal sinuses. PLIC: posterior limb of the internal capsule). 
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5.3.2 Burst Identification 
The total number of bursts identified in each infant ranged from 87 to 257, with a median 
of 129.  An example of an identified burst is shown in Fig. 5.3.1. Most bursts had a 
duration between 1 and 7 seconds. The single most common burst duration across the 
group was 4-6 seconds.  A histogram of burst durations by infant, binned as per the DOT 
analysis, is shown in Fig. 5.3.2. 
 
Figure 5.3.1: EEG snapshot from infant patient 19 showing a typical example of burst 
activity lasting approximately 6 s with low amplitude IBIs prior to burst onset and after 
burst offset respectively.  
 
Figure 5.3.2: Burst durations binned as per DOT datasets. The x axis represents the 
different bin durations in seconds and the y axis the absolute number of bursts per bin 
duration. The different colours represent the different patients as shown in the legend on 
the right upper part of the figure. 
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5.3.3 Haemodynamic Response to Bursts 
The number of DOT channels rejected across the 6 datasets ranged from 2 to 9, with 
median of 4 per dataset (from a total of 58 channels).  HRFs were successfully extracted 
for burst durations in the range 2-4, 4-6, 6-8, 8-10 and 10-12 s across the group of six 
infants. However, only the ranges 2-4, 4-6 and 6-8 s contained enough bursts (>5) to meet 
our criteria for all 6 infants.  The proportion of DOT channels exhibiting a statistically 
significant oxy-haemoglobin response to bursts with duration 4-6 s ranged from 30 % (in 
patient 7), to 100 % (in patient 19). In figure 5.3.3 one can see the channel-wise 
haemodynamic response to EEG bursts of 4-6 s durations in patient 2.  A pronounced 
response is noticeable on most of the channels, with a clear spatial variation in amplitude 
and morphology.  
 
Figure 5.3.3: Representation of the HRFs to bursts lasting from 4 to 6 s in patient 2. The 
arrangement of the channels is mimicking the array of channels across the scalp based on 
the DOT channel layout (see Fig. 3.2.2).  Note that some of the channels are not displayed at 
all due to rejection. In each graph, the black vertical line represents the burst onset, the 
green line the HbT, the red line the HbO2 and the blue line the HHb. These results are 
referring to 50 out of a total of 58 channels.  
The PCA-extracted HRF to 4-6s duration bursts in all 6 infants can be seen in 
figure 5.3.4. These provide a representation of the typical response across the cortex in 
each case. The number of components required to account for 80% of the channel-wise 
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variance ranged from 1 to 3 components. In each infant, there is a clear response to burst 
activity, which on closer inspection appears similar for all infants: the response consists 
of a marked decrease in both HbO2 and HHb and consequently in HbT before or with the 
onset of burst activity. This response is identical in the first 3 infants but appears to have 
a slight delay in patient 14 and patient 21 (see Fig. 5.3.4). In patient 19 (see Fig. 5.3.4) it 
appears that this drop occurs at least 5 seconds prior to the onset of the burst activity. In 
all infants, however, the initial shape of the HRF is identical with slight temporal 
variation. This decrease is then followed by a large increase in HbO2, HHb and HbT, 
which reaches a peak approximately 20 s after the burst onset before returning towards 
the baseline and exhibiting an undershoot.  In patient 19 (see Fig. 5.3.4) the HbO2 
response shape does differ; the peak increase in HbO2 occurs at a similar time to that of 
the other infants, but its increase is more gradual and commences during the actual burst 
activity. It is worth noting at this point that the HHb response is less pronounced in 
comparison to that of HbO2. In all cases, the HHb shows a notable increase that reaches 
a peak between 10 and 20 s post burst onset. 
 
Figure 5.3.4: The PCA-extracted HRFs to bursts lasting from between 4 to 6 s in each infant.  
The grey shaded area indicates the period of the average duration burst. The value of ‘N’ 
in each case indicates the number of bursts between 4 and 6 s identified in each infant. The 
green line the HbT, the red line the HbO2 and the blue line the HHb. 
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5.3.4 Imaging of the Haemodynamic Response to Bursts 
The reconstructed HRFs can be visualised on an image basis across the scalp (see Figures 
5.3.5-8). These were reconstructed based on a neonatal head atlas for the correct gestation 
per infant (404). Figure 5.3.5 shows three views of the reconstructed cortical image of 
changes in HbT for patient 12 at the minimum of its initial decrease (as defined from the 
PCA-extracted representative response, see Fig. 5.3.4). This moment in time coincides 
with the minimum decrease in both HbO2 and HHb.  A small decrease in HbT is apparent 
across the cortex, but the changes appear more pronounced in the bilateral temporal and 
temporal-parietal regions.  Figure 5.3.6 shows data from the same infant at the peak of 
the increase in HbT, which occurs at approximately 12 s post burst onset. This moment 
in time coincides with the maximum increase in both HbO2 and HHb. The frontal lobes, 
right temporal and left parietal regions exhibit the largest increases in HbT, while the 
occipital cortex displays a slight decrease. The combination of regions that show a 
pronounced increase in HbT during the peak phase (see Fig. 5.3.6) are not completely 
consistent with those exhibiting the largest decreases in HbT during the initial dip phase 
of the HRF (see Fig. 5.3.5). 
Similarly, figure 5.3.7 shows the reconstructed cortical image of HbT at the peak 
of the post-burst increase in patient 19, which is also the point of maximum increase in 
both HbO2 and HHb. The increase is broadly global, with the largest increases occurring 
in both temporal lobes, and an apparent lack of response over the right parietal lobe.  The 
structural MRI of the same patient (see Fig. 5.3.9) revealed swelling of the bilateral 
medial temporal cortices and a possible haemorrhagic lesion over the right parietal lobe. 
The last figure 5.3.8, depicts the HbT image associated with the undershoot phase in 
patient 19, which shows the largest decreases occurring in the bilateral frontal cortices 
and reflects the minimum decrease in both HbO2 and HHb.  
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Figure 5.3.5: The reconstructed image for the HbT-HRF associated with the initial decrease 
in the response to 4-6 s duration EEG bursts for patient 12.  These images represent the 
change in HbT at the time point indicated by the black vertical line in the lower panel. Note 
that the most significant decrease in HbT is localised to the bilateral temporal-parietal 
boundary (see Movie 5.1). 
 
Figure 5.3.6: The reconstructed image for the HbT-HRF associated with the peak increase 
in the response to 4-6 s duration EEG bursts for patient 12. These images represent the 
change in HbT at the time point indicated by the black vertical line in the lower panel. Note 
the marked increase in HbT in the prefrontal cortex (see Movie 5.1). 
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Figure 5.3.7: The reconstructed image for the HbT-HRF associated with the peak increase 
in the response to 4-6 s duration EEG bursts for patient 19. These images represent the 
change in HbT at the time point indicated by the black vertical line in the lower panel. Note 
the marked increases in HbT in the bilateral temporal regions and the absence over the 
right superior parietal area (see Movie 5.2).  
 
Figure 5.3.8: The reconstructed image for the HbT-HRF associated with an undershoot in 
the response to 4-6 s duration EEG bursts for patient 19. These images represent the change 
in HbT at the time point indicated by the black vertical line in the lower panel. Note that 
this decrease is most apparent in the frontal cortices (see Movie 5.2). 
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Figure 5.3.9: Comparison of MR image and DOI for patient 19: (A) T1 weighted MRI of 
patient 19, showing bilateral temporal oedema, and (B) DOT images of patient 19 showing 
the maximum increase in HbO2 (top section of figure) and minimum decrease of HbO2 
concentration (lower section of the figure) in response to burst activity. Note the localisation 
of the haemodynamic changes in both temporal cortices, where the MRI has identified 
bilateral temporal oedema.  
Movies showing the haemodynamic response to 4-6 s duration bursts in patients 
12 and 19 will be provided with the presentation of this thesis.  
A 
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5.4 Discussion and Conclusions 
Burst suppression has traditionally been considered as a uniform, global, brain state. It 
appears that regardless of the causative mechanism of BS the EEG trace typically seems 
consistent and synchronous across the scalp. This has led to the perception that BS reflects 
a state of global brain inactivity and thus can be pharmacologically induced in cases of 
head injury (405) or status epilepticus (406), as a therapeutic means of minimising or 
depressing cortical activity.  However, it is still unclear as to whether BS is truly a state 
of global suppression of brain function. 
There is supporting evidence form the literature that despite the apparent cortical 
inactivity in BS, there can be increased activity in subcortical structures, which may 
trigger and signal activity in the hyper-excitable cortex. This is a possible hypothesis of 
the origin of the observed bursts in BS.  This activity has been described as a novel 
neurophysiological parameter, known as ‘Nu-complexes’ that originate from the 
hippocampus at different depths  of coma and therefore in BS (407).  Researchers have 
attempted to capture more spatial information by performing high density electro-
corticography as opposed to standard scalp EEG on propofol-induced comatose human 
adults.  They demonstrated that, unlike traditional perception, BS is not a global, unified 
phenomenon; it can be localised to specific cortical areas, whilst other regions may 
exhibit continuous activity and bursts may occur asynchronously across different brain 
locations (263). 
These findings have opened new horizons in the way we perceive cortical activity 
and have introduced the potentially crucial role of the subcortical structures in the 
observed neuronal activity. This gives rise to questions as to how the sub-cortex interacts 
with the cortex and as to whether there is a similar interaction between subcortical 
neuronal structures and the cortical vasculature, which may contribute to the observed 
neurovascular coupling as shown in previous studies (363) and ours (365, 408). They 
have also enhanced the importance of using neuroimaging techniques with increased 
spatial specificity than scalp EEG to investigate BS and discontinuous EEG phenomena.  
Simultaneous DOT-EEG approaches have the advantage of allowing the 
investigation of both the temporal and spatial features of the haemodynamic correlate of 
BS, which facilitates the investigation of the relationship between discontinuous EEG 
states and cerebral function.  
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In this part of the study a significant haemodynamic response to burst activity in 
infants with HIE was shown.  To date, this appears to be the first study to examine this 
phenomenon in this patient group.  The haemodynamic component of burst activity in 
infants with HIE was best characterised by an initial decrease in HbO2, which reaches a 
minimum during or soon after the burst, followed by a pronounced increase (see Fig. 
5.3.4) peaking at 10 to 12 s after the burst onset.  The changes in HHb are more variable, 
but follow the trend of the HbO2 changes and it is quite clear that they are not consistent 
with the typical, expected HRF shown in healthy adults (409). There is ongoing debate 
regarding the nature of the healthy neonatal HRF.  While several studies suggest the 
neonatal (and even early pre-term) haemodynamic response is consistent with that 
observed in the mature brain (328, 410), a recent study in the rat model suggests that the 
haemodynamic response to an external stimulus varies significantly with postnatal age 
(411). The latter showed that in the infant rat, the haemodynamic response consists of a 
small increase in HbO2, followed by increase in deoxy-haemoglobin, while the response 
in the adult rat was consistent with the expected adult human response; an increase in 
HbO2 with a parallel decrease in HHb.  
A possible interpretation of the observed HRF shape in our data, is that burst 
activity induces a regional increase in perfusion and therefore blood volume. The oxygen 
extraction is either abnormally low or the oxygen supply exceeds the regional metabolic 
demands and hence, the increase in perfusion results in little change in oxygen saturation 
with no occurring decrease in HHb. It may, nevertheless, be part of a physiological 
process based on most recent literature and a normal variant of haemodynamic response 
observed in infancy (411). Another possible explanation to the observed result is 
considering the pathophysiological mechanisms of HIE in the following hours post injury, 
and specifically the biochemical changes associated with reperfusion injury (412-414). 
There are additional confounding factors which may affect the neurovascular 
coupling and subsequently the observed HRF, such as therapeutic hypothermia, 
anticonvulsant treatment, inotropic support. Anticonvulsant treatment is known to 
depress the EEG background activity and its effects are dependent on the type of 
medication, the dosage and the timing of administration, and the gestational age of the 
infant (415).  Standard phenobarbitone loading doses (10-20 mg/kg) only moderately 
affect the EEG background activity in full term infants.  However, evidence suggests that 
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the more severe the hypoxic ischaemic insult, the more  discontinuous and suppressed the 
EEG may become post phenobarbitone administration (416). Midazolam is another 
medication frequently used in cases of HIE, for its anticonvulsant effects and occasionally 
for its sedative effects during mechanical ventilation. It appears that its administration has 
limited if none effect on the EEG background appearance (416). The effect of 
anticonvulsant treatment on the background electro-cortical activity is decreased over 
time as the drugs are metabolised with a median time-to-recovery of 2.5 hours, ranging 
from 2 to 15 hours (417). A recent study looking at the effect of anaesthetic drugs on 
neurovascular coupling concluded that there is no actual variation across different agents 
(398). A recent study on the influence of therapeutic hypothermia on cortico-vascular 
activity in infants with HIE, using frequency domain NIRS and diffuse correlation 
spectroscopy, showed that compared to the post-hypothermic phase, cerebral oxygen 
metabolism and CBF were lower and CBV was higher during hypothermia (418).  
While all six infants included in this study were diagnosed with HIE and were 
receiving therapeutic hypothermia, the severity of their clinical situation varied. They had 
also received a range of anticonvulsants at different times relative to the period of 
recording (see Table 5.1).  Despite these many confounding factors, the shape of the 
principal haemodynamic response to burst events is remarkably consistent across our 
cohort (see Fig. 5.3.4).   
In 4 out of 6 infants, the peak increase in total haemoglobin occurs between 11 
and 12.5 s after the onset of burst activity. A possible explanation for this could be their 
common EEG state acts as a control for the many other experimental variables: i.e. the 
haemodynamic correlate of BS may be consistent despite the various factors that have led 
to that neurological state.  However, as is apparent from figures 5.3.5-8, the spatial 
distribution of the haemodynamic response to EEG bursts is highly variable across 
infants.  Furthermore, the dominant features of the representative responses shown in Fig. 
5.3.4 are not necessarily at their most pronounced in the same cortical area; while the 
initial dip of one infant may be most pronounced at the bilateral temporal-parietal 
boundaries (see Fig. 5.3.5), the peak increase in HbT in the same infant can be most 
pronounced in the prefrontal cortex (see Fig. 5.3.6).   
These results constitute evidence that electro-cortical burst activity in HIE infants 
invoke variable haemodynamic responses in different cortical regions. Whether this 
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reflects localized neuronal activity, which otherwise is grossly seen as BS on scalp EEG 
must be explored further. So far, there is limited scientific evidence to show that the 
phenomenon of BS can be dependent on local dynamics rather than a global state (263). 
Future studies on animal models of neonatal asphyxia combining cortical EEG and DOT 
measures could elucidate this further.  
It is also of striking interest that the MRI of patient 19 (see Fig. 5.3.9) revealed 
swelling of the bilateral medial temporal cortices and a possible haemorrhagic lesion over 
the right parietal lobe.  These findings, to some extent, appear to correlate with the 
distribution of the peak HbT changes shown in figure 5.3.7. The largest response is 
apparent in the temporal lobes, while a distinct absence of a response can be noted in the 
right parietal region. 
With this work, the haemodynamic correlate of electro-cortical burst activity in 
the burst-suppressed and discontinuous EEG traces of human infants with HIE was 
identified.  These responses exhibit a consistent morphology but highly variable spatial 
distributions across different infants.  This observation is consistent with the emerging 
picture of BS as a representation of a complex and variable functional brain state, rather 
than simply an indication of globally suppressed neuronal activity.  DOT-EEG 
approaches are likely to play a significant part in future investigations of the 
neurophysiological and clinical implications of burst-suppressed and discontinuous EEG 
states.
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6.1. Background on functional imaging of perinatal stroke 
This part of the thesis focuses on perinatal arterial ischaemic stroke (PAIS). The majority 
of perinatal stroke is arterial and ischaemic in origin (as also mentioned in section 1.1.3), 
which affects 1 in 2,300 infants (61) not including cases of PAIS recognised outside the 
neonatal period. PAIS, is associated with hemiplegia, epilepsy, cognitive impairment, and 
lifelong disability (419).   
At present, there is no definitive treatment, other than a symptomatic and 
supportive one, unlike large vessel stroke in the adult population. Although PAIS is 
defined as occurring anytime between the second trimester of pregnancy and the first 28 
days of life (60), the exact timing of injury for those of acute onset in the immediate 
postnatal period, is often not clear. The first clinical signs, usually being focal seizures, 
tend to present in the first few days of life but may go unnoticed. The current diagnostic 
tools are summarised in section 1.4 of chapter 1. A neuro-investigative tool facilitating 
early diagnosis of PAIS would aid in the study and application of early treatment 
strategies, such as therapeutic hypothermia (TH) (420). 
Continuous wave NIR-DOT is a safe, portable, non-invasive brain-imaging tool, 
which allows long-term monitoring of critically ill infants. Various research groups have 
recorded changes in oxygenation during stroke using different NIR methodologies. Wolf 
et al. used NIRS to demonstrate a decrease in the concentration of HbO2 and increase in 
the concentration of HHb during focal cerebral ischaemia in rats (421), with similar 
results obtained by Stankovic et al. in piglets (422). Analogous results were obtained in 
humans by Calderon-Arnulphi et al., who studied patients undergoing neurovascular 
surgery with quantitative frequency-domain (FD) NIRS and demonstrated a decrease in 
HbO2 and HbT, accompanied by an increase in HHb in all patients who suffered an 
ischaemic event  (423). Culver et al. used a simultaneous FD-DOI and diffuse correlation 
spectroscopy (DCS) device following MCA occlusion in rats. They demonstrated little 
changes in relative cerebral blood volume (rCBV) and HbT, but oxygen saturation (StO2) 
decreased by 11%, once again agreeing with a decrease in HbO2 concentration, and 
increase in HHb concentration the initial phases of MCA stroke (424).  
In the examples mentioned, most NIR recordings were obtained after the stroke 
has occurred, as the precise timing of injury is unknown. Consequently, it becomes 
impossible to record an in vivo “baseline” chromophore state before MCA occlusion. 
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Therefore, alternative approaches, such as investigating transient non-physiological 
phenomena (such as burst suppression activity), measuring quantitative markers such as 
StO2, or comparing the frequency content of the affected and healthy hemispheres have 
been employed. Cooper et al. used a simultaneous CW-DOI and EEG system to identify 
transient haemodynamic phenomena in a term infant with extensive unilateral stroke 
(366). This study reported successive distinct changes in both HbT and HbO2 that were 
significantly different between the healthy and stroke-affected brain region (see Fig. 
6.1.1).  Earlier, Vernieri et al. demonstrated discrepancies between hemispheres in adult 
stroke patients by using NIRS and transcranial doppler (TCD) to study the effects of 
hypercapnia on CBV. Amongst the subjects studied there were two with unilateral MCA 
stroke, in which the increased CBV expected following hypercapnia was only detected 
over the healthy hemisphere (425). More recently, Moreau et al. published a FD-NIRS 
study of brain oxygenation in adults with stroke, which found that all affected patients 
had an area of reduced StO2 in the stroke-affected hemisphere (426). Whilst these studies 
provide valuable insight, transient haemodynamic changes are not always observed, and 
it is not possible to subject stroke-affected infants to hypercapnia. Additionally, 
commercial NIR technologies that can measure quantitative variables (such as FD-NIRS) 
tend to be expensive and bulky. 
 
Figure 6.1.1: Cortical haemodynamic changes in an infant affected by left sided MCA 
infarct: (A) spectroscopic analysis of the optical signal showing a spontaneous significant 
decrease in both total and oxy-haemoglobin  on the site of injury, whereas the changes on 
the right side are minimal, (B) reconstruced haemodynamic change according to the array 
used for the study of the infant as depicted on the head of the model, (C) T2 weighted image 
of the patinet’s MRI showing an extensive left sided MCA infarct. Adapted from reference 
(366). 
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Another method for detecting stroke is to look at the disturbance of normal brain 
physiology. Spontaneous low frequency oscillations (LFOs) of cortical vasculature occur 
in the healthy brain, and their clinical significance remains under debate. They are 
believed to be associated with myogenic (427), metabolic (428) and neurogenic stimuli 
(429), sympathetic tone (430), and cerebral autoregulation (CA) (387, 431). Dynamic 
cerebral autoregulation maintains a constant cerebral blood flow (CBF) in the face of 
changing cerebral perfusion pressure; this protects the brain from rapid increase or 
decrease in CBF during fluctuations of the arterial blood pressure. Numerous studies 
support the idea that CA is altered in cases of brain injury, such as ischaemic stroke (432-
436).  
The LFO band can be subdivided into very low (VL) frequency oscillations from 
0.004 to 0.009 Hz (385, 386), RS frequency oscillations from 0.01 to 0.08 Hz (355, 356), 
and Mayer waves from 0.09 to 0.4 Hz (437, 438). Very low frequency oscillations were 
originally detected in 1960 as spontaneous fluctuations in the intraventricular pressure of 
patients with intracranial disease (439). They have been observed physiologically in 
healthy adults by measuring intracranial pressure (440), flow velocity in the MCA (441), 
and MR imaging of intraventricular CSF and CBF (442), thus suggesting a link to a 
vascular myogenic mechanisms, possibly associated with the smooth muscle cells of the 
vessel bed. Resting state oscillations that display a synchronous, symmetrical pattern 
across homologous brain regions between hemispheres were initially detected with 
BOLD fMRI and are believed to possibly be a precursor to the default mode network 
(359). These same RS oscillations have also been observed in neonates using NIR 
imaging systems (443-445). More recently, both VL and RS oscillations have been 
explored as an indirect marker of CA in adult stroke patients receiving thrombolytic 
therapy; showing that stroke severity positively correlated with the degree of altered CA 
which was less impaired in the treated group (446). The functional significance of Mayer 
waves is a topic of continuing investigation and debate. Mayer waves have been detected 
in several species at different inherent frequencies, at 0.1 Hz in humans (458, 459), 0.1 
Hz in cats (460, 461), 0.3 Hz in rabbits (462) and 0.4 Hz in rats (463). Some studies have 
suggested that Mayer waves are global oscillations in arterial blood pressure correlating 
with sympathetic neuronal activity (437), others that they trigger the release of 
endothelial-derived nitric oxide during vascular stress (464), or that they are part of 
normal vascular baroreflex mechanisms and of no particular function (465). 
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Diffuse optical imaging allows a novel method for the detection and further 
investigation of LFOs in PAIS patients. To date, few DOI based studies exist focussing 
on the role of LFOs in stroke, and only one of these had a neonatal application. In 2012, 
White et al. used CW-DOI to study RS networks in the occipital cortices of healthy term 
and preterm infants, demonstrating the absence of inter-hemispheric connectivity in one 
neonatal case with mono-hemispheric occipital stroke (see Fig. 6.1.2) (355). 
 
Figure 6.1.2: Diffuse optical images of functional connectivity; using independent 
component analysis to demonstrate occipital resting state functional connectivity in 
different subsets; (A) healthy term infant, (B) healthy preterm infant with no significant 
anatomical brain injury, (C) preterm infant with a complicated clinical course, and (D) a 
preterm infant with unilateral occipital stroke. Note the absence of interhemispheric 
connectivity in subset D. Adapted from reference (355). 
Given the ability of CW diffuse optical systems to quickly obtain cerebral 
haemodynamic information early in the life of an infant, and the potential to meaningfully 
analyse post-injury data, a further investigation of LFOs of the optical signal in PAIS-
affected infants was warranted. As previously described, spontaneous LFOs potentially 
derive from normal neuronal, myogenic, and other brain functions, which are likely 
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affected in cases of brain injury. Therefore, the hypothesis of this part of the study was 
that uni-hemispheric stroke would lead to a detectable difference in spontaneous LFOs 
between stroke-affected and healthy brain regions. A secondary objective of this study 
was to investigate how the results from the DOT data would differ depending on whether 
MRI-guided stroke location was encountered in the analysis.  
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6.2 Patients and Methods 
6.2.1 Patients and Data Acquisition  
Out of the cohort of infants studied in this project, 5 were selected for this part of the 
analysis.  This was a retrospective investigation and patients were selected based on the 
detection of an arterial stroke on the MRI. The MRIs were performed as part of standard 
clinical care. Each infant was studied with the DOT-EEG device (as described in chapter 
3) for a duration varying from 30 to 120 minutes whilst receiving intensive care on the 
NICU. 
To support the hypothesis of interhemispheric difference for the LFO bands in 
perinatal stroke, the same methodology was applied to control subjects. Out of the cohort 
of healthy controls, 4 were selected based on the quality of their continuous DOT data. 
The control subjects were healthy newborn infants and most of them were scanned in the 
first week of life (except for one, Preterm_1).   
Infants presenting with seizures and suspected stroke were scanned within 3 days 
from birth. The incidence and location of stroke was later confirmed by MRI between 7 
to 10 days of life. Subjects presenting with seizures but no evidence of stroke on MRI as 
well as subjects with MRI confirmed bilateral stroke were excluded from the study.  All 
infants were scanned at the cot-side in the NICU whilst receiving intensive clinical care. 
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6.2.2 EEG Analysis 
Alongside the DOT recordings there was simultaneous video-EEG monitoring. The 
spectral analysis of the EEG traces was performed prior to the known diagnosis and MRI 
findings. The EEG traces were also reviewed and reported by the Clinical 
Neurophysiologist, Dr Andrew Michell (AWM). The key elements which would lead to 
suspicion of stroke would be lateralised signal attenuation of background activity, 
unilateral loss of certain frequencies within the electrical activity, detection of seizures 
consistently across a specific hemispheric brain region.  
A further computational analysis of the raw EEG data was applied using the 
EEGLAB toolbox within MATLAB. The aim of this was to plot the channel spectra and 
cortical maps to identify whether there were any broad discrepancies between the two 
hemispheres for different frequencies of the EEG signal. For the purposes of this, each 
dataset was bandpass filtered (hpf 0.5 Hz, lpf 40 Hz) and visually inspected. For each 
dataset, artefact-free epochs were used for the calculation of the power spectra for certain 
frequencies between 2 and 25 Hz. An example of the power plots can be seen in figure 
6.2.1. Using a spherical dipfit model within the EEGLAB toolbox which recognises the 
registration of EEG electrodes across the array used in the study, the spectral power for 
these frequencies was plotted and presented as cortical spectra maps. This is a simple 
approach to establish differences in the spectral power for certain frequencies of the EEG 
signal across different parts of the scalp. 
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Figure 6.2.1: Example of power spectra plot of an EEG dataset for frequencies between 2 
and 25 Hz. This is a plot of spectral power (in µV2/Hz) on the y axis over frequency (in Hz) 
on the x axis. The different colours represent different channels and the isolated yellow line 
is the ECG. This shows a very similar distribution of power over frequency for all the 
different channels with no clear spectral features.  
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6.2.3 DOT analysis 
The initial study design and analysis, described in this section, was devised, and 
performed by me. It was refined and expanded by RJC and LAD using bespoke scripts 
and MATLAB functions.   
Pre-processing of the optical data 
The initial pre-processing steps were followed as described in section 3.2.3 in chapter 3. 
For the selection of ‘healthy channels’, an arbitrary mean threshold of optical intensity 
was used (10e-4). If the mean measured optical intensity was found to be below this 
threshold the channels were excluded from the analysis. The motion related artefacts were 
removed manually (see Fig. 6.2.2). The remaining artefact-free epochs were concatenated 
thus producing continuous epochs of a minimum 20-minute duration of optical data per 
infant. The concatenation takes the non-motion sections and sandwiches them together.  
As part of this process, the mean intensity value of each non-motion segment is adjusted 
to match that of the previous segment, thus producing a continuous signal.  The set 
minimum epochs of continuous DOT data required to capture and detect LFOs was 20 
minutes. The length of every optical dataset, used in the analysis, satisfied the Nyquist 
criterion for the slowest investigated frequency (0.0055 Hz). 
The intensity data were converted to optical density. Based on the modified Beer-
Lambert Law the optical density data were converted to HbO2, HHb, and HbT using a 
DPF of 4 for both wavelengths (447). The Hb oscillation data were bandpass filtered into 
the following low frequency bands: a) the VL, between 0.0055 and 0.0095 Hz, b) the RS, 
between 0.01 and 0.08 Hz, and c) the Mayer wave band, between 0.09 and 0.3 Hz. This 
process was guided by review of the literature as mentioned in section 6.1 as well as 
careful inspection of the spectral power of the data (for example see Fig. 6.2.6). 
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Figure 6.2.2: Raw optical signal of patient 25. This image depicts the raw optical signal; 
changes of optical density over time, as acquired by the DOT device. The y axis represents 
the changes in optical density and the different colours reflect separate optical channels. 
The x axis represents time in milliseconds. Note the sudden change of the trace of the signal 
from the baseline between 2.2 and 2.8 x104 milliseconds which reflects motion related 
artefact and would be rejected in the pre-processing phase of the analysis.  
The main trajectory of the analysis was to compare interhemispheric difference in 
a channel-wise manner between the healthy and stroke affected brain regions. The 
distribution of the stroke in the MCA territory guided the initial channel selection. These 
channels were labelled ‘blind channels’ as their selection was an approximation based on 
the array and the MCA territory.  Therefore, a more specific approach was attempted 
using the MRIs, as described below.  
MRI processing, mesh manipulation, and ROI specification 
The quality of the patients’ MRIs was adequate to detect anatomical structures and the 
stroke affected brain regions. The MRIs were inspected in FSL (FMRIB Software 
Library, Oxford: functional MRI of the brain Software Library), which is a library of 
methodological tools for functional, structural and diffusion MRI brain data (448, 449)). 
The anatomical landmarks of nasion, inion, Ar, Al, and Cz were measured and recorded 
in mm, in each patient’s MRI.   
The next challenge in the analysis was to certify that the optical data coordinates 
were in alignment with each patient’s MRI. This required that the optical atlas mesh was 
transformed to match the individual patient’s anatomy. For each patient, an age-matched 
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neonatal head atlas (404) was chosen. This was based on each patient’s GA at birth. This 
atlas was then affine transformed to the patient’s individual head coordinates, as defined 
by the 5 anatomical landmarks on the MRI. The produced mesh contained all separate 
layers of the extra-cerebral tissues, CSF, grey matter, and white matter and its nodes were 
connected to these volumetric elements respectively. To each one of these volumetric 
elements, different optical properties were attributed, based on the type of tissue they 
originated from.  
TA inspected the MRIs and marked the stroke-affected brain region across all 
layers, thus creating a 3D volumetric stroke mask. This was then utilised to detect the 
mesh nodes that overlapped with the stroke-affected region. In most cases, the sequence 
used to identify the stroke areas, was typically T2-weighted Fast Spin Echo (T2-FSE). 
The following step was to identify which channels of the existing array were more 
sensitive to the stroke-affected region. This was accomplished by creating a simulation 
of light propagation by using the finite element method (FEM) and TOAST++ (351). The 
patient-based mesh was used as the finite element mesh. The 10-5 positions (370) of the 
58 fibres in the cap provided the 3D locations on the mesh. Based on this, a model of how 
photons travel through tissue was calculated, otherwise known as the sensitivity matrix 
(for further details see section 2.2.5 in chapter 2, and previously published (365, 408)). 
This led to the photon measurement density function (PMDF) between a source and 
detector. This function generally explains how sensitive the detected optical signal is to 
the underlying mesh elements.  
A channel was then deemed sensitive if all the nodes were 10% or greater of the 
maximum absolute sensitivity of the PMDF for that channel. The stroke related nodes 
were matched to the sensitive PMDF nodes. The ones overlapping were determined as 
the region of interest (ROI) channels. As previously mentioned when the ROI channels 
were not considered, they were referred to as blind channels. Only blind channels were 
used for the assessment of the control infants.   
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Figure 6.2.3: Flowchart of the MRI and mesh processing: A) the anatomical head atlas is 
affine transformed to the patient’s head coordinates, B) creation of a stroke-specific mask 
in FSL, which is combined with the patient’s mesh to determine which nodes in the mesh 
contain the stroke (the ROI nodes), C) a mesh with the labelled stroke region combined with 
light simulation (i.e. PMDFs) to determine D) which channels overlap by least 10% with the 
stroke area. 
Frequency analysis 
Power spectral density (PSD) was calculated for the HbO2 and HHb signals and integrated 
within the three LFO bands (VL, RS, and Mayer wave).  
Statistical analysis 
The Wilcoxon signed-rank test was used to assess any difference in spectral power 
between the controls and the stroke-affected patients. The threshold for statistical 
significance was Bonferroni-corrected by the number of LFO bands to 
pα=0.01/3=0.0033. 
Pearson’s R between every homotopic channel pair were calculated in relation to 
the HbO2 and HHb signals in the three LFO bands. To assess the interhemispheric 
correlation difference between the control and PAIS-affected patient groups, the controls’ 
95% confidence interval (CI) of the correlation R values for 6 different conditions was 
calculated. This included the calculation of 95% CI of all the control R values for the 
HbO2 oscillations in the VL, RS, and Mayer wave frequencies and the HHb oscillations 
in the VL, RS, and Mayer wave frequencies. This was then compared against the mean 
correlation R values in the PAIS blind and PAIS ROI groups to estimate the number of 
patients that lied within the CI values for each separate condition.  
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6.3 Results  
6.3.1 Clinical Details 
Within the cohort of infants studied, 5 had a large stroke detected by conventional MRI. 
Those were patients 16, 18, 20, 25 and 29. Patients 16, 25 and 29 had an isolated diagnosis 
of cerebral infarction, whereas patients 18 and 20 had a diagnosis of both HIE and 
cerebral infarction. Patient 20 was excluded from the analysis due to poor data quality. 
The clinical details of each patient, including the MRI findings can be seen in tables 6.1 
and 6.2.  
Within the cohort of infants studied with no identified or reported brain injury, 
controls 4, 8, 10, and preterm 1, were included in the stroke analysis. For the clinical 
details of the controls please refer to tables 3.2 and 3.3 in section 3.1.3, chapter 3.   
Patients 18 and 20 presented with suspected HIE and seizures, fulfilling both 
criteria A and B as per TOBY cooling criteria for therapeutic hypothermia (43). However, 
in patient 20 therapeutic hypothermia was discontinued within the first 24 hours as it was 
determined that her primary diagnosis was not HIE but septicaemia/meningitis. The rest 
of the patients were admitted due to initial presentation with clinical seizures or a strong 
suspicion of seizures in the first 12 hours of life.  
There are several clinical entities associated with the presentation of neonatal 
stroke which could possibly play a causative role (see section 1.1.3). The identified 
predisposing maternal factors in this cohort were gestational diabetes, prolonged rupture 
of membranes, and chorioamnionitis. The identified predisposing neonatal factors were 
suspected or confirmed infection/sepsis, HIE, profound anaemia, and persistent 
pulmonary hypertension of the newborn (PPHN). 
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Infant GA 
 
BW  Maternal 
Factors 
Birth Presentation Neonatal 
Course 
Outcome at 
Discharge 
Patient 16 
 
38+4 3470 None SVD, No resus. Apnoeic 
episodes. 
SVIA, received 
Phenobarbitone, 
Suspected 
sepsis, CSF 
clear. 
Discharged 
home on 
Phenobarbitone 
maintenance. 
Breast feeding 
on demand. 
Normal 
neurology. 
Patient 18 
 
37+2 3150 GDM 
modulated 
by diet and 
Metformin 
EmLSCS for 
suspicious CTG, 
Profound 
anaemia (Hb of 
2.5), Intubated. 
Hypotonia, 
episodes of 
decerebrate 
posturing 
associated 
with 
desaturations. 
Ventilated for 3 
days, oxygen 
therapy till day 
10 of life. 
PPHN, 
Anaemia, 
multiple 
transfusions, 
received 
Phenobarbitone.  
Discharged back 
to local unit. 
NGT feeds. 
Some reduced 
tone on upper 
limbs compared 
to lower.  
Patient 20  41+3 3580 Chorioamni
onitis,  
PROM 
 
SVD, 
Meconium,  
Intubated.  
Back arching, 
generalised 
clonic, cycling 
movements of 
lower limbs, 
eye flickering. 
Ventilated for 3 
days, SVIA 
since, received 
Phenobarbitone, 
Phenytoin and 
Midazolam, 
GBS sepsis and 
meningitis. 
Discharged back 
to local unit. 
Breast feeding 
on demand. 
Normal 
neurology. 
Patient 25 
 
40 3500 PROM Vaginal forceps,  
Stimulation and 
facial mask O2, 
fast recovery. 
Generalised 
clonic 
movements. 
Ventilated for 1 
day, SVIA 
since, received 
Phenobarbitone 
Phenytoin, and 
Clonazepam. 
Discharged back 
to local unit. IV 
fluids and NGT 
feeds. 
Normal 
neurology.  
Patient 29 
 
41 3688 Chorioamni
onitis, 
Maternal 
CRP: 181,  
PROM 
EmLSCS for 
pathological 
CTG. No resus. 
Apnoeic 
episodes and 
Rt sided clonic 
movements. 
SVIA, received 
Phenobarbitone 
and Phenytoin, 
suspected 
sepsis, CSF 
clear. 
Discharged 
home. Breast 
feeding on 
demand. 
Normal 
neurology. 
Table 6.1: Clinical details of the patients diagnosed with PAIS. The information was 
gathered from the clinical notes, discharge summary and the clinical staff looking after the 
patients. The maternal factors refer to events prior to the infant’s delivery. (GA: gestational 
age at birth in weeks /40 weeks of expected normal pregnancy duration, BW: birth weight 
in grams, GDM: gestational diabetes mellitus, PROM: prolonged rupture of membranes 
>24 hours prior to delivery, CRP: c-reactive protein (normal when <1), SVD: spontaneous 
vaginal delivery, no resus: no resuscitation required at birth, EmLSCS: emergency low 
segment Caesarean section. CTG: cardiotocogram, Hb: haemoglobin, SVIA: self-
ventilating in air, CSF: cerebro-spinal fluid, PPHN: persistent pulmonary hypertension of 
the newborn, GBS: group B streptococcus, NGT: nasogastric tube, IV: intravenous). 
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Infant GA 
 
CGA  
 
CrUS Single-channel 
aEEG 
Clinical EEG MRI findings 
Patient 16 
 
38+4 38+6 Lt temporal 
lobe lesion 
suggestive 
of infarction 
Seizures 
detected, normal 
background 
Normal  Large haemorrhagic lesion in the Lt 
temporal lobe associated with 
overlying subdural haemorrhage; 
secondary to venous infarction 
related to the subdural or bled from 
a pre-existing vascular anomaly 
such as deep venous anomaly. 
Patient 18 
 
37+2 37+2 Normal  Seizures 
detected, 
discontinuous 
background 
Mildly 
discontinuous. No 
evidence of 
seizures. 
Abnormal signal intensities within 
the territory of the Lt middle 
cerebral artery consistent with 
infarction. Involvement of the basal 
ganglia, thalami and PLIC on the Lt 
with abnormal diffusion in the Lt 
cerebral peduncle. 
Patient 20  41+3 41+3 Possible 
cerebral 
oedema 
Seizures 
detected, 
discontinuous 
background 
Discontinuous, no 
evidence of 
seizures. 
Bilateral infarct of both posterior 
parietal, temporal, occipital white 
matter, and cortex (some sparing of 
the Lt visual cortex but involvement 
of both optic radiations). 
Patient 25 
 
40 40+3 Normal  Seizures 
detected, normal 
background 
Asymmetry with 
attenuation over the 
Rt hemisphere. 
Sharpened 
theta discharges 
over the Rt 
temporal region. No 
evidence of 
seizures. 
Large infarct over the Rt 
hemisphere, involving the temporal, 
parietal, and occipital lobe. 
Patient 29 
 
41 41+3 Normal  Seizures 
detected, normal 
background 
Low amplitude 
activity over the Lt 
anterior region and 
runs of sharp waves 
maximal over the 
Lt temporal region. 
No evidence of 
seizures. 
Abnormal signal intensity within 
white matter, cortex, and basal 
ganglia within the territory of the Lt 
middle cerebral artery consistent 
with infarction.  
Table 6.2: Results of investigations of the patients diagnosed with PAIS. The cranial 
ultrasound results refer to the findings of scans performed by the clinical team 
(neonatologists) on admission and on day 3 of life. All patients had 72 hours’ continuous 
single channel aEEG monitoring, and the results refer to the activity noted in the first 24 
hours’ post admission. The EEG results refer to routine 20 minute 21-lead video EEG 
performed as per standard clinical investigation of any infant presenting with seizures or 
seizure-like activity. The MRI findings refer to structural MRI, T1 and T2 weighted images 
obtained after day 7 of life as per standard clinical care (GA: gestational age at birth, CGA: 
corrected GA at time of study, both expressed in weeks /40 weeks of normal pregnancy 
duration, CrUS: cranial ultrasound scan, aEEG: amplitude integrated EEG, Rt: right, Lt: 
left). 
As per standard clinical care all patients had 72 hours’ continuous single channel 
aEEG monitoring. Serial cranial ultrasonography was performed on admission and day 3 
of life as standard practice by the clinical team for identification of any obvious structural 
abnormality, haemorrhage or other. Within the first 48 hours of admission to the unit a 
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20-minute 21-lead video EEG was performed for exploration of the background activity 
and any ongoing seizure activity. All infants had received some form of anticonvulsant 
treatment prior to this EEG. Depending on presentation, clinical suspicion, matter of 
urgency and scan availability, the patients had a structural MRI within the first 10 days 
of life. The results of all the investigations performed can be seen in table 6.2. A 
representative sample of MR images per patient can be seen in figure 6.3.1 and a specific 
one to the patients included in the analysis in figure 6.3.2.  
 
 
Figure 6.3.1: MR images for each of the stroke-affected patients. (A) T2-weighted image of 
patient 16 showing a large haemorrhagic lesion in the left temporal lobe associated with 
overlying subdural haemorrhage secondary to venous infarction, (B) T2-weighted image of 
patient 18 showing a left-sided MCA infarct with left-sided involvement of the basal ganglia, 
thalami and PLIC, (C) T2-weighted image of patient 20 showing global infarction of both 
hemispheres with some sparing of the left occipital lobe, (D) T2-weighted image of patient 
25 showing a right-sided MCA infarct, (E) T2-weighted image of patient 29 showing a large 
left-sided MCA infarct, (F) Diffusion-weighted image of the same patient 29. (PLIC: 
posterior limb of the internal capsule). 
 
A B C 
D E F 
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Figure 6.3.2: Anatomical MR images for the subjects in the PAIS group. A) Sagittal T1-
weighted images of each stroke-affected patient (patient 16, 18, 25 and 29 from left to right 
respectively), B) Axial views showing abnormal signal in the stroke location (patient 16, 18, 
25 and 29 from left to right respectively). From left to right, the MR sequences depicted here 
were T1 SE (Spin Echo), T2 FSE (Fast Spin Echo), T2 FSE, and ADC (Apparent Diffusion 
Coefficient). (A: anterior, P: posterior, R: right, L: left). 
 
    Patient 16     Patient 18    Patient 25     Patient 29 
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6.3.2 EEG Results 
The results of the spectral analysis of the EEG, as reported by AWM were the following: 
Patient 16: EEG recording of good quality, with no lateralisation or asymmetry. 
Overall background activity of low amplitude with apparent variation between sleep and 
wakefulness. No seizure activity detected.  
Patient 18: EEG recording of moderate quality, with discontinuous background 
trace but not burst suppressed. No asymmetry identified. Seizure activity over the anterior 
midline seizure activity between 176 to 338s, 1,788 to 2,019s, 2,109 to 2,427s, 2,689 to 
2,749s, 3,000 to 3,526s).  
Patient 25: EEG recording of good quality, with no lateralisation or asymmetry. 
Overall normal background activity with variation between sleep and wakefulness. 
Sharpened theta discharges over the right temporal region No seizure activity detected. 
Patient 29: EEG recording of good quality. Continuous background activity with 
low amplitude activity over the Lt anterior region and runs of sharp waves maximal over 
the Lt temporal region. No seizure activity detected.  
Further information was obtained from the extraction of the power spectra of the 
EEG signal. The spectral maps are presented in figures 6.3.3-6.3.5.  
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Figure 6.3.3: Power spectra plots with cortical maps in patient 16. These were calculated 
based on frequencies 6, 10 and 22 Hz of an artefact-free segment of EEG data. The plot 
depicts the power spectra (µV2/Hz), on the y axis, over different frequencies (Hz) on the x 
axis. The different colours represent different EEG channels. The separated lime green line 
represents the ECG signal, whose power spectra is consistent throughout with few 
fluctuations.  
For patient 16, there was lower spectral power at 6 Hz over the left hemisphere, 
and much lower at higher frequencies of 22 Hz with an overall paucity in the frontal and 
anterior parietal regions (see Fig. 6.3.3). For patient 25, it appears that overall there was 
increased power spectra over the right for all frequencies, which could be attributed to 
the occasional sharps of varied frequency content arising from the right temporal region 
(see Fig.6.3.4). For patient 29, there was overall paucity of power spectra for all 
frequencies on the left hemisphere compared to the contralateral one (see Fig. 6.3.5).  
 
 
 
 
 
 
Frequency (Hz) 
R L 
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Figure 6.3.4: Power spectra plots with cortical maps in patient 25.  These were calculated 
based on frequencies 6, 10 and 22 Hz of an artefact -free segment in patient 25. The plot 
depicts the power spectra (µV2/Hz), on the y axis, over different frequencies (Hz) on the x 
axis. The different colours represent different EEG channels. The separated lime green line 
represents the ECG signal, whose power spectra is consistent throughout with some 
fluctuations. 
The quality of the EEG recording for patient 18 was suboptimal and no 
meaningful spectral map could be obtained as there was increased artefact interference. 
Excessive processing of the artefact would interfere with the frequencies under 
investigation for these spectral maps and hence was not performed.  
Frequency (Hz) 
R L 
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Figure 6.3.5: Power spectra plots with cortical maps in patient 29.  These were calculated 
based on frequencies 6, 10 and 22 Hz of an artefact -free segment in patient 29. The plot 
depicts the power spectra (µV2/Hz), on the y axis, over different frequencies (Hz) on the x 
axis. The different colours represent different EEG channels. The separated lime green line 
represents the ECG signal, whose power spectra is consistent throughout with few 
fluctuations. 
Frequency (Hz) 
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 6.3.3 DOT Results 
Optical data quality 
The quality of the optical signal from the stroke-affected patients was good, with roughly 
83% of channels included in the analysis. An example of the data quality can be seen in 
figure 6.3.6A, which represents the continuous concatenated optical intensity signal for 
the selected channels per hemisphere. The selection of the channels as guided by the 
sensitive PMDFs for the same patient, are depicted in figure 6.3.6C. For each ROI 
channel, its homotopic partner was selected. In the spectral power graph (see Fig. 6.3.6B), 
one may notice a clear signal power from the cardiac and respiratory cycles at 
approximately 1.9 Hz and 0.6 Hz, respectively. Most of the power spectral density across 
the different datasets was located below 0.3 Hz. The length of each stroke-affected 
patient’s data was on average 27.04 ± 9.21 min (mean ± standard deviation). The length 
of each control patient’s data was on average 12.77 ± 5.89 min.  
Spectral power content 
There was no significant interhemispheric difference in any of the control infants. In the 
stroke-affected population, only patient 18 showed a significant interhemispheric 
difference, with the spectral power of the HbO2, HHb, and HbT being significantly less 
in the healthy hemisphere compared to the stroke-affected hemisphere in all three 
frequency bands. 
 
Figure 6.3.6: Processed optical data from patient 25. A) Raw concatenated intensity data 
from all channels with SNR >5. B) Power spectral density of the channels in (B). C) DOI 
channels sensitive to the stroke (red) and the healthy homotopic channels (blue). One 
channel from the ROI had insufficient signal to noise ratio (SNR) (grey) and neither that or 
its homotopic one was used in the analysis.  
B 
C 
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Correlation results 
As mentioned above in the optical data quality section, the optical signal from the stroke-
affected patients was good, with roughly 83% of channels included in the analysis.  The 
selection of the channels as guided by the sensitive PMDFs (ROI group) was narrowed 
based on whether the channels were sampling the area of the stroke.  In the ROI group, 2 
pairs of channels were deemed to be sampling the area of the stroke for patient 16, 16 
pairs for patient 18, 9 pairs for patient 25, and 18 pairs for patient 29.  
The mean interhemispheric correlation values for patients 18, 25 and 29 lied 
outside the 95% CI of the controls for the HbO2 and HHb oscillations in all three 
frequency bands. This was consistently noted in both the blind and ROI group. The mean 
interhemispheric correlation values of the ROI channels tested in patient 16 for the HbO2 
oscillations in the resting state frequency fell within the 95% CI of the controls, 0.656 
(95% CI: 0.635 - 0.713). The rest of the mean interhemispheric correlation values of the 
ROI channels tested in patient 16 (as seen below in Table 6.3) lied outside the 95% CI of 
the controls. Similarly, the mean interhemispheric correlation values of the blind channels 
tested in patient 16 (as seen below in Table 6.3) lied outside the 95% CI of the controls.  
 The absolute mean values per patient in each condition were either similar or 
marginally lower in the ROI group compared to the blind group except for patient 16, 
where the mean values of the blind group were the lower ones. The absolute mean values 
of patient 16, in both the ROI and blind groups, were much higher compared the ones of 
the rest of the patients.  This was consistently seen across the different frequency bands. 
The mean correlation values of patient 18, 25, and 29 were significantly and consistently 
low regardless of MRI-guided channel selection (with values ranging from 0.109 to 0.598 
across the ROI and blind groups, see Table 6.3).   
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ROI        
  P16 P18 P25 P29 95% CI 
HbO2 VL 0.823 0.289 0.357 0.510 0.693 - 0.792 
 RS 0.656 0.348 0.214 0.498 0.635 - 0.713 
 Mayer 0.736 0.485 0.226 0.319 0.432 - 0.542 
HHb VL 0.833 0.235 0.117 0.377 0.581 - 0.724 
 RS 0.764 0.177 0.205 0.248 0.624 - 0.704 
 Mayer 0.653 0.281 0.109 0.119 0.341 - 0.441 
Blind       
  P16 P18 P25 P29 95% CI 
HbO2 VL 0.639 0.315 0.464 0.598 0.693 - 0.792 
 RS 0.618 0.352 0.365 0.561 0.639 - 0.712 
 Mayer 0.621 0.484 0.300 0.379 0.432 - 0.542 
HHb VL 0.581 0.197 0.316 0.436 0.582 - 0.724 
 RS 0.509 0.174 0.333 0.357 0.624 - 0.704 
 Mayer 0.471 0.266 0.204 0.182 0.339 - 0.441 
Table 6.3: Mean interhemispheric correlation values of patients 16, 18, 25, and 29 for HbO2 
and HHb oscillations in the VL, RS, and Mayer wave frequency bands compared against 
the 95% CI of all the controls in each condition. The table is referring to the two study 
groups the ROI group (top half of the table) where channels were selected based on MRI-
guided stroke localisation and the blind group where channels were selected without 
imaging-guidance.  Note that the given 95% CI values are the same for both the ROI and 
blond group. For the controls only one standard channel election was performed, which was 
not MRI informed, as there were no neurological concerns or lateralised clinical findings.  
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6.4 Discussion and Conclusions 
The results of this part of the thesis are in keeping with some evidence of disrupted 
lateralised and inter-hemispheric brain function in stroke-affected subjects. No difference 
in the LFO spectral power of either hemisphere was identified in either of the controls or 
patients, apart from patient 18. There was a difference in interhemispheric correlation 
between controls and PAIS-affected patients in HbO2 and HHb oscillations for all three 
frequency bands, with deviation from the relevant 95% CIs of the controls. It was only 
the mean interhemispheric correlation value of the ROI channels in HbO2 resting state 
oscillations of patient 16, which lied within the 95% CI of the controls in the same 
frequency band.  
 The EEG recordings during the study were similar to the expected results from 
other studies (148, 150). In two of the patients, patient 18 and 20, electrographic seizure 
activity with focal onset was detected, thus aiding the diagnosis. The EEG can be a 
reliable tool for detection of features characteristic or suggestive of stroke. However, if 
the lesion is not extensive enough, it does not always appear to cause attenuation or sharp-
like waveform activity (150). In the absence of long, multi-channel recordings it is much 
less informative. If no seizures are captured during the EEG recording, it is difficult to 
establish the presence of a focal point of their origin or suspect stroke in the first instance. 
Administration of medication (such as phenobarbitone) for cessation of seizure activity, 
may alter the background activity and mask potential peri-ictal elements suggestive of 
perinatal stroke. A pathological EEG does aid the diagnosis but a completely normal one 
does not exclude the final diagnosis of perinatal stroke. In the EEG power spectra results 
there was some suggestion of lower frequency content over the affected side for patients 
16 and 29 (see Figures 6.3.3 and 6.35) and higher frequency content over the right side 
for patient 25 where sharp wave activity was ongoing in keeping with lateralisation of 
stroke (see Fig. 6.3.4). However, the source analysis performed here was limited by the 
small number of EEG electrodes used in the study, thus limiting the use of this tool and 
its interpretation.  
The MRIs performed, invariably between day 4 to 10 of life, ultimately establish 
the diagnosis of perinatal stroke. The cranial ultrasound scans were not diagnostic apart 
from patient 16, where the one performed within 24 hours from clinical presentation, 
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accurately detected an echogenic lesion in the left temporal region later confirmed on 
MRI.  
 The optical power spectra content in the different low frequency bands did not 
return any significant results for any of the control or PAIS-affected patients, apart from 
patient 18. The presumption was that stroke-affected regions would have altered vascular 
tone and abnormal circulation patterns which would be represented in the frequency 
content of the optical signal. A possible explanation could be that PAIS patients were 
scanned with DOT before bulk tissue necrosis had occurred; meaning any change to the 
frequency power content of underlying circulation patterns was undetectable. There is 
ongoing research to improve the understanding of recovery mechanisms following stroke 
not only looking at the infarcted region but also the peri-infarct zone (450-452). In 
contrast to our results, Li et al. studied spontaneous cerebral oscillations amongst healthy 
adults and patients at risk for atherosclerotic stroke by performing a wavelet transform 
analysis on a single left prefrontal NIRS signal in five frequency bands subdivided 
between 0.005-2.0 Hz. They found significantly lower oscillation power for HbT and 
HbO2 in the group of patients at risk of stroke versus the controls (453). Perhaps the 
primarily different origin (haemorrhagic as opposed to ischaemic) and pathophysiological 
cascade in adult compared to perinatal stroke may help explain why no interhemispheric 
differences in spectral frequency band power were noticed. 
The interhemispheric difference in spectral power content was detected only in 
patient 18, who had lower spectral power of the HbO2, HHb, and HbT in the healthy 
hemisphere compared to the stroke-affected hemisphere in all three frequency bands. This 
could be attributed to the ongoing electrographic seizure activity noted on the 
simultaneous continuous EEG recording (five discrete episodes of epileptiform activity 
were noted, see Table 4.3). This activity was originating from the left hemisphere (stroke-
affected side), spreading across the cortex within seconds of onset.  Further studies are 
warranted to investigate how the LFO spectral power content of the optical signal could 
be used as a method of seizure-detection in the NICU.  
The mean interhemispheric correlation values of all patients deviated from the 
95% CIs of the controls. This was noted for both HbO2 and HHb oscillations in all three 
frequency bands consistently in the blind and ROI groups. The exception was patient 16, 
where there was deviation for one of the conditions tested. More specifically, the mean 
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correlation value of the ROI channels for HbO2 resting state oscillations in patient 16 was 
the one found to lie within the 95% CI of the controls (0.656, 95% CI: 0.635 - 0.713). 
Overall these results (see Table 6.3) demonstrated a significant difference in 
interhemispheric correlation in cases of stroke-affected patients. Additionally, the 
absolute mean values of patients 18, 25 and 29 were much lower in both the blind and 
ROI groups, thus supporting low interhemispheric correlation in stroke-affected patients.  
This interhemispheric correlation difference was noted consistently regardless of MRI-
informed channel selection. This potentially supports that having the patient’s MRI is not 
necessarily a prerequisite for extracting some early diagnostic information from the 
optical data prior to definitive imaging. However, this was only tested on four patients.  
The absolute mean values of patient 16 were much higher than the ones of patients 
18, 25, and 29. This was a consistent observation regardless of MRI-informed channel 
selection, although the values were noted to be lower in the blind-channel assessment.  
This would suggest a higher interhemispheric correlation between homotopic channels in 
patient 16 as opposed to the rest of the patients. This difference noted could be attributed 
to the fact that the lesion in patient 16 was significantly smaller, only occupying a small 
region of the left temporal lobe, whereas the lesions in all other patients were significantly 
larger (see Figures 6.3.1 and 6.3.2). It was observed that the correlation values for patient 
16 were lower in the blind-channel group compared to the ROI-channel assessment. It is 
worth noting here that the ROI channels sampling the stroke lesion in patient 16 were 
only two homotopic pairs compared to a fair number of channels assessing the stroke 
regions in the rest of the patients. The relatively sparse array over the temporal lobe and 
small stroke lesion per se would have this effect upon the MRI-guided channel selection 
and assessment of interhemispheric correlation. In the blind-channel assessment, 
however, the interhemispheric values for patient 16 were lower and still outside the 95% 
CI of the controls.  
This indirectly could suggest that interhemispheric correlation appears lower in 
the event of larger lesions, something which also appears in the EEG literature regarding 
perinatal stroke; the larger the lesion, the more pronounced the attenuation of the signal 
on the stroke-affected side (150). These results also highlight the importance of using a 
dense array over the areas of interest and is explained in further detail later in the 
discussion. 
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In a similar fashion, White et al. observed inter-hemispheric Pearson’s R values 
of approximately 0.8 for HbO2 and 0.65 HHb in healthy term patients, whereas the patient 
with occipital stroke had markedly decreased correlation of approximately 0.2 for HbO2 
and -0.15 for HHb (355). White et al., however, demonstrated this only on one patient at 
a later stage (at 10 weeks of life) using a high density (HD) DOI device with 106 channels 
covering the occipital cortex only. No follow up studies have been presented by the group.  
Certain research groups have also explored Hb oscillations in the respiratory and 
heart rate frequency bands. Muehlschlegel et al. used bi-hemispheric CW-NIRS to 
investigate inter-hemispheric correlation coefficients for the respiratory and cardiac 
oscillations amongst nine healthy adults and twelve stroke-affected patients, identifying 
that the latter had a lower inter-hemispheric correlation coefficient for both the cardiac 
and respiratory frequency bands (454). In this thesis, the respiratory and heart rate 
frequencies were not included in the analysis due to the absence of continuous monitoring 
of these physiological parameters. There is, however, ongoing work on recording and 
integrating this information into the analysis for future studies. Similarly, arterial blood 
pressure (ABP) was not recorded, due to no consistently existing continuous invasive 
blood pressure monitoring across all the subjects.  
Other groups have investigated the interhemispheric phase shift between the ABP 
in relation to the flow velocity across the MCA (as measured by transcranial Doppler 
(TCD)) and the low frequency HbO2 oscillations using NIRS in both healthy and stroke-
affected adults (446, 455). It was demonstrated that HbO2 inter-hemispheric phase shift 
was significantly less in subjects undergoing thrombolytic therapy compared to untreated 
stroke adults (446). Han et al. investigated inter-hemispheric phase synchronisation of 
HbO2 oscillations in the prefrontal area of stroke-affected elderly patients (21 patients 
with cerebral infarction and 21 controls). The group looked at low frequencies (0.021-
0.052 Hz and 0.052-0.145 Hz) and higher frequencies (0.145-0.6 Hz and 0.6-2 Hz), 
finding significantly lower phase coherence within the lower frequency bands in 
hypertensive patients with cerebral infarction (456). Although this study was a single 
channel NIRS experiment on elderly patients, it still demonstrated the disruption of inter-
hemispheric coherence due to stroke primarily within the VL and RS frequency bands. In 
healthy adult volunteers, Kuo et al. identified high coherence between the spontaneous 
oscillations of the MCA blood flow velocity (as measured by TCD) and ABP only within 
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low frequencies above 0.04 Hz, but not for very low frequencies (0.016 to 0.04 Hz) (431). 
Further analysis in their study showed that the phase angle between ABP and the MCA 
flow velocity was particularly dependent upon frequencies in the RS band (431). Both 
studies add credence to the idea that physical injury to the MCA would most directly 
affect VL and RS oscillations, and that these frequency bands should be a primary target 
of investigation for stroke detection as presented in this thesis.  
The sample of the patients is small, but the consistency of the results suggests an 
interhemispheric difference deviating from the expected interhemispheric correlation 
seen in controls. Additionally, the results appear to be consistent and independent to MRI-
informed stroke localisation. This supports further research and development of this 
technology in early assessment and cortico-vascular monitoring in the first few days of 
life until more definitive imaging such as MRI is available or applicable depending on 
the patient’s overall clinical condition.   
With currently available commercial DOI systems there is insufficient channel 
count to densely cover the entire head with sources and detectors; consequently, the only 
way to sample the entire cortex was to create a sparse array. As the most likely site of 
PAIS injury is the MCA, the richest data generally came from channels sampling the 
frontal and parietal cortical regions. A custom-made array to sample the MCA territory 
could have been designed. However, the repercussion of this approach is that stroke 
located in other brain regions, will be insufficiently sampled. This would decrease the 
possibility of providing information on an individual patient basis. There is ongoing 
research in the field of high-density DOI systems (see section 7.2 of chapter 7 for further 
details). 
This part of the thesis is one of very few evaluating PAIS using DOT in the acute 
phase of the perinatal stroke, and to current knowledge, it is the first to assess inter-
hemispheric connectivity in stroke-affected infants using a multichannel, whole-head 
DOT-EEG system. However, this project is limited by the small number of subjects, 
sparse channel arrangement, and lack of access to peripheral physiology data. However, 
the inter-hemispheric correlation results, warrant further investigations to develop 
definite conclusions regarding the potential for early monitoring and detection of PAIS. 
These findings could serve as the basis of a larger study in establishing DOT as an early 
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diagnostic tool of PAIS at the cot-side, one which would complement the existing neuro-
monitoring and neuro-imaging tools to inform clinical management and prognosis. 
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7.1 Summary of Conclusions 
This thesis has presented certain encouraging results in the field of simultaneous DOT 
and EEG investigation of neonatal term brain injury with a focus on HIE and PAIS. The 
results have hopefully contributed to a better understanding of these clinical entities and 
associated neurophysiological phenomena such as seizures and burst suppression.  
This project demonstrated the feasibility of studying critically ill infants in their 
first few days of life by the cot side, without interfering with acute clinical care or causing 
any adverse reactions. The methodology of combined EEG and multi-channel continuous 
wave DOT application proved to be safe, non-invasive, available out of hours, and 
portable to the cot side.  
As shown, in the case study published by our group (365), DOT and EEG can be 
used to capture neonatal seizures and investigate the associated cortico-vascular 
fluctuations of HbO2, HHb and HbT. This was an encouraging first step in recognising 
some of the haemodynamic changes occurring during a seizure on an infant’s cortex. 
However, there was little reproducibility of this data in the later part of this project as 
described in my thesis in chapter 4. Although it was incredibly challenging to time and 
capture seizure activity in an infant at risk, in 1 to 4-hour recordings, such data were 
collected from 4 patients. During these recordings, some changes in the concentration of 
mainly HbO2, HbT and less of HHb were noted. Some of the features of these changes 
were unlike the typical functional stimulation response seen in infants (457, 458). On the 
contrary they were of an amplitude greater than the typically observed in healthy infants 
(305, 316). However, the recordings were overall heavily corrupted with artefact, thus 
minimising their contribution to substantial analysis and reproducibility of the original 
data seen in the case study (365). The artefacts noted were not always patient-related or 
seizure related as one would expect (as this was the case for patient 24). In one recording 
there was a harmonic oscillation which could be attributed to electrical interference (in 
patient 15). In two other recordings, there was a slower superimposing artefact which 
seemed to be synchronised with the periodic inflation of the cooling mattress the patient 
was wrapped in (patient 18 and 20). These events coincided with either seizure onset or 
offset, thus making the extraction of the haemodynamic response challenging.  
The first ever images of the cortical haemodynamic changes associated with burst 
suppression in the clinical background of neonatal HIE were published during this 
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research project (408). A significant increase in the HbO2, HbT, and HHb concentrations 
was noted in response to burst activity. This again did not follow the expected functional 
stimulation response in infants. The observed changes could potentially be attributed to 
either insufficient supply to meet the metabolic demand of the injured tissue or part of the 
developmental processes occurring in the neonatal period. The increased spatial 
resolution of multichannel DOT, revealed spatiotemporal characteristics of the 
haemodynamic changes across the neonatal cortex which in a retrospective analysis, 
appeared to be associated with pathological findings in the patient’s own MRI. However, 
there is still the requirement for methodological development in establishing image-based 
statistical approaches comparable to the ones used in other means of functional neuro-
imaging.  
In the investigation of PAIS, there was a consistent deviation of the stroke-
affected patients’ mean interhemispheric correlation from the 95% CI of the 
interhemispheric correlation values of all controls in HbO2 and HHb low frequency 
oscillations. These results were consistent and somewhat independent to MRI-guided 
stroke localisation as the results were similar in both the ROI-channel and blind-channel 
selection groups. A variation in the mean interhemispheric correlation values amongst the 
patients suggested that the interhemispheric correlation is much lower in cases of large 
unilateral lesions. However, one must err on the side of caution as the total number of 
patients was only 4 in total. The results indeed originated from a very small number of 
patients, principally because of the relative scarcity of PAIS patients.  This could still be 
an initial step towards further research in the development of a DOT-based methodology 
that can complement the existing diagnostic methods in the early detection of perinatal 
stroke. The small number of patients in combination with a relatively sparse whole head 
array were the main challenging factors in this part of the thesis.  
The key issues and challenges identified in this thesis are described in section 7.2 
alongside suggestions on how to improve the methodological approach and 
reproducibility of this research.   
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7.2 Challenges and Methodology Development 
The key challenges during the conduction of this research and different aspects of this 
study were the following: motion artefact, physiological parameters that may affect or 
contaminate the optical signal, design and density of the array, lack of image-based 
statistical approach to the methodology and number of patients. This section attempts to 
address some of these key issues.  
One of the most significant issues in acquiring DOT data is the impact of motion 
in signal quality. As one may imagine, and as shown in the previous chapters, this is even 
more challenging when performing infant studies. Even subtle movement between the 
optical fibre and the scalp can cause changes of high amplitude in the optical signal that 
only cease as the movement stops. Slight variation in the force applied upon an optical 
fibre against the skin affects the intensity measurements significantly, and the same 
applies to the presence of hair. As described in the methodology there are ways to 
overcome motion artefacts. One way to avoid or minimise the occurrence of motion, is to 
make sure the infant is in a comfortable position, ideally in the postprandial phase 
(especially in the case of a healthy term infant), asleep or quiet. Prior to the beginning of 
the recording, it is also important to arrange the headgear and optical fibres in an optimal 
position to avoid their movement during the study. In the pre-processing phase one may 
proceed to careful visual inspection and manual rejection of artefact-corrupted periods. A 
last option is to apply post-processing methods for filtering artefacts (374). Most DOT-
based studies use all the above-mentioned ways to identify artefact-free epochs whilst 
there are ongoing advances in motion artefact rejection (459, 460).  
However, there are occasions where movement is inevitable, for instance if the 
infant is seizing (as seen in chapter 4). As described previously, clinical seizures in infants 
are often subtle, and most frequently detected retrospectively by video-EEG. A possible 
way of addressing this would be to include an accelerometer (or other motion sensor) into 
the existing DOT headgear. All the above notions could be maintained in minimising 
motion with the added advantage of being able to separately capture any movement of 
the head whilst acquiring the data. This would allow fully automated detection of motion-
related events and thus aid the artefact filtering processing.   
A different type of artefact identified in the group of patients with seizures during 
the recordings raised different questions as to what the potential effect on surrounding 
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factors to data acquisition and the optical signal is.  In chapter 4, a re-occurring slow wave 
in the optical signal was observed. This was noted in two patients (patient 18 and 20) who 
were undergoing hypothermia at the same time. This artefact coincided with the inflation 
and deflation of the cooling mattress that the patients had wrapped around them (see 
Figures 4.3.8, and 4.3.10-11). The patients’ torso upper and lower limbs were wrapped 
within the mattress, whereas the head was exposed as the elastic headgear was applied. 
The head part of the cooling mattress was still lying underneath the patients head with the 
headgear applied on. There was increase of the optical signal from the baseline with the 
inflation of the mattress and decrease relevant to the baseline with the deflation of the 
mattress. These changes coincided with either the onset or offset of seizure events making 
the extraction of the haemodynamic response to seizure activity challenging. One theory 
that could explain this, is that as the mattress was inflating there was slight head 
movement. However, the observed morphology of this change in the optical signal was 
slower than the one expected to be associated with a motion-related artefact (see Figures 
4.3.8, and 4.3.10-11). Another theory that could explain this phenomenon is that the 
inflation and deflation of the mattress causes arterial blood pressure changes observed as 
cortico-vascular changes in a hypoxic encephalopathic patient with presumed altered 
cerebral autoregulation.  
To explore the above-mentioned theory there are a lot of questions that remain 
unanswered and require further development of the technology for any justifiable 
conclusions to be reached. The assessment of any movement of the head could be 
addressed with the use of an accelerometer applied onto the headgear as described 
previously. The assessment of any peripheral changes such as changes in arterial blood 
pressure or heart rate is challenging if there is no simultaneous ongoing monitoring of 
these parameters during data acquisition. For future projects, continuous monitoring of 
physiological parameters such as heart rate, respiratory rate, SaO2 and arterial blood 
pressure should be considered as a requirement. It improves the understanding of cortico-
vascular changes observed and informs the analysis. And finally, is it possible that the 
observed changes are not reflective of cortical changes but more superficial tissue 
changes?  
A frequent issue in DOT data acquisition and analysis is the contamination of the 
signal by vascular activity in the layers of extracerebral tissue. Light must penetrate 
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several layers of tissue before reaching the brain, including the skin and skull. 
Physiological changes, such as those due to heart rate, blood pressure or respiration, 
occurring within these superficial tissues may contaminate the signal. Recent work shows 
that the use of short source-detector NIRS channels (<15 mm), (which are used to 
measure haemodynamics of the scalp alone rather than cortical signal) can be used to 
improve the brain-specificity of NIRS and DOT measures (see Fig. 2.2.10). Further 
analytical methods such as signal regression (346, 461, 462), independent component 
analysis (ICA) (463) or principal component analysis (PCA) (464, 465) can be utilised to 
calculate and hence eliminate the cortico-vascular changes attributed to superficial layers 
of the head. The process of DOT image reconstruction (as mentioned in chapter 2 and 3) 
includes the separation of signals arising from the separate superficial structures over the 
brain tissue (351). Therefore, the presence of short separation channels onto the head 
array during data acquisition would further inform signal analysis and should be 
considered in further developing this DOT-EEG technique. Furthermore, in situations like 
the presumed “artefact” seen secondary to the cooling mattress, the presence of short 
separation channels would clarify whether this could be a response to changes in 
superficial vasculature.  
The whole-head array used in the project was designed to capture seizure activity 
arising from different areas of the cortex. The arrangement of the sources and detectors 
was chosen to maximise head coverage and provide good quality signal without the 
optical fibres being arranged too sparsely. DOT requires the use of relatively large source-
detector separations to provide sensitivity to deeper regions of the tissue. This sparsity 
affects the spatial resolution of the final DOT images. However, denser arrays with 
source-detector separations down to <15 mm have been described in the literature (466). 
It is anticipated that the limiting trade-off between channel count and cortical coverage 
will disappear in the next few years as HD-DOI systems become more widely available. 
Indeed, the first diffuse optical images of cortical activation that parallel the spatial 
resolution and accuracy of BOLD fMRI have recently been reported (467).  
A denser array could have been achieved with the system employed in this thesis. 
For instance, if the cortical target is well known, one may increase the density of the 
optical fibres by sacrificing a wider field-of-view. In the case of perinatal stroke, a denser 
array could be designed, thus addressing the primary areas of interest. As the most 
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frequent location of perinatal stroke is the MCA territory, one could target high density 
coverage of these cortical regions. However, targeting very specific brain regions would 
increase the risk of missing stroke in the ACA territory or in the posterior fossa. On the 
other hand, the possibility of using a HD-DOT system would maximise the coverage of 
the stroke region whilst sampling the whole head.  
Continuous wave DOT systems are simple, portable, inexpensive, and able to 
provide images with a good spatiotemporal resolution. One of the challenges in data 
acquisition, is the large number of optical fibres between head gear and device. This 
inevitably is accountable for movement and friction between the fibres and the scalp, thus 
that any minimal movement of the infant’s head may introduce artefact. Having discussed 
various ways of extracting motion related artefacts, it is worthwhile mentioning at this 
point that different  groups, , including the UCL BORL group, are in the process of 
creating wireless, wearable fNIRS systems, with the first HD-DOT images from adult 
functional studies recently published (468, 469). This offers the potential of advanced 
fNIRS systems to be used in cognitive tasks performed in normal daily life (331). This 
widens the research horizons allowing longer continuous recordings both on healthy 
controls and critically ill subjects. 
Diffuse optical tomography allows image reconstruction of the human cortex. The 
accuracy of the images reproduced significantly relies on the head model used. The model 
applied in this thesis for image reconstruction, is based on a 4D neonatal head atlas 
(http://www.ucl.ac.uk/medphys/4dneonatalmodel) (404). This was developed by the 
UCL BORL. It consists of an infant anatomical brain atlas based on an MRI image 
database of 324 infants between 29 to 40 weeks of gestational age. This indeed offers a 
good basis for group analysis. However, when it comes to looking at spatial 
characteristics of the cortico-vascular changes at rest or in pathological situations, on an 
individual basis, there is a certain degree of approximation of the calculations and 
reproduced images. Obtaining the subject’s individual MRI would optimize the 
representation of spatial characteristics of the cortico-vascular changes (355, 365).  
Another significant challenge in DOT is that the methodological approaches used 
for image-based analysis require further development. Due to fundamentally different 
characteristics and signal to noise ratio between the two technologies, immediate 
application of the statistical methods used in fMRI can be inappropriate. However, in this 
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thesis a general linear model (GLM) approach was used to extract the haemodynamic 
response to EEG bursts. As in fMRI statistical analysis, there are statistical parametric 
mapping (SPM) tools using a GLM approach to yield statistical maps. These have 
similarly been used in fNIRS for image reconstruction  (470). However, there is still the 
need for ongoing assessment and refinement of these techniques to account for certain 
noise characteristics of DOT data prior to their full integration to DOT image 
reconstruction (471).  
Additionally, to the above-mentioned challenges in DOT data the, there remains 
the limitation of absolute quantification of HbO2 and HHb concentrations. Without 
additional information regarding the optical properties of the interrogated tissues, CW-
DOT devices can only provide relative measurements of the observed cortico-vascular 
changes, rather than absolute measurements of the chromophore concentration. More 
advanced optical systems can provide both quantitative measurements and a better 
understanding of the optical properties of the investigated tissue such as time domain 
fNIRS systems (for details see section 2.2.4 of chapter 2) (350, 472-474). However, 
compared to CW-DOT systems, they remain expensive. Although they are portable, they 
are often physically large, which makes them less suitable for neuro-imaging in the 
neonatal intensive care unit. They are sensitive to movement and stability of their laser 
alignment making them less easy to use. With the development of relatively low cost 
single photon avalanche detectors (SPADS), the cost and size of time-domain devices 
will likely be minimised, allowing these technologies to also become wireless and 
wearable in the coming years (475).  
Finally, one of the main issues in this study has been the numbers of patients 
studied. Given the frequency and nature of some of the conditions investigated, for 
instance perinatal stroke, the recruited numbers are expected to be low. However, ways 
to improve this in the future is to consider communication of research studies to satellite 
referring units to facilitate the consenting process. Another possibility is to consider 
seeking ethics approval for consenting over the telephone. This would improve the 
recruitment in the acute phase when targeting acute admissions of infants presenting with 
seizures.  Most of the infants presenting with seizures that were recruited in this study, 
were referred from other units and transferred in frequently without their parents being 
present in the first hours or days of admission to the unit.  This attempt will require careful 
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consideration, but it would potentially improve the consenting and recruiting process. 
Another possibility would be to consider running such studies on a multi-centre basis. 
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7.3 Future Directions 
As this project comes to its end, it is natural to contemplate how it has contributed to 
research and what the next step would be in its further evolution. Overall, this project has 
shown DOT-EEG to be a safe, cot-side method to study critically ill infants, without 
interference in their clinical care and any adverse events during its conduction. It has 
shown the potential of CW-DOT in exploring the neurovascular coupling of seizures, and 
burst suppression, and investigating perinatal stroke in relation to physiological, low 
frequency, haemodynamic oscillations. This has broadened the horizons of infant optical 
neuro-imaging studies and provided new knowledge regarding brain injury in the 
neonatal term population. It has also highlighted certain challenges in the investigation of 
the above-mentioned patient groups and clinical entities which were summarised above, 
in section 7.2, alongside suggestion for further development of the technology, 
recruitment, data acquisition, and analysis.  
Following the results and challenges identified in this thesis, there is scope for 
ongoing investigation in the field of neonatal seizures, neurophysiological phenomena, 
and perinatal stroke. The key areas of future investigations identified are described in the 
following paragraphs.  
The notion of cortical spreading depression or depolarisation (CSD) is one that is 
better defined in adults and considered to be associated with brain injury (397), head 
trauma (476), stroke (477), migraine with aura (478), and seizures (479). CSD is 
described as a wave of electrical hyperactivity followed by relative inactivity across the 
neurons and glial cells, occurring at a speed of 2 to 9 mm/min across the cortex (480, 
481). Santos et al., more recently published images of the CSD phenomenon in male 
swine models under deep anaesthesia with intrinsic optical imaging demonstrating waves 
of spreading depolarisation varying according to the surface of the gyri, sulci and pial 
vessels (482). The observed prolonged decrease in HbO2 and HbT lasting for a few 
minutes after the excitation, in this instance of seizure activity (365) mimics the 
morphology of CSD. Based on this theory and as to whether the observed cortico-vascular 
response to seizure activity in infants could be secondary to CSD, the methodology of 
DOT-EEG could be applied on an animal model. This would allow a controlled prolonged 
observation of neurovascular coupling of induced seizure activity.  
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Elevation of the baseline optical signal suggesting increase in HbT, observed in 
patients undergoing TH, and coinciding with the periodic inflation of the cooling 
mattress, suggested a potential impact of the restraining of limbs to arterial blood pressure 
and subsequently cortical vasculature in situations of impaired CA. The fact that this was 
observed in very few patients amongst the group undergoing TH further supports the 
above-mentioned notion. However, further refinement of the technique is required and 
more specifically the addition of short separation channels (as described in section 7.2) 
to elucidate potential corruption of the signal from superficial layers. This in combination 
with the synchronous acquisition of physiological parameters such as heart and ABP 
could facilitate the understanding of the impact of therapeutic hypothermia in the cortical 
vasculature.  
As described in chapter 6, refinement of the methodological approach and image-
based analysis are the main two areas towards improving the investigation of perinatal 
stroke. With HD-DOT systems becoming more widely available in the years to come, a 
denser array could be developed for the exploration of stroke in the neonatal period. Such 
an evolution of the technology could potentially lead to reproduction of the presented data 
in this thesis on a limited number of patients and lead to a multicentre study on perinatal 
stroke. At present, TH remains the principal neuroprotective treatment of neonatal brain 
injury following HIE with significant reduction in lifelong neuro-disability (43, 44), with 
a recent systematic review showing its benefits on patients and reduction of mortality 
without increasing the risk of disability (483). Therefore, it has been debated in the 
literature as to whether its beneficial effects, such as reduced metabolic demand and 
reduced free radical and reactive oxygen species (ROS) formation, can be translated in 
other forms of ischaemic injury such as perinatal stroke (85, 86) (for review see reference 
(484)). The evolution of DOT and its potential future as a cot-side, neuro-imaging tool in 
the NICU, could facilitate clinical trials in perinatal stroke. 
The fundamental techniques employed in this project are directly transferable to 
the preterm neonatal population. This could form the basis of a study in preterm infants 
in the future. There are two main trajectories which could be investigated with 
simultaneous DOT-EEG in preterm infants: an investigation of the haemodynamic 
correlates of developmental changes in their EEG and an investigation of seizures in the 
pre-term neonatal population.  
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As described in chapter 2 (see section 2.1.4), the neonatal EEG differs between 
different gestational ages at birth and similarly matures as the infant reaches term 
equivalent age. Studies of neonatal EEGs have provided the research community with 
wealth of knowledge regarding the behaviour and phenomenology of neonatal brain 
activity (179, 190, 203, 485). One of the main characteristics of preterm neonatal EEG is 
its discontinuity, which resembles the appearance of burst suppression with alternating 
periods of inactivity and burst like activity. As the infant matures from prematurity to 
term, the periods of inactivity shorten, and the EEG progressively becomes continuous. 
Most of the emerging features of EEG maturation are noted in active sleep, rather than 
quiet sleep, with the latter remaining a period of relative inactivity up to 34-36 weeks of 
postconceptional age (trace alternant-for further details see section 2.1.4). Similarly, to 
the investigation of burst suppression (see chapter 4), combined DOT-EEG could be 
applied in the study of neurovascular coupling of discontinuous neonatal EEG. Coupling 
to this burst-like activity of preterm EEG has been shown before using NIRS (363). 
However, the methodology described in this thesis could provide further spatiotemporal 
information regarding preterm neuronal activity and lead to image reconstruction of the 
associated haemodynamic changes. Additionally, longitudinal follow-up with scans of 
extreme preterm infants (born below 28 weeks of gestation) could help identify any 
maturational process in the cortico-vascular activity in line with the described and well 
established evolution of the electrical brain activity (203). Considering distinct occipital 
characteristics in the neonatal EEG as well as the excess of motion artefact when studying 
well preterm infants, a denser array and ideally wireless technology would facilitate such 
as a project. The basis of the technology, and analysis would be similar with the advantage 
of a wireless, HD-DOT system.   
Finally, simultaneous DOT-EEG could be applied in the study of seizures 
amongst preterm infants at risk. There is debate as to the frequency of seizure occurrence 
in the preterm population with certain studies showing a low incidence using continuous 
EEG monitoring (486) as opposed to a high incidence using aEEG (487). Nevertheless, 
there is great variation in such studies based on the population selection, investigating 
tools, access to expertise in neonatal neurophysiology and level of neonatal care (regional, 
tertiary as opposed to smaller, lower intensity units). Single centre studies have shown an 
incidence of up to 48% in low birth weight infants (birth weight of less than 1,500 grams) 
(488-490). A recent multicentre study considered the incidence and characteristics of 
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seizures in preterm infants as well as in comparison to term infants. Amongst 611 infants 
being diagnosed with seizures, 92 were preterm (born with a GA of less than 37 weeks), 
with main aetiological factors being HIE and intracranial haemorrhage. The incidence of 
subclinical seizures and the overall mortality were significantly higher in the preterm 
versus the term population (24% versus 14% and 35% versus 15%, respectively) (491). 
This highlights the importance of monitoring, but also the significance of further 
investigation of underlying physiology and mechanisms with the help of simultaneous 
DOT-EEG. The fact that the haemodynamic signal in response to seizures in the HIE 
infant appeared of high amplitude was easily observed within the raw optical trace (365), 
also poses the potential of DOT aiding in the primary identification of seizures.  
Most importantly though, in all the above suggested potential future projects, 
there is the requirement of correlating the observed phenomena or results to long term 
neuro-developmental follow up at 2 years of age and ideally at 5 years of age. This study 
works as a basis of observed phenomena which could be reproduced in future projects 
and explain as to what they may mean with regards to the future neurological status and 
cognitive function of the patient. The presence of outcome data could help justify further 
development of the DOT-EEG technology as a neuro-monitoring tool in the NICU. 
In conclusion, this study has demonstrated the feasibility of DOT-EEG to be used 
at the cot side, revealing novel physiological information and potentially contributing as 
an early detection tool. More importantly, though, it has highlighted the main challenges 
and key areas to be addressed towards the use of this methodology for future studies. 
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Index of Abbreviations 
2D: two-dimensional 
3D: three-dimensional 
AA: arachidonic acid 
ACA: anterior cerebral artery 
ADC: Apparent Diffusion Coefficient 
aEEG: amplitude integrated EEG 
AS: active sleep  
ASL: arterial spinning labelling  
ATP: adenosine triphosphate 
AW: active wakefulness  
BGT: basal ganglia and thalamus 
BOLD fMRI: blood oxygen level dependent functional magnetic resonance imaging 
BORL: Biomedical Optics Research Lab 
BP: blood pressure 
BW: birth weight  
Ca++: calcium 
CA: cerebral autoregulation 
CBF: cerebral blood flow 
CBV: cerebral blood volume 
CCA: common carotid artery 
CFM: cerebral function monitor 
CGA: corrected gestational age 
CMRO2: cerebral metabolic rate of oxygen 
  Index of Abbreviations 
 
303 
 
CNS: central nervous system  
COOL-AID: cooling for acute ischaemic brain damage 
CP: cerebral palsy 
CPAP: continuous positive airway pressure 
CRP: c-reactive protein (normal when <1) 
CrUS: cranial ultrasonography  
CSD: cortical spreading depression 
CSF: cerebro-spinal fluid 
CSVT: cerebral sinus venous thrombosis 
CTG: cardiotocogram (foetal heart rate monitoring device) 
CT: computed tomography  
CtOx: cytochrome c oxidase 
CUH: Cambridge University Hospitals 
CW: continuous wavelength 
DoH: Declaration of Helsinki 
DOI: diffuse optical imaging 
DOT: diffuse optical tomography 
DPF: differential pathlength factor 
DQ: developmental quotient 
DWI: diffusion weighted imaging  
ECG: electro-cardiogram  
ECMO: extracorporeal membrane oxygenation  
EEG: electro-encephalogram 
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EMG: electro-myogram  
EmLSCS: emergency low segment Caesarean section 
EOG: electro-oculogram  
EPIC: Evelyn Perinatal Imaging Centre 
EPSP: excitatory post-synaptic potential  
FEM: finite element method 
FFT: fast Fourier transform 
fMRI: functional magnetic resonance 
fNIRS: functional near-infrared spectroscopy 
FSE: Fast Spin Echo 
FSL: FMRIB Software Library  
GA: gestational age at birth in weeks /40 weeks of expected normal pregnancy duration  
GABA: γ-aminobutyric acid 
GBS: group B streptococcus (Streptococcus agalactiae) 
GDM: gestational diabetes mellitus 
GLM: general linear model 
Hb: haemoglobin 
HbO2: oxy-haemoglobin 
HHb: deoxy-haemoglobin 
HbT: total haemoglobin 
Hbvol: volume haemoglobin 
HFNC: high frequency nasal cannula 
HFOV: high frequency oscillatory ventilation 
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HIE: hypoxic ischaemic encephalopathy 
hpf: high pass filter 
HPI: haemorrhagic parenchymal infarct 
HR: heart rate 
HRF: haemodynamic response function 
IBI: inter-burst interval 
ICA: independent component analysis 
ICTus: intravascular cooling in the treatment of stroke 
iNO: inhaled nitric oxide 
IOL: induction of labour 
IPSP: inhibitory post-synaptic potential  
IQR: interquartile range 
IUGR: intrauterine growth restriction  
IV: intravenous 
IVH: intraventricular haemorrhage 
K+: potassium 
LEOG: left electro-oculogram  
LFOs: low frequency oscillations 
LMWH: low molecular weight heparin  
lpf: low pass filter 
MABP: mean arterial blood pressure 
MCA: middle cerebral artery 
MRA: magnetic resonance angiography 
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MRI: magnetic resonance imaging 
MRS: magnetic resonance spectroscopy 
Na+: sodium 
NAA: N-acetyl-asparate 
NE: neonatal encephalopathy 
NGT: nasogastric tube 
NICU: neonatal intensive care unit 
NIR: near infrared  
NIRS: near infrared spectroscopy 
NMDA: N-methyl-D-asparate 
NO: nitric oxide 
No resus: no resuscitation required at birth 
OEF: oxygen extraction fraction  
PAIS: perinatal arterial ischaemic stroke 
PASL:  pulsed arterial spinning labelling  
PCA: posterior cerebral artery 
PCA: principal component analysis 
PCr: phosphor-creatinine 
PC-MRA: phase contrast magnetic resonance angiography  
PET: positron emission tomography  
PLIC: posterior limb of the internal capsule 
PMDF: photon measurement density function  
PPHN: persistent pulmonary hypertension of the newborn 
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PROM: prolonged rupture of membranes >24 hours prior to delivery 
PSP: post-synaptic potential  
PVL: periventricular leukomalacia 
QS: quiet sleep  
QW: quiet wakefulness 
rCBV: regional cerebral blood volume  
REM: rapid eye movement  
REOG: right electro-oculogram  
RI: resistance index 
ROI: region of interest 
ROS: reactive oxygen species 
RR: respiratory rate 
RS: resting state 
RSFN: resting state function network 
rSO2: regional cerebral oxygen saturation 
SaO2: oxygen saturation  
SAT: spontaneous activity transient  
SE: Spin Echo  
SIMV: synchronized intermittent mandatory ventilation 
SNR: signal to noise ratio 
SVD: spontaneous vaginal delivery 
SVIA: self-ventilating in air 
TA: tracé alternant 
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TCD: transcranial doppler 
TD: trace discontinu 
T2-FSE: T2-weighted fast spin echo 
TH: therapeutic hypothermia 
TOAST++: time-resolved optical absorption and scatter tomography 
TOBY: TOtal BodY therapeutic hypothermia for perinatal asphyxia 
TOI: tissue oxygenation index 
TPSF: temporal point spread function 
TTTS: twin to twin transfusion syndrome  
UCL: University College London 
Vg: volume guarantee 
VL: very low  
VLFOs: very low frequency oscillations  
WMA: world medical association 
Xe: xenon 
 
